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SUMMARY
A number of Pasteurella haemolytica isolates from cattle and sheep, 
including representatives of all serotypes and untypables, was examined for 
leukotoxin (LktA) production at the end of the log phase of growth in brain-heart 
infusion broth. The bacteria produced most toxin with very high and high 
aeration, at 37 °C, in a low concentration of NaCl and at alkaline pH (pH 8). 
There were marked differences in leukotoxic activity in culture supernate 
samples, as measured by chemiluminescence-inhibition assays with bovine and 
ovine neutrophils, even between strains of the same serotype. There was also 
some variation in the amount and mol. wt of the LktA protein produced by 
different strains, as judged by SDS-PAGE, immunoblotting and ELISA. Some 
strains produced normal amounts of LktA protein which had only low leukotoxic 
activity. Most strains (28/32) produced LktA of 105 kDa whereas four strains 
produced a higher mol. wt form of c.108 kDa, including two of the five serotype 
A2 strains examined. Thus, the P. haemolytica isolates showed considerable 
heterogeneity in terms of leukotoxin production, mol. wt and activity, even 
within a given serotype. Serial passage of P. haemolytica did not affect the 
production of leukotoxin (LktA). The mol. wt of LktA was more than 300 kDa 
as judged by ultrafiltration, due presumably to aggregation. Attempts to 
disaggregate LktA with SDS, zwittergent, EGTA and urea were not successful.
Although P. haemolytica can produce LktA in the absence of calcium, for 
activity of LktA, calcium was found to be necessary. Active and non-activated 
rLktA was prepared after transformation of IktA and IktC  genes into different 
strains of E. coli. The biological activities of active recombinant LktA were the 
same as that of native LktA, but the amount of leukotoxin obtained from E. coli 
was greater than that from P. haemolytica.
xxvii
Although previous reports had shown that LktA affected and killed only 
ruminant leukocytes, in this study it was found that LktA had different effects on 
ruminant and non-ruminant neutrophils. Leukotoxin killed ruminant neutrophils 
and bovine lymphoma (BL3) cells by cell swelling and lysis, but it had no effect 
on rabbit and guinea pig neutrophils and a mouse macrophage cell line (J774.2). 
Surprisingly, native and recombinant LktA partially inhibited the CL response of 
human neutrophils, although it did not kill the cells. This partial inhibition was 
due to leukotoxin and not to other components of bacteria such as LPS. Slightly 
different results were found by a cell tracking assay in which the neutrophils 
were incubated with active and non-activated recombinant LktA. The active 
toxin killed bovine neutrophils, but caused the migration of human neutrophils. 
However, the same concentration of non-activated rLktA had no effect either on 
CL response or movement of human neutrophils. The reason why LktA 
promoted movement of human neutrophils, but partially inhibited the CL 
response deserves further investigation as it suggests two opposing effects of 
LktA i.e. inhibition of chemiluminescence and production of cell movement.
Although non-activated leukotoxin had no effect on CL response of different 
ruminant and non-ruminant target cells, it bound to these cells in a similar way to 
that of the active form of rLktA. The active and non-active LktA bound to target 
cells at 4 °C, but to a lesser extent than at 37 °C but no lysis of ruminant cells 
was observed at 4 °C, indicating that binding and subsequent lysis can be 
dissociated and probably represent two separate events.
Different monoclonal antibodies were used in an attempt to neutralise the 
toxicity of LktA, but none of them could completely neutralise its activity. A 
polyclonal antibody raised against rLktA completely neutralised the homologous 
LktA but only partially neutralised heterologous LktA from other straiiBof P.
XXVIII
haemolytica. In contrast, bovine convalescent serum neutralised homologous and 
heterologous LktA.
In addition to its leukotoxin activity, LktA also has haemolytic activity. This 
activity is weak and variable in different isolates of P. haemolytica. Non- 
activated LktA had no haemolytic activity.
Non-activated rLktA was activated in vitro in the presence of LktC and
cytosolic activating factor (CAF). This activated toxin affect bovine neutrophils 
some
and had effect on rabbit neutrophils, as judged by CL inhibition assay. 
However, lower LktA activity was found with the m-v/fro-activated toxin than 
with m-vivo-activated rLktA.
. INTRODUCTION
IN T R O D U C T IO N 1 P A R T I
1.1 PASTEURELLA HAEM OLYTICA-THE ORGANISM
1.1.1 History
According to the present classification, the ‘Family Pasteurellaceae' 
consists of three genera of Gram-negative, facultatively anaerobic and 
fermentative bacteria, namely: Actinobacillus, Pasteurella and Haemophilus 
(Mannheim, 1984). The name of the genus Pasteurella  was proposed by 
Count Trevisan in 1887 (cited by Carter, 1984) in recognition of the work of 
Louis Pasteur, the early investigator of fowl cholera epidemics in turkeys. The 
early classification of members of the genus was based on the place of 
isolation, the type of lesion found in the particular animal or the person who 
worked with them. Currently, six species are recognised; P. multocida, P. 
pneumotropica, P. ureae, P. gallinarum, P. aerogenes and P. haemolytica 
(Carter, 1984; Mutters et a i ,  1986). These species are differentiated by their 
ability to produce beta haemolysis, growth on MacConkey's agar, indole 
production, urease activity, gas from carbohydrates and acid production from 
lactose or mannitol.
Pasteurella strains have also been examined by other techniques such as 
DNA/DNA hybridization, 2-dimensional protein electrophoresis and rRNA 
sequence analysis which have resulted in a proposal for a new classification of 
Pasteurella into 11 species in the genus Pasteurella sensu stricto (Confer, 
1993). With these methods, a number of subspecies of P. multocida are 
recognised and these tend to be relatively animal-species specific. In fact, 
rRNA analysis has suggested that P. haemolytica may not even belong in the 
genus of Pasteurella sensu stricto (Dewhirst et a l ,  1992).
Pasteurella species are Gram-negative, ovoid or rod shaped 0.25-0.4 J im  
in width and 0.6-2.5 pm in length, non-motile, catalase-positive, facultative
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anaerobic, gelatinase-negative and commonly show bipolar staining (Carter,
1984).
P. multocida is an important pathogen of animals and man. Although 
found in the nasopharynx of clinically healthy animals as a part of the normal 
nasal flora, it can cause a number of diseases such as fowl cholera in birds and 
haemorrhagic septicaemia in cattle. Apart from having an endotoxin (LPS) 
similar to that of other Gram-negative bacteria, some strains produce a protein 
toxin that is lethal for mice, guinea pigs, swine and turkeys. This species is 
often pleomorphic, with bipolar staining, but is usually in the coccobacillary 
and rod form (Carter, 1984).
P. pneumotropica is a commensal in the upper respiratory tract of 
laboratory animals including mice, rats and guinea pigs and produces disease 
in ducklings as well as turkeys. This bacterium grows on blood agar but does 
not produce haemolysis (Carter, 1984).
P. ureae is infrequently found in the respiratory tract of healthy humans 
and it can occasionally produce disease (Mannheim, 1984). Medium with 
blood or serum is best for growth of this bacterium (Carter, 1984).
P. gallinarum cannot grow on MacConkey’s agar and does not produce 
haemolysis on blood agar. This species is isolated from chickens and turkeys 
(Hall e ta l ,  1955).
P. aerogenes can grow on MacConkey’s agar but it cannot grow on 
Salmonella-Shigella agar. It is non-capsulated and does not produce visible 
growth at 25-28 °C in 24 hours. The organism occurs in domestic swine and 
wild boars and is only seldom isolated from man (Frederiksen, 1989).
Another organism, P. anatipestifer occurs worldwide in both domestic 
and wild birds. Although strain P-2361 (serotype 7) of P. anatipestifer 
produces haemolysis in blood agar, haemolysis is not a normal characteristic 
of this species (Brogden et a i , 1989). This is a non-fermentative organism and
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does not properly belong in the genus of Pasteurella, according to Carter 
(1984).
The first observations on P. haemolytica were reported by Jones (1921) 
after studying bovine bacterial isolates. He divided these isolates into three 
groups and located atypical strains in group one. This group fermented 
lactose, maltose and mannitol and did not produce indole. In 1932, Newsom 
and Cross isolated organisms similar to this group from sheep and cattle and 
named them P. haemolytica (cited by Mutters et a l ,  1989)
1.1.2 Characteristics of P. haemolytica
P. haemolytica is a part of the normal nasal flora of cattle and sheep and 
is widely distributed in the ruminant population (Gilmour, 1980; Frank, 1989). 
This species has also been isolated from milk and the female genital tract 
(Gilmour, 1980; Carter, 1984).
Although bovine respiratory disease is due to a complex interaction of 
environmental factors or etiological factors that can involve various viral and 
bacterial pathogens, P. haemolytica is one of the most important factors in 
acute pneumonia in feedlot cattle. It is also the cause of economically 
important diseases in sheep (Thomson, 1980; Gilmour, 1980). P. haemolytica 
has a cytotoxic effect on leukocytes of ruminants and there are two biotypes 
and 17 serotypes that are differentiated by their fermentative activity, 
pathogenicity and serological characteristics.
P. haemolytica is Gram-negative, rod-shaped, non-motile, facultatively- 
anaerobic, oxidase-positive, indole-negative, urease-negative and shows the 
property of slight pleomorphism and occasional bipolar staining. A zone of 
haemolysis is produced around the colonies of fresh isolates. After many 
subcultures, this zone may be reduced or lost. A double zone of haemolysis on
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lamb's blood agar is a characteristic feature. Colonies that grow on blood agar 
are round and greyish.
P. haemolytica grows on MacConkey's agar and produces small, round, 
pink to red colonies. Although, the optimum temperature for growth is 37 °C, 
these bacteria can grow between 25 °C and 40 °C (Carter, 1984). Large 
numbers of fimbriae and an extensive anionic glycocalyx have been 
demonstrated at the surface of P. haemolytica A1 (Morck et a l ,  1987).
The first analysis of DNA of P. haemolytica revealed that the mol % G+ 
C was 42.3-43.6 (Carter, 1984). However, Lo (1992) showed that the mol % 
G+C is 38.5%, after analysis of approximately 17 kbp of nucleotide sequence 
from three regions of the genome of P. haemolytica Al. This difference is 
probably due to certain regions in the DNA of this bacterium containing a 
much higher mol % G+C.
1.1.3 Biotypes and serotypes
Various techniques have been used to differentiate strains of P . 
haemolytica. For biotyping, the methods have included cultural and 
biochemical behaviour, antimicrobial resistance (Smith, 1961), gel diffusion 
(Muraschi et al., 1965), SDS-PAGE patterns (Thompson and Mould, 1975), 
growth inhibition (Olmos and Biberstein, 1979), agglutination by lectins 
(Craft et al., 1987) and crossed immunoelectrophoresis (Tsai et a l ,  1988).
In biotyping based on biochemical and cultural characteristics, P . 
haemolytica has been divided into two biotypes, A and T (these letters stand 
for arabinose and trehalose fermentation respectively). The A and T types also 
differ in nucleic acid homology (Biberstein and Francis, 1968) and antibiotic 
sensivity. Biotype A is more sensitive to penicillin than biotype T. In addition, 
catalase is produced by biotype A but not biotype T and untypable strains 
(Mutters e ta l ,  1986).
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Lectins are sometimes used for biotype differentiation: wheat germ lectin 
agglutinates P. haemolytica biotype T but not biotype A (Craft et al., 1987).
The principal location of biotype A in the normal host is the nasopharynx 
whereas biotype T strains tend to be found in the tonsils (Biberstein, 1978). 
Most septicemic forms of disease in feeder lambs (3-12 months old) are due to 
biotype T isolates whereas biotype A isolates are associated with pneumonic 
disease (Biberstein, 1978). Biotype A produces different effects in lambs and 
sheep. In very young lambs, it produces septicaemia and in adult sheep it 
causes pneum onia (Gilmour, 1980). These and other d ifferential 
characteristics of the two biotypes are listed in table 1.
The early serological approaches to the subdivision of biotypes were 
based on somatic and capsular antigens. The somatic antigens were suggested 
to be responsible for direct bacterial agglutination by antisera (Biberstein et 
al., 1960). Using autoclaved whole cells of 98 isolates of P. haemolytica, 13 
somatic types were recognised. The capsular polysaccharides antigens are 
presumed to play a role in the indirect haemagglutination (IHA) reaction and 
these antigens are now commonly used for serotyping (Biberstein, 1978). 
Strains that cannot be typed by indirect haemagglutination are IHA-negative 
or untypable, possibly due to a deficiency in capsular polysaccharide. 
Biberstein et al. (1960) reported that approx. 10% of P. haemolytica isolates 
from sheep and cattle were untypable. Seventeen serotypes of P. haemolytica 
have now been distinguished (Biberstein et al., 1960; Pegram et al., 1979; 
Fraser et al., 1982; Fodor et al., 1988; Younan and Fodor, 1995) and the 
relationship between biotype and serotype is presented in fig. 1. Thirteen of 
those serotypes (1, 2, 5, 6 ,7 , 8, 9 ,1 1 ,1 2 ,1 3 , 14,16 and 17) belong to biotype 
A and four (3 ,5 ,1 0  and 15) belong to biotype T.
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Table. 1
Characteristics of biotypes A and T of P. haemolytica.
Characteristics A T
Acid production from arabinose 
and xylose +
Acid production from trehalose 
and salicin +
Loss of viability of cultures fast slow
Penicillin susceptibility susceptible relatively
Colonial morphology small grey
resistant
large-
Site of presence in healthy animals nasopharynx
yellow-
grey
tonsils
Diseases and hosts pneumonia in septicemia
cattle and sheep- in feeder-
septicemia in lambs
Wheat germ lectin agglutination
nursing lambs
+
Adapted from Biberstein (1978), Carter (1981; 1984) and Craft eta l. (1987).
Xfl<B*1O
+Q<T></}
w
V!
T3<n
>3
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Although untypable strains can be found in healthy ruminants, they have also 
been isolated from animals with pneumonia (Ali et al., 1992). However, 
Gentry et al. (1988) showed that representatives of five serotypes 1, 2, 5, 6 
and 9, produced lesions when injected into the lungs of healthy cattle but an 
untypable strain did not cause extensive lesions after injection into the lungs. 
Untypable strains are found in non-ruminant animals such as rabbits, mice and 
in other sites of the body such as the genital tract, placenta, udder and intestine 
in ruminants (Biberstein et a l ,  1960; Quirie et al., 1986).
Other methods, such as OMP and lipopolysaccharide (LPS) profiles and 
immunobloting with specific antibody, might help to resolve some of the 
difficulties in conventional typing methods, especially with untypable isolates. 
It has been shown that there are clear difference in the OMP and LPS profiles 
of the different biotypes and serotypes of P. haemolytica (Ali et al., 1992; 
McCluskey et a l ,  1994). Ten LPS types and 11 OMP types of P. haemolytica 
were distinguished within a collection of serotypes A l, A2 and untypable 
strains. For example, among the serotype A l isolates, the majority (19/23) of 
isolates possessed LPS of type 1, two had type 2 LPS and two had type 3 LPS 
(Ali, 1993). However, these was no clear correlation of a particular LPS or 
OMP type in these isolates with the disease status of the host animal.
1.1.4 Plasmids
Plasmids are extrachromosomal DNA structures found in a wide range of 
bacteria (Novick, 1980) and they are sometimes associated with antibiotic 
resistance. There are many reports of antimicrobial resistance in P. 
haemolytica. Chang and Carter (1976) showed that about 92% of P . 
haemolytica isolates were resistant to streptomycin, penicillin, tetracycline 
and chloramphenicol. After a study of 35 isolates P. haemolytica from sheep 
or cattle (most of which are used in this study), Azad et al. (1992) reported
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that eight isolates (four of serotype A l, three of serotype A2 and one 
untypable) contained plasmid DNA and isolates of the same serotype had 
similar plasmid profiles. All plasmid-containing A l strains exhibited 
ampicillin resistance which was shown, by transfer studies, to be plasmid- 
mediated. These strains contained a 4.3 kb plasmid. Strain S/C 84/3 
additionally contained two other plasmids of approximately 20 kb and 2.8 kb. 
The three serotype A2 strains contained two plasmids and an untypable strain 
contained three plasmids. Neither the T4 nor T10 strains examined contained 
plasmids.
1.2 P. HAEM O LYTICA -THE DISEASES
P. haemolytica is a major cause of pneumonia in cattle and septicaemia in 
sheep. Other diseases are mastitis in ewes, arthritis and meningitis in sheep 
and lambs (Gilmour, 1980), and salpingitis in poultry (Carter, 1981). There 
are a few reports of P. haemolytica being isolated from human lesions 
(Frederiksen, 1989). The bacterium has a low pathogenicity for laboratory 
animals including rabbits and mice (Carter, 1984) but it can be pathogenic for 
mice when inoculated intraperitoneally with gastric mucin or alone 
administered intracerebrally (Smith, 1958).
1.2.1 Disease in cattle
P. haemolytica is found in the upper respiratory tract of healthy cattle 
(Gilmour, 1978; Wilkie and Shewen, 1988 ). There are many factors which 
are thought to result in pneumonic pasteurellosis, including overcrowding, 
weather, transportation, fasting or other stress and viral disease. These may 
cause a decrease in lung defences and increase the risk of infection. The most 
important serotype isolated from cattle with pneumonic pasteurellosis in 
Britain and North America is A l (Reggiado, 1979; Gibbs et a l ,  1983; Quirie
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et al., 1986). Other serotypes are reported with less frequency and 
sporadically (Wray and Thompson, 1971; Frank, 1980; Quirie et a l, 1986). 
Samples collected from the nasopharynx of non-vaccinated cows have shown 
that serotype A l was more prevalent than the other serotypes (Frank, 1985).
Fig. 2 shows the probable mechanism of pathogenesis of bovine 
pneumonic pasteurellosis caused by P. haemolytica A l. The organism is 
frequently found in low numbers in the upper respiratory tract of healthy 
cattle. Viral infection and stress play important roles in initiating the disease 
process. The bacteria colonize the mucosal surfaces, survive and multiply. 
The large number of multiplying bacteria in the nasopharynx can then travel 
to the lungs. P. haemolytica produces both pili and a glycocalyx in the lungs. 
Pili are surface structures that help the bacterium attach to epithelial cells and 
thus aid colonization. The glycocalyx is a polysaccharide material that the 
bacterium produces to protect itself from the host’s defence mechanisms 
(Frank, 1988). The bacteria also produce LPS and leukotoxin (LktA) and 
these cause lysis of the defence cells which subsequently lead to the 
production of acute disease with exudative fibrinous pneumonia.
It is well established that macrophages and neutrophils play a 
predominant role in pulmonary defences against many acute microbial 
infections and alveolar macrophages produce inflammatory response 
modifiers. The primary defence of the lung, when the bacteria are present in 
low numbers, is alveolar macrophages. In addition macrophages secrete 
interleukin 8 (IL-8), a potent neutrophil chemotactic and activating factor, 
which causes the migration of neutrophils from the blood vessels to the tissues 
(Baggiolini et al., 1989). A few hours after the beginning of infection, 
migration of neutrophils into the lungs has been shown (Walker et al., 1985; 
Slocombe et al., 1985) and these neutrophils are less resistant to the damaging
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effect of leukotoxin than the resident alveolar macrophages (Czuprynski et al., 
1987; O’Brien and Duffus, 1987).
The antimicrobial systems of the neutrophils are classified according to 
oxygen metabolism. The oxygen-independent agents constitute a group of 
granule-associated proteins which are released into the phagocytic vacuole 
and extracellularly (e.g. myeloperoxidase is fungicidal and bactericidal in high 
concentrations, lysozyme is bactericidal for certain species, lactoferrin is 
bacteriostatic and proteolytic enzymes are involved in digestion of the foreign 
particles) (Quie, 1986). The oxygen-dependent systems include several 
reactive derivatives of oxygen. The initial product of this “respiratory burst” is 
the superoxide anion. Subsequent reactions lead to the formation of hydrogen 
peroxide, hypochlorous acid, hydroxyl radicals and singlet oxygen (Rossi,
1986) (see section 1.5.5). It has been shown that the generation of oxygen- 
derived free radicals and proteolytic enzymes from macrophages and 
neutrophils in response to infection may cause direct lung injury. Moreover it 
has been suggested that LktA, in addition to its cytocidal effect on bovine 
neutrophils, also stimulates a respiratory burst and degranulation of lysosomes 
(Maheswaran et al., 1992). The release of the lysosomal contents as a result of 
degranulation can initiate harmful inflammatory reactions and may be 
responsible for killing of pulmonary endothelial cells and tissue necrosis 
(Shewen and Wilkie, 1982; Wilkie and Shewen, 1988; Maheswaran et al., 
1992; 1993).
P. haemolytica LPS has been shown to induce a variety of clinical and 
pathological effects when directly instilled into the lungs (Adlam, 1989). 
There was a decline in the number of circulating leukocytes but lung lavage 
cell counts were increased with the majority being neutrophils. LPS has
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Fig. 2.
Flow diagram showing the mechanism of pathogenesis of bovine 
pneumonic pasteurellosis caused by P. haemolytica serotype A l. 
Adapted from Frank (1989) and Dalgleish (1990).
H ealthy calf carrying small num ber o f  
P. haem olytica  A l  in nasopharynx
H ealthy calves
Elim inate
infection
StressV iral infection
E ntry into lungs in aerosol droplets
R apid growth in lungs and production  
o f leukotoxin and endotoxin
Lysis o f alveolar m acrophages and  
recruited neutrophils dam aged
Rapid growth in nasopharynx
Acute exudative fibrinous pneum onia
Release o f lysosom al contents into  
local pulm onary environm ent
Nasopharynx and lungs susceptible 
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been shown to produce inflammation, oedema, hyperaemia and haemorrhage 
in the lungs.
Symptoms of pneumonic pasteurellosis include fever (40 °C to 42 °C), 
dyspnea, fibrinous pneumonia, anorexia, a serous nasal discharge, cough, 
increased pulse rate, shallow respiration and pleuric sounds in the 
cranioventral region of the lung (Siegmund et a l, 1979). The lesions of 
pneumonia after natural exposure to P. haemolytica are seen in ventral parts 
of cranial lobes (Jericho, 1989).
1.2.2 Disease in sheep
P. haemolytica produces disease in sheep of all ages and this disease can 
be acute, hyperacute or chronic depending on predisposing factors. P. 
haemolytica A2 is the most prevalent and pathogenic of all the serotypes 
causing disease in sheep. This bacterium produces two different disease 
syndromes: in very young lambs, the septicemic form of pasteurellosis and in 
slightly older lambs (two to three months), a fibrinous pleurisy with focal lung 
consolidation has been reported (Gilmour and Gilmour, 1985). However, 
biotype T produces a septicaemic form in young adult sheep which is 
associated with a hyper-acute disease (Gilmour 1978) and T strains are 
cultured from lung lesions in all ages of sheep (Gilmour and Gilmour, 1989).
The clinical signs of pneumonic pasteurellosis in sheep range from 
sudden death to occasional coughing. Sheep or lambs with pneumonia are 
dull, anorexic, pyrexic and tachypnoeic or dyspnoeic (Gilmour and Gilmour,
1985).
1.3 VIRULENCE FACTORS
P. haemolytica possesses a variety of putative virulence factors which 
might be involved at the different stages of the diseases caused by this
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organism. These include leukotoxin, haemolysin, capsular polysaccharide, 
lipopolysaccharide, fimbriae, neuraminidase, various outer-membrane 
proteins and sialoglycoprotease.
1.3.1 Leukotoxin
Leukotoxin of P. haemolytica is said to be target-cell specific and has 
been reported to act only on ruminant leukocytes. This toxin has been 
implicated as an important virulence factor which contributes to the 
pathogenesis of pneumonic pasturellosis by its action on immune effector 
cells in the lung. More details are provided in section 1.5.
1.3.2 Capsular polysaccharide (CPS)
Polysaccharide capsules are present in most of the species of the family 
Pasteurellaceae and routine methods are used to detect them. The method of 
Maneval (1941) and the fluorescent antibody technique (FAT) have proved to 
be better than the other methods for capsular staining of P. haemolytica.
The capsule of P. haemolytica changes with time, being more abundant in 
log phase than in stationary phase cultures (Corstvet et al., 1982). Gentry et 
al. (1987), however, showed that in serotype A l, serial passage 128 times did 
not affect the production of capsular polysaccharide.
For extraction of capsule, various methods have been used, including 
extraction with water or saline at 56 °C (Carter, 1956; Gentry et al., 1982) and 
extraction with potassium thiocyanate (Mukkur, 1977) or sodium salicylate 
(Gilmour et al., 1979). These extracted fractions are contaminated with other 
substances (Gentry et al., 1982) and for recognising the contaminating 
substance in the capsule preparation, antibodies are used from sera (Confer et 
al., 1985) and lavage fluid (Townsend et al., 1987) of vaccinated or 
experimentally-infected calves.
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Adlam (1989) showed that CPS of serotypes A l, A2, A7, T4 and T15 are 
structurally heterogeneous e.g. A l CPS is composed of a polymer of N-acetyl- 
D-mannosaminuronic acid linked 1,4 to N-acetyl-D-glucosamine and is 
immunogenic in lambs. The CPS of serotype A2 is an a-(2-8)-linked polymer 
of N-acetylneuraminic acid, but this did not induce an antibody response in 
lambs (Donachie, 1988).
Injection of purified capsular polysaccharide from serotype A l has shown 
that it is immunogenic for sheep but not for rabbits (Adlam et al., 1984). It 
does not stimulate interleukin-1 by bovine monocytes and is not toxic for 
neutrophils but purified CPS may affect the phagocytic abilities of alveolar 
macrophage and neutrophils to engulf the bacteria (Czuprynski et al., 1989; 
1991a).
1.3.3 Outer-membrane proteins
In Gram-negative bacteria, the outer membrane is composed of 
phospholipids, proteins and lipopolysaccharide and plays a crucial role in the 
survival and multiplication of the organism. Relatively little is known about 
the structure and function of the outer-membrane protein components of P. 
haemolytica. The major OMPs of serotype A l (S/C 82/1 isolate) are in the 
range 30-45 kDa (31, 41 and 43 kDa). Minor proteins of 18, 32 and 98 kDa 
are also present (Ali, 1993). The profiles obtained by SDS-PAGE are different 
between the biotypes A and T (Adlam, 1989; Ali, 1993). Variation of OMP 
profiles within a group of serotype A l isolates has been reported and these 
variations could be detected only by western blotting. Variation within 
serotype A2, however, was detected both by SDS-PAGE and western blotting 
(McCluskey, 1994).
The OMP profiles of P. haemolytica grown under iron-replete and iron- 
restricted condition have been studied (Deneer and Potter, 1989; Davies et al.,
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1992). Iron-regulated proteins (IRPs) are located in the outer-membrane of the 
bacterium and such proteins are often important in bacterial virulence 
(Weinberg, 1978). The role of IRPs is to help the bacteria in the uptake of iron 
e.g. bound to host transferrins. Donachie and Gilmour (1988) reported that 
IRPs of serotype A2 P. haemolytica had mol. wts of 70 and 100 kDa. These 
proteins were found to be present in the outer membrane of P. haemolytica A2 
cells isolated directly from the pleural fluid of infected sheep. They were 
expressed only at a low level in A2 cells grown in vitro on iron-replete 
medium. Recently Lainson et al. (1991) described the presence of a third IRP 
of 35 kDa in P. haemolytica A2. Similarly, when P. haemolytica serotype A l 
was grown under iron-limited conditions, additional outer-membrane proteins 
of 71, 77 and 100 kDa were noted. Immunoblotting of OMPs with 
convalescent sera from P. haemolytica infected calves indicated that 
antibodies against all three protein were present, suggesting that the proteins 
were expressed in vivo (Deneer and Potter, 1989; Davies et al., 1992).
1.3.4 Lipopolysaccharide (LPS)
Lipopolysaccharide (endotoxin) is located in the outer-membrane of 
Gram-negative bacteria. It consists of three separate regions; an O-specific 
polysaccharide chain composed of repeating oligosaccharide units, a low- 
molecular-weight core oligosaccharide region, composed of approx. 10 
monosaccharide units, and a hydrophobic lipid A region (Hitchcock et al.,
1986). The core polysaccharide and O-chain polysaccharide are used for 
serotyping in many organisms and these are antigenic and immunogenic 
(Rutter, 1988).
Two types of LPS can occur: smooth-type LPS consisting of the lipid A- 
oligosaccharide core region and O-antigen region, and rough-type LPS
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consisting only of lipid A-oligosaccharide core region. Both LPS forms have 
been shown in P. haemolytica isolates.
Until recently, it was assumed that there was a difference in LPS between 
biotype A and T strains. Biotype A was reported to possess rough-type LPS 
and biotype T possessed smooth-type LPS (Adlam, 1989). However, the 
presence of smooth LPS in isolates of the biotype A has been demonstrated by 
SDS-PAGE and immunobloting (Davies et al., 1991b). Ali et al. (1992), after 
examining 40 isolates of P. haemolytica including 23 serotype A l, seven 
serotype A2, one serotype T4, one serotype T10 and eight untypables from 
healthy and diseased cattle and sheep, were able to distinguish 10 different 
LPS profiles by SDS-PAGE and immunoblotting. Davies et al. (1992) 
reported that when two P. haemolytica A l isolates were grown in various 
conditions in vitro such as iron-restriction and different aeration conditions, 
the LPS profiles did not change markedly.
Endotoxin activity in the culture supemate of P. haemolytica serotype A l 
grown in non-supplemented medium (RPMI) was initially low, but increased 
during the growth period. However, in bovine serum albumin-supplemented 
culture supernates, endotoxin activity decreased with time in culture (Confer 
and Durham, 1992).
LPS of P. haemolytica is known to be toxic for calves and sheep and in 
pneumonic pasteurellosis is thought to result in increased capillary 
permeability, thrombosis and coagulation necrosis (Jensen and Mackey, 
1979). Different concentrations of LPS have different effects on phagocytosis. 
At low concentrations, phagocytosis of [125I]-labelled Staphylococcus aureus 
by polym orphonuclear leukocytes was decreased but with higher 
concentrations, phagocytosis was increased (Confer and Simons, 1986).
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1.3.5 Fimbriae
Fimbriae are proteinaceous filamentous appendages of bacteria and are 
involved in various forms of attachment. In pathogenic organisms, they may 
have an important role in colonisation of the host. P. haemolytica A1 strains 
produce fimbriae at their surface in the logarithmic phase. Their role in bovine 
respiratory disease is not clear, but it is has been suggested that they may be 
important in the colonization of the bovine respiratory tract (Adlam, 1989). 
There are two types of fimbriae on the surface of P. haemolytica A l. The 
small flexible fimbriae are approximately 5 nm in width and up to 300 nm in 
length (Morck et al., 1987) and the large rigid fimbriae are approximately 12 
nm in width and up to 500 nm in length (Potter et a l ,  1988). Morck et al. 
(1987) reported that when P. haemolytica was grown in shaken culture, they 
did not find any evidence of fimbriae.
1.3.6 Neuraminidase
Neuraminidase is an enzyme that is reported as a virulence factor of 
several microorganisms. Scharman et al. (1970) first reported that Pasteurella 
species produce this enzyme and found neuraminidase activity in 102 of 104 
strains of P. multocida and 3 of 5 strains of P. haemolytica. However, its role 
as a virulence determinant in P. haemolytica is not clear.
Neuraminidase of P. haemolytica serotype A l has a mol. wt of approx. 
150 kDa when analysed by gel filtration and approximately 170 kDa as 
estimated by SDS-PAGE. The production of neuraminidase increases when 
the bacteria enter the stationary phase of growth and continues during this 
phase (Straus et al., 1993). The optimum pH for activity of this enzyme is 6.5. 
It is stable at 4 °C for 3 h and loses 25% of its activity after 3 h at 37 °C, and 
55% of activity after 1 min at 50 °C.
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1.3.7 Haemolysin
A complete zone of 6 haemolysis is seen around P. haemolytica colonies 
on blood agar plates and this observation is important for differentiating 
between this species and others. Although all P. haemolytica produce 
haemolysin, the size of zones of haemolysis may differ between different 
strains. Haemolysin is not dependent on the presence of plasmids (Chang et 
a l , 1987a) and is related to the activity of LktA (see section 1.5.5).
1.3.8 Sialoglycoprotease
Sialoglycoprotease is a proteolytic enzyme and is found in most of the 
serotypes of P. haemolytica (Adlam, 1989). However, the role of this enzyme 
in the pathogenesis of P. haemolytica is not clear. Sialoglycoprotease can 
release sialoglycopeptides from human RBCs (Otulakowski et al., 1983).
1.4 CONTROL OF P. HAEMOLYTICA INFECTIONS
1.4.1 Immunity to P. haemolytica
P. haemolytica, like other Gram-negative bacteria, has numerous 
potential immunogens. Those with the most potential for stimulating 
immunity include CPS, LPS, OMPs, fimbriae and LktA (Adlam et al., 1984; 
Shewen and Wilkie, 1985; Morck et al., 1987; Adlam, 1989).
The most studied mechanism of immunity is the humoral immune 
response which involves a number of complex interactions. Humoral antibody 
against P. haemolytica involves production of antibodies to specific 
components of the bacterium in addition to LktA-specific antibodies (Confer,
1993). Secretory immunoglobulin A and other factors at mucosal surfaces 
may inhibit attachment and multiplication of bacteria and thus prevent 
colonisation of the respiratory tract. These factors may also opsonise the
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bacterial cells and enhance phagocytosis and/or neutralize the LktA by 
binding to leukotoxin.
Information about immune responses to P. haemolytica has been obtained 
from both natural and experimental infections. When cattle are moved to 
feedyards, the titre of serum antibody to P. haemolytica increases both in 
those that remain healthy and in those that become ill with respiratory disease 
over a four week period after arrival at the feedyard. However, the antibody 
titres of the sick cattle increase more than those of the healthy cattle during the 
first week (Frank, 1989).
Systemic and pulmonary responses of calves to P. haemolytica have been 
evaluated by measuring immunoglobulin production in blood for 9 days and 
in pulmonary lavage fluid for 7 days after intrapulmonary inoculation. The 
pulmonary response consisted of production of IgG, IgE, and IgM antibodies 
to P. haemolytica. Antibodies of the IgM isotype to P. haemolytica were 
demonstrated as early as 8 h and for 7 days. Of the anti-P haemolytica  
isotypes, IgM was found in the highest concentration. In all of the inoculated 
calves, IgE was found 1 to 2 days after inoculation, and IgG was found in 2 of 
3 inoculated calves from day 1 through 7 after inoculation. Detection of IgG 
correlated with smaller pulmonary lesions. However, IgA was not detected in 
lavage fluid. Specific IgM in serum was detectable 5 days after inoculation, 
and IgG was detectable 7 days after inoculation. P. haemolytica antigens were 
not detected in serum or plasma. Antigen was detected in lavage fluid by use 
of monoclonal antibodies raised against P. haemolytica CPS, OMP antigens, 
and LktA in all inoculated calves 8 h after inoculation (McBride et a l, 1992).
Tigges and Loan (1993) showed that purified CPS from serotype A l 
stimulated production of CPS-specific IgM, IgG l, and IgG2 in calves and 
predominantly IgM and IgGl in mature cows. Different adjuvants stimulated 
different immunoglobulins when mixed with CPS. CPS in oil adjuvant
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stimulated the highest mean CPS-specific IgGl and IgG2 responses, whereas 
CPS in aluminium hydroxide adjuvant stimulated the highest mean CPS- 
specific IgM response.
Confer (1993) suggested that because OMPs stimulate homotypic 
immunity and capsules of various serotypes appear to be serotype specific, 
LktA may be of major importance for stimulating cross-protection against 
various serotypes.
In cell-mediated immunity, T-lymphocytes are involved which can act 
directly on bacterial cells or enhance macrophage killing of intracellular 
bacteria. However little research has been documented to characterise this 
particular response to P. haemolytica.
1.4.2 Vaccines
Although pneumonic pasteurellosis is thought of as a multifactorial 
disease, many researchers believe that control of P. haemolytica infection 
would result in a significant decrease in the severity and prevalence of the 
disease and economic losses caused by it.
Initial attempts to control infections by Pasteurella revolved around the 
use of bacterins (Carter, 1957; Palotay et al., 1963). Results of using such 
vaccines shown that a form alin-killed P. haemolytica bacterin given 
simultaneously by subcutaneous and aerosol routes resulted in more severe 
lesions in vaccinated animals than in controls after experimental challenge 
with P. haemolytica (Friend et al., 1977). Combinations of P. haemolytica and 
P. multocida have been used with variable success as vaccines. In one field 
study with such a vaccine, a reduction in respiratory disease was reported 
(Palotay et al., 1963) but in another study, no significant reduction was found 
(Martin et al., 1984). Viruses (bovine herpes virus 1 and parainfluenza-3 
virus) (Jericho et a l, 1976; Mosier et a l,  1989) either alone or in combination
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with P. haemolytica and P. multocida bacterin have also been used in 
vaccines. The results of viral vaccination alone showed little consistent effect 
in their ability to control shipping fever (Bennett, 1982; Ludwig and Goebel, 
1991). In another study, various combinations of viruses and bacterins gave 
no difference in disease incidence between the vaccinated and controls 
animals (Mosier etal., 1989).
The use of live vaccines for prevention of shipping fever has shown some 
promising results. When live P. haemolytica was used subcutaneously, 
intradermally or by aerosol, the reduction of lung lesions and clinical signs of 
disease shown after experimental challenge compared well with bacterin- 
vaccinated animal (Confer et a l, 1985).
The enhanced protection afforded by most live vaccines compared to 
bacterins may be due to the stimulation of antibodies to antigens associated 
with live but not killed organisms (Panciera et a l,  1984). Although live 
vaccines often provide better immunity than non-living vaccines (Confer et 
a l, 1986), vaccines that are produced with live organisms on occasion 
produce disease symptoms and may only protect against one serotype (Confer 
et a l ,  1988). Weekley et a l  (1993) reported that vaccination with live P. 
haemolytica produced both morphological and functional changes in 
pulmonary vascular endothelium in sheep. Recently, Petras et a l  (1995) 
produced a LktA -deficient m utant o f P. haem olytica  A l with 
nitrosoguanidine. When this strain was tested for virulence in goat and cattle 
challenge experiments, a reduction of mortality and lung lesions was observed 
in comparison with wild-type strains. Thus, such strains may be suitable live 
vaccine candidates.
More recent experiments have shown that vaccine efficacy may be 
dependent on the various adjuvants, dosage and routes of administration used 
(Mosier et a l, 1989). Confer et a l  (1987) showed that different adjuvants,
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including aluminium hydroxide adjuvant (ALH), Freund’s complete adjuvant 
(FCA) and Freund’s incomplete adjuvant (FIA), mixed with P. haemolytica 
bacterins, all stimulated high antibody responses to somatic antigens but low 
anti-leukotoxin antibody titres. These workers reported that vaccination with 
killed P. haemolytica in Freund’s complete or incomplete adjuvant elicited 
increased resistance to transthoracic challenge, but incorporation of 
aluminium hydroxide gel as an adjuvant did not. The oil adjuvant bacterin was 
shown to be reasonably efficacious. The vaccine produced 6-9 months of 
immunity following initial vaccination in young animals and could protect the 
animal for 12 months after revaccination (Carter and de Alwis, 1989). This 
vaccine is viscous and difficult to use, undergoes rapid deterioration at room 
temperature, has a short storage life and sometimes causes adverse local 
reactions. Reducing the viscosity of the vaccine usually results in a decrease 
in immunity compared with the conventional oil adjuvant vaccine.
Intramuscular vaccination of cattle with rLktA or with culture supemate
containing LktA has shown that although LktA is an important virulence
factor of the organism, an immune response to LktA alone does not protect
animals against respiratory disease or against development of post-mortem
lung lesions after experimental challenge (Conlon et al., 1991). Confer and
Durham (1992) showed that vaccination with the culture supernate of P.
haemolytica grown in RPMI 1640 medium supplemented with FCS did not
effect a change in morbidity of 1140 calves. They suggested that this may
of
have been due to a lack^appropriate surface antigens in the culture supemate.
In an experimental challenge system in SPF lambs, the lambs were 
challenged with an aerosol of P. haemolytica A2 but the challenge was 
preceded by infection with PI3 vims, a method which consistently induced 
severe pneumonia in SPF lambs. A crude cytotoxin vaccine of P. haemolytica 
A2 in alhydrogel alone or combined with sodium salicylate extract (SSE)
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were tested and the crude cytotoxin vaccine gave 86% protection. A combined 
SSE with crude cytotoxin gave 98% protection in sheep (Sutherland et a l, 
1989).
Conlon and Shewen (1991) reported that vaccination of calves with 
purified CPS was ineffective at protecting calves against P. haemolytica 
challenge. These authors subsequently examined the effects of purified CPS, 
culture supemate containing LktA, rLktA and various combinations of the 
above as vaccines. No significant protection was obtained with any factor 
alone or in combination (Conlon and Shewen, 1993).
Purdy et a l  (1993) evaluated the effect of various P. haemolytica A l 
vaccines in goats and reported that only injection of live P. haemolytica  
induced solid protection. However, CPS induced partial protection but LPS 
and LktA vaccines were ineffective in protecting goats against challenge with 
P. haemolytica A l.
1.5 RTX TOXINS
The RTX (repeats in toxin) cytolytic toxins are a family of toxins 
produced by different Gram-negative bacteria. They are calcium-dependent 
and pore-forming and characterised by a series of glycine-rich repeat units 
containing nine amino acids at the C-terminal end of the protein. The number 
of the basic repeat units varies between 6 (in LktA of P. haemolytica) and 47 
(in the adenylate cyclase-haemolysin of B. pertussis) (Ludwig and Goebel,
1991). It has been suggested that each toxin is a major virulence factor of its 
producer organism. The RTX family includes haemolysins produced by 
members of the Enterobacteriaceae (Escherichia coli haemolysin [HlyA], 
Proteus vulgaris, Proteus mirabilis and Morganella morganii haemolysins), 
P. haemolytica leukotoxin (LktA), Actinobacillus actinomycetemcomitans 
leukotoxin (AktA), A. pleuropneumoniae toxins (ApxIA-III) and Bordetella
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pertussis adenylate cyclase toxin/haemolysin (cyclolysin) (CyaA) (Coote,
1992). Although there are functional similarities between the different 
products of the RTX operons, the target cells of the toxins are different. Some 
of them lyse a wide range of animal and human cells; others are more specific 
(Shewen and Wilkie, 1982; Cavalieri etal., 1984; Hewlett and Gordon, 1988; 
Clinkenbeard and Upton, 1991). Target cell specificity is presumably 
determined by the primary structure and subsequent folding of the toxin which 
influences its interactions with cell receptors and/or its ability to produce 
pores in cell membranes of different compositions (Coote, 1992).
E. coli haemolysin (HlyA) is the best characterised member of this 
family. This bacterium causes urinary tract infections in man and intestinal 
infections in many species. The toxin has a lytic effect on a wide range of 
target cells from man and animals. The formation of active extracellular 
haemolysin requires the products of four hfy (/i/yCABD) genes that may be 
located either on the chromosome or on plasmids (Oropeza-Wekerle et al., 
1989). Most haemolytic E. coli isolates from urinary tract infections or other 
extra-intestinal infections in humans, and also from the normal human faecal 
flora, carry the haemolysin genes on the chromosome. However, haemolysin 
plasmids are present in haemolytic strains from animals (Ludwig and Goebel, 
1991).
Lkt is a member of the RTX family (Strathdee and Lo, 1989). The genetic 
organisation of the P. haemolytica leukotoxin operon is similar to that of E. 
coli HlyA (Strathdee and Lo, 1989). It is oxygen-stable, inactivated with 
trypsin, chymotrypsin and protease (Baluyut et a l., 1981; Sutherland and 
Redmond, 1986; Chang et al., 1987b), pH-stable: range 2-12, heat-labile and 
inactivated at 100 °C for 30 min or by autoclaving for 15 min but active at 60 
°C for 30 min (Sutherland and Redmond, 1986). Lkt has been reported to be 
unstable at room temperature where 50% of the activity of the toxin is lost in
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24 h. However, it appears to be stable at -70 °C for 10 days while storage at 4 
°C only maintains toxin activity for 2 days (Sutherland and Redmond, 1986). 
The maximal production of cytotoxin is reported to be in the logarithmic 
phase of bacterial growth, at which time the number of viable bacteria is 
greater than at other phases of growth (Baluyut et al., 1981).
A. actinomycetemcomitans is a gram-negative coccobacillus and is 
isolated from local juvenile periodontitis and blood samples from patients 
with endocarditis and abscesses. This bacterium produces a variety of putative 
virulence factors including a leukotoxin with cytotoxic activity against 
polymorphonuclear leukocytes and monocytes from man and some monkey 
species. The toxin is inactive on other cells from man or other species. 
Although this leukotoxin (AktA) from A. actinomycetemcomitans is related to 
HlyA from E. coli (51% amino acid identity), it differs from other members of 
the RTX family in that it remains cell-associated (membrane bound) and is not 
secreted into the culture supernate (McArthur et al., 1981; Ludwig and 
Goebel, 1991; Coote, 1992).
A. pleuropneumoniae is a highly contagious pathogen in pigs, causing 
pneum onia, and also produces exotoxins that are cytolytic. A . 
pleuropneumoniae is divided into 12 serotypes and produces three different 
exotoxins in the culture supernate. Two of these toxins possess both 
haemolytic and cytotoxic activity while the third has cytotoxic but not 
haemolytic activity. A. pleuropneumoniae-RTX-toxin I (ApxAI) is strongly 
haemolytic and cytotoxic, like E. coli haemolysin HlyA, and it has a mol. wt 
of 105 kDa. It is present in serotypes 1, 5a, 5b, 9, 10 and 11. ApxAII, of 103 
kDa, is weakly haemolytic and cytotoxic and resembles P. haemolytica 
leukotoxin LktA. This toxin was found in all serotypes except 10. ApxAIII, of 
120 kDa, is cytotoxic but not haemolytic. This toxin is found to be present in 
serotypes 2, 3 ,4 , 6 and 8 (Frey et al., 1993; Tu et al., 1994).
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Adenylate cyclase toxin (CyaA) is produced by Bordetella pertussis, the 
causative agent of whooping cough. Its enzymic activity is activated by the 
host factor calmodulin to produce a supra-physiological level of cyclic 3'-5' 
AMP in target cells. CyaA is a 177-kDa protein and, in addition to adenylate 
cyclase activity, has weak haemolytic activity. Like active HlyA, the toxin 
affects a wide variety of target cells (Coote, 1992).
1.5.1 Structure
Four genes are required for synthesis, activation and secretion of the RTX 
toxins and these are generally arranged and transcribed in the order of CABD. 
The similarity in organisation of the RTX toxin genes in the different species 
is shown in fig. 3a. Four chromosomal genes IktCABD (fig. 3a C) are needed 
for production of P. haemolytica leukotoxin (Strathdee and Lo, 1989). Of 
these genes, IktC and IktA, are required to produce an active toxin (Lo et al.,
1987) and IktB and IktD are required for secretion of this protein (Strathdee 
and Lo, 1989). There are two promoters separated by 258 base pairs and these 
are located upstream from the IktC gene (Strathdee and Lo, 1987; Welch, 
1991; Coote, 1992).
The gene encoding the leukotoxin structural protein has been cloned and 
expressed in E. coli (Lo et al., 1985), and its nucleotide sequence has been 
reported (Highlander et al., 1989). lkt A, encodes a 102 kDa protein which is 
inactive without the presence of the 20 kDa IktC  gene product (Lo et al.,
1987).
RTX toxins possess a series of glycine-rich amino acid repeats within the 
toxin structure and the number of glycine-rich repeat unit varies with different 
toxins e.g. CyaA has 41 glycine-rich repeats, P. haemolytica LktA has 6 
repeat units and HlyA has 11 repeat units. Calcium is required for haemolytic 
activity of active HlyA and interacts with the repeat region. Higher levels of
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Fig. 3.
Organisation of RTX toxin genes.
a.
The A  gene in each case is the toxin structural gene, and this protein is 
activated by the C gene product by an acylation reaction. The activated 
toxin will be secreted by the BD gene products. A. Bordetella pertussis 
adenylate cyclase/haemolysin. The stippled region encodes the adenylate 
cyclase catalytic region of CyaA. B. Escherichia coli haemolysin. The 
unlinked tolC gene is required for secretion. C. Pasteurella haemolytica 
leukotoxin. D. Actinobacillus actinomycetemcomitans leukotoxin. E. 
Actinobacillus pleuropneumoniae haemolysin. Arrows indicate the 
direction of transcription.
Adapted from Coote (1992); Frey (1995).
b.
The E. coli H lyA  haem olysin  consists o f an am ino-term inal 
am phipathic helix, four amphipathic helices (cross hatched) and four 
hydrophobic helices (black), which are thought to form  the pore in 
eukaryotic cell m em branes, as well as the acylation site(s) (fatty 
acids), the calcium -binding site and the carboxy-term inal secretion 
signal.
Adapted from Ludwig and Goebel (1991).
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calcium were required for haemolytic activity of active HlyA when one repeat 
unit was removed and the haemolytic activity was abolished by removal of 
three units (Ludwig et al., 1988; Boehm et al., 1990a). Three regions in active 
HlyA are involved in pore formation by E. coli haemolysin. ' snare 
extensive homology (41% and 47% respectively) with HlyA (107 kDa, 1023 
amino acids) and HlyC (20 kDa, 170 amino acids) respectively of E. coli 
(Strathdee and Lo, 1987). However, the carboxy terminus of LktA has little 
homology to that of HlyA (Lo et a l, 1987). From the amino acid sequences of 
LktA and LktC, Lo et al. (1987) predicted that LktA would be highly acidic 
(isoelectric point, 6.27) and LktC would be highly basic (isoelectric point, 
9.83). The LktB and HlyB proteins are 80% alike whereas the LktD and HlyD 
proteins have 60% homology.
Although the mol. wt of LktA from its amino acid sequence is calculated 
to be 101.9 kDa, the apparent molecular weight was found to be more than 
400 kDa by gel exclusion chromatography, 105 kDa as judged by SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE) (Chang et a l , 1987b) and 
104 kDa as judged by size-exclusion high-performance liquid chromatography 
(Czuprynski etal., 1991b).
1.5.2 Production and activation of RTX toxins
When rLktA was expressed in E. coli, both LktA and LktC were detected 
by immunobloting of urea extracts of the cells with specific antibodies. 
However, with antisera raised against the soluble antigens in culture supemate 
of P. haemolytica A l, only LktA was detected. So, LktC is an intracellular 
component and is known to be involved in activation of LktA by chemical 
modification (Lo et al., 1987). A characteristic of RTX toxins is production of 
inactive toxin by the A gene which then becomes active after modification by 
the C gene product. Post-translational modification and activation of inactive
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HlyA requires an acyl carrier protein (acyl-ACP) (Issartel et al., 1991) and a 
number of such cellular proteins contain covalently-bound fatty acids. 
Myristic and palmitic acid are often covalently linked to proteins, the former 
by an amide linkage and the latter by ester or by thio-ester linkages. The 
linkage can be determined on the basis of sensitivity of the lipid-protein 
linkage to hydroxylamine (Towler and Glaser 1986; Magee, 1990).
The acylation site on HlyA has been located between the pore-forming 
domain and the calcium-binding RTX motif (fig. 3b). The activity of HlyC is 
absolutely required for HlyA acylation but its exact function is unknown. It 
most likely acts as an acyl transferase, but a catalytic activity is difficult to 
reconcile with the large amount of HlyC required for acylation, which is 
equivalent to the amounts of HlyA needed. Interestingly, the acylation 
reaction has been shown not to influence the target ceil specificity of the 
active toxin. For example, E. coli with hlyA, hlyB, hlyD and IktC produces a 
protein (HlyA) which is neither leukotoxic nor haemolytic. Thus, LktC does 
not activate HlyA (Forestier and Welch, 1990). However E. coli with lkt A and 
hlyCBD produces a protein (LktA) with weak haemolytic and leukotoxin 
activity so inactive LktA is activated by HlyC (Forestier and Welch, 1990), 
but the specificity of the toxin for ruminant cells was unchanged (Highlander 
et al., 1990). The calcium-binding repeat domain is involved close to the 
modification site and it is possible that an interaction takes place between 
these two sites to create the final conformation required for binding and 
membrane insertion by the toxin (Coote, 1992).
1.5.3 Secretion
After production and activation of the toxin, it must be transported across 
two membrane barriers (in Gram-negative bacteria) and all RTX toxins, 
except AktA, are secreted extracellularly. The systems for secretion appear to
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be similar. AktA, however, is localized in the periplasm and it can be released 
into the culture supemate by polymyxin B treatment (Tasi et a l ,  1984) or by 
increasing the amounts of M gCh (0 to 10 mM) or NaCl (0 to 50 mM) (Ohta et 
al., 1993). AktA has many basic amino acids (compared to other RTX toxins) 
which are clustered at the C-terminal end (Kraig et al., 1990) and this may 
affect its secretion. It has been reported that sequences at the C-terminus of 
active HlyA are involved in the secretion of protein (Felmlee et al., 1985) (fig. 
3b). The secretion signal appears to reside in the C-terminal 38-60 amino 
acids (Ludwig and Goebel, 1991; Coote, 1992). Secretion of HlyA does not 
involve a classical N-terminal secretion signal (Ludwig and Goebel, 1991).
The key elements in HlyA secretion are the translocator protein, HlyB, a 
member of a superfamily of ATP-dependent membrane-localized transporters, 
and HlyD, an accessory protein, thought to be required for direct translocation 
across the cell envelope (Blight and Holland, 1994) (see fig. 4). The carboxy- 
terminal region of HlyB, which is thought to be located in the cytoplasm, 
contains two domains that form an ATP-binding site. HlyB most likely 
transports HlyA through the cytoplasmic membrane at the expense of ATP 
hydrolysis. In HlyB+ HlyD" cells, the HlyA protein can be detected by 
immunogold labelling at the cell surface (Oropeza-Wekerle et al., 1990). 
HlyD has been proposed to be anchored to the cytoplasmic membrane via its 
amino-terminal transmembrane moiety while the remainder of the polypeptide 
is localised to the periplasm (Wang et a l,  1991). HlyD could thus form the 
bridge between the cytoplasmic and outer membranes through which HlyA 
crosses the periplasmic space. In fact HlyA has never been found in the 
periplasm, suggesting that it is translocated via fusions of the cytoplasmic 
membrane and the outer membrane. The HlyA is thus exported directly into 
the medium without a periplasmic intermediate. When HlyB is absent, HlyA 
is associated with the cytoplasmic membrane whereas in the presence of HlyB
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and N-terminal two-thirds of HlyD, HlyA is associated with both membranes 
with part of it exposed on the cell surface.
B and D gene products are required for export of the LktA and both genes 
have been expressed in E. coli to produce an 80 kDa LktB and 54 kDa LktD 
protein, respectively (Highlander et al., 1990; Ludwig and Goebel 1991). 
HlyB and HlyD can be used to secrete the LktA from E. coli but secretion of 
LktA by using LktB and LktD protein in E. coli was not successful 
(Highlander et a l ,  1989). An additional, outer-membrane protein of E. coli, 
TolC, is required for HlyA secretion from the cell. The tolC gene is unlinked 
to the hly operon. Proteins which have homology with TolC have been found 
in B. pertussis (CyaE) (Braun et a l ,  1993). The specific function of TolC 
during HlyA translocation is not clear. It might be involved in the formation 
of fusion sites, or may actually form a pore through which HlyA is 
translocated through the outer membrane (Braun et al., 1993). In the presence 
of hlyA, hlyC and the absence of hlyB, hlyD , the active toxin accumulates in 
inclusion bodies and its activity was shown to be the same as that of 
extracellular active toxin (Oropeza-Wekerle et al., 1989). The accumulation of 
a relatively large amount of active internal LktA or active HlyA in the 
logarithmic phase suggests that this cytolytic protein does not damage the 
membrane of the producing bacterial cell (Oropeza-Wekerle et a l ,  1989).
1.5.4 Target cell binding and pore formation
Calcium has been shown to have an important role in the activity of RTX 
toxins. The calcium can bind to the hlyA gene product and the binding site 
consists of 11 tandemly-repeated glycine-rich units of nine amino acids 
(residues 739-849) (Braun et al., 1993). Calcium can bind to HlyA in the 
presence or absence of HlyC (Boehm et al., 1990b). Ludwig et al. (1988) 
suggested that haemolysin-binding to natural membranes is Ca2+ dependent.
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Fig. 4.
Model of the E. coli HlyA translocator complex. HlyB, HlyD and an 
additional outer membrane protein of E. coli, TolC, are required for HlyA 
secretion into the culture medium.
Adapted from Blight and Holland (1994).
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Rowe et al. (1994) reported that lower concentrations of calcium were 
necessary for lysis of RBC than for BL3 cells. These workers also showed that 
HlyA could bind to BL3 cells under calcium-deficient conditions that would 
not allow cytolysis and they suggested that calcium may not be necessary for 
HlyA to initiate an association with leukocyte membranes (Rowe et al., 1994). 
However, it was shown that haemolytic activity of active HlyA produced by 
E. coli grown in medium where Ca2+ was absent was Ca2+-dependent whereas 
that produced by E. coli grown in the presence of Ca2+ was Ca2+-independent. 
Calcium was required for binding to RBC at both 4 and 37 °C (Boehm et a l ,  
1990a).
It has been suggested that calcium induces a conformational change in 
CyaA which is necessary for its insertion into the target cell membrane and 
for maximal intoxication of target cells (Hewlett et al., 1991). Haemolysis of 
sheep RBC induced by active CyaA occurred in the absence of added Ca2+ 
and in the presence of EGTA (ethyleneglycol-bis(B-aminoethylether)- 
N,N,N',N'- tetraacetic acid), a calcium chelator, but it is assumed that 
sufficient Ca2+ was sequestered by the toxin during growth of B. pertussis.
The influence of calcium on secretion and activity of the cytolysin of A. 
pleuropneumoniae was investigated. A. pleuropneumoniae produced toxin in 
the absence of calcium in the growth medium, but this toxin required calcium 
both for binding to RBCs and for haemolytic activity (van Leengoed and 
Dickerson, 1992).
Cruz et al. (1990) suggested that both lysis and agglutination of 
neutrophils was dependent upon the presence of calcium , whereas 
Clinkenbeard et al. (1989b) found that P. haemolytica LktA could bind to BL- 
3 cells in the presence of EGTA. Platelet lysis by P. haemolytica A l culture 
supemate was found to be Ca2+-dependent and addition of 2 mM calcium to 
Ca2+-free medium increased the toxin activity whereas addition of 4 m M
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EGTA to the buffer containing 2 mM Ca2+ decreased toxin activity 
(Clinkenbeard and Upton 1991). In the presence of EGTA, the release of 
lactate dehydrogenase by LktA from BL3 cells was blocked but it had no 
effect on K+release or cell swelling (Clinkenbeard et al., 1989b). Active 
rLktA had lytic activity for BL3 in the presence of 1 mM calcium, and was 
inhibited by preincubation with 5 mM ethylenediamine tetraacetic acid 
(EDTA) (Cruz e ta l ,  1990).
It was shown by Oropeza-Wekerle et al. (1989) that active extracellular 
and intracellular HlyA bound to RBCs, whereas the inactive form of HlyA did 
not bind. Deletion of HlyC or deletion of amino acids 673-726 of HlyA 
prevented RBC binding, suggesting that in the absence of HlyC modification, 
HlyA does not bind to RBCs (Rowe et al., 1994). However, it was reported 
that inactive CyaA can bind to Jurkat cells as effectively as the active form 
(Hewlett et al., 1993). These differences may reflect differences in 
methodology used to detect binding
The data from Ludwig et al. (1993) indicate that aggregation of two or 
more HlyA molecules takes place after secretion from the E. coli cell and that 
these aggregates are then able to generate transmembrane pores. The most 
important part of HlyA for pore formation is the region between amino acids 
238-410 of active HlyA, spanning the three hydrophobic subregions (Ludwig 
et al., 1991) (fig. 3b). Eberspacher et al. (1989) showed that binding of E. coli 
haemolysin to erythrocytes occurred both at 0 and 37 °C. However, 
haemolysis did not occur at the lower temperature. These results indicate that 
the toxin first absorbs to the cell surface with membrane insertion and pore 
formation following as a second step. Thus, the process of binding and pore 
formation by E. coli active HlyA are two distinct processes that may be 
temporally dissociated from each other. It was also suggested that E. coli
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haemolysin preparations contain a mixture of bindable and nonbindable 
molecules, the latter being haemolytically-inactive toxin.
Rogel and Hanski (1992) reported that the process o f active CyaA 
penetration into sheep RBCs could be resolved into three consecutive steps: 
insertion, translocation and intracellular cleavage. Translocation of the NH2- 
terminal catalytically-active fragment across the membrane occurred only 
above 20 °C and was highly temperature-dependent. While a single exposure 
of the toxin to calcium was sufficient for its insertion into the plasma 
m embrane, toxin translocation required exogenous calcium at mM 
concentrations. Insertion of the toxin into cell membrane occurred over a wide 
temperature range (4 °-36 °C). Active CyaA without its C-terminal moiety did 
not insert into the cells indicating the essential role of this part of the 
molecule. The N terminus of active CyaA is cleaved inside target cells 
releasing the active enzyme adenylate cyclase into the cytosol(Rogel and 
Hanski, 1992).
Rogel et a l  (1991) showed that intracellular cAMP generation by active 
CyaA was absolutely dependent on extracellular Ca2+ whereas haemolysis 
occurred in the absence of added Ca2+ and the presence of EGTA. These 
workers suggested that the toxic and haemolytic functions of active CyaA are 
separable and probably mediated by different domains on the molecule. 
Similarly, Cruz et al. (1990) found that the cell-binding and lytic domains of 
the leukotoxin of P. haemolytica were separable.
Native A. pleuropneumoniae  ApxIIA toxin is both haemolytic and 
cytotoxic. When recombinant toxin was expressed in E. coli, Tu et al. (1994) 
found two forms of ApxIIA protein. The toxin which remained intracellular 
had haemolytic and cytotoxic activity, while the secreted toxin was cytotoxic 
with little or no haemolytic activity. This indicated that cytotoxicity of 
ApxIIA was independent of its haemolytic activity.
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Lysis of cells by RTX toxins presumably occurs by the mechanism 
described for active HlyA acting on RBCs. It was proposed that lysis of RBCs 
results from a colloid osmotic shock due to the formation of hydrophilic pores 
in the plasma membrane which allow movement of small solutes through the 
pore, whereas large internal molecules cannot pass through (Menestrina et al., 
1994).
1.5.5 Production of LktA and effect on target cells
P. haemolytica LktA released from the bacteria may be directly involved 
in pathogenesis of pneumonic pasteurellosis by impairing pulmonary defences 
such as alveolar macrophages and neutrophils. All serotypes of A and T 
biotypes of P. haemolytica are reported to produce leukotoxin (Shewen and 
Wilkie, 1982; Chang et al., 1987a; Burrows et a l., 1993). Chang et al. 
(1987a), however, reported that four untypable strains of P. haemolytica did 
not produce leukotoxin. The leukotoxin produced by P. haemolytica serotype 
A l isolates has been reported to be significantly more active against bovine 
leukocytes than the leukotoxin produced by P. haemolytica biotype T serotype 
3 and the latter serotype was shown to produce a toxin which is larger than the 
A l toxin, as seen by immunoblotting (Winfield and Lo, 1991). Similar low 
toxicity has been reported for a serotype A l l  strain. The toxic activity of 
culture supernate of serotype A l was found to be 50-fold higher than that 
from A ll  (Mdurvwa and Brunner, 1994).
Although LktA is produced by all serotypes (1-16) of P. haemolytica and 
the toxins appeared in similar amounts and to be immunologically related, 
there are at least seven related lkt genes present in these bacteria (Burrows et 
al., 1993). The seven classes of genes were characterized by their restriction 
enzyme profiles.
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A variety of environmental factors such as temperature, pH, iron and 
different culture media have been examined for their role in the regulation of 
P. haemolytica LktA (Gentry et a l , 1986; Strathdee and Lo, 1989; Confer and 
Durham., 1992; Gatewood et a l, 1994). For example, iron has been shown to 
be important for the production (Gentry et a l,  1986) and secretion of 
leukotoxin (Czuprynski et a l, 1989) and in the absence of free iron in the 
medium, toxicity is reduced (Strathdee and Lo, 1989).
Baluyut et a l  (1981) found that the optimum time for maximal toxin 
production was found to be in the logarithmic phase of bacterial growth. 
Secretion of leukotoxin started in early log phase and continued until mid-log 
phase, after which time secretion began to decrease (Strathdee and Lo, 1989). 
Gatewood et a l  (1994), however, found that the increasing cytotoxicity in the 
growing culture could not be explained simply by the increasing number of 
viable organisms. The production of LktA was more closely associated with 
growth rate.
Although the secretion of leukotoxin was not affected by growth at 40 °C 
or 37 °C, it was slightly reduced at 35 °C and was not detectable at 30 °C. 
Secretion was unaffected at pH 7.3, 7.5, and 8 although at pH 7 and 6.5 the 
amount of toxin was reduced (Strathdee and Lo, 1989).
P. haemolytica  has been grown in different media to study toxin 
production: brain-heart infusion broth (BHIB) (Strathdee and Lo, 1989); 
RPMI alone (Kaehler et al., 1980); RPMI containing 0.05, 0.1 and 0.5% 
bovine serum albumin (Confer and Durham, 1992); RPMI containing 2.5% 
fetal calf serum (FCS), RPMI containing 700 mg FeSC>4, RPMI containing 
FCS and FeS0 4  (Gatewood et a l, 1994); or the bacteria have been grown in 
BHIB for 4.5 h and then in RPMI 1640 containing 7% FCS ( Shewen and 
Wilkie, 1982). The growth curves of bacteria in RPMI alone or with different 
concentration of BSA were similar. However, the maximum LktA activity
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was found when bacteria were grown in RPMI containing 0.5% BSA (Confer 
and Durham., 1992). Comparing the LktA activity in different media such as 
BHIB, RPMI, RPMI + FCA and RPMI + FCS + FeS0 4 , LktA activity was 
greatest in RPMI containing FCS. However, the growth curves of bacteria in 
this medium were greater than in the other media (Gatewood et al., 1994).
Gentry et al. (1987) found that after 128 passages of P. haemolytica 
serotype A l in culture, the cytotoxicity and virulence of the bacteria were 
unaffected.
With regard to target-cell specificity of LktA, it has been reported to 
affect bovine macrophages (Markham and Wilkie, 1980), bovine leukocytes 
(Shewen and Wilkie, 1982), bovine neutrophils and bovine lymphoma cells 
(BL3) (Berggren et al., 1981; Baluyut et al., 1981; Gennaro et al., 1983; 
Burrows et al., 1993), mononuclear leukocytes (Kaehler et al., 1980), the 
proliferation of bovine lymphocytes (Majury and Shewen, 1991) and 
endothelial cells (Maheswaran et al., 1993). Neutrophils are more sensitive 
than bronchoalveolar or mammary macrophages and peripheral blood 
mononuclear cells are less sensitive than mammary neutrophils (O’Brien and 
Duffus, 1987).
There are differences in susceptibility of ruminant neutrophils to active 
LktA e.g. bighorn sheep neutrophils were four- to eight-fold more susceptible 
to cytotoxin damage than domestic sheep neutrophils and neutrophils from 
deer and elk were resistant to killing by active LktA preparations from P. 
haemolytica strains isolated from any species tested (Silflow and Foreyt, 
1994). It has been reported that active LktA was not haemolytic for bovine or 
ovine erythrocytes (Berggren et al., 1981) and that it had no effect on 
leukocytes from pigs, horses (O’Brien and Duffus, 1987) and man (Kaehler et 
al., 1980). Other researchers have reported a weak haemolytic activity of the 
active form of LktA against sheep erythrocytes (Forestier and Welch, 1990;
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Burrows et al., 1993). Recently Murphy et al. (1995) created a P. haemolytica 
mutant incapable of producing LktA and this strain had neither leukotoxic 
activity nor haemolytic activity.
The leukotoxin acts on target cells by two mechanisms: firstly causing 
secretion of K+ from inside to outside of the cells and secondly by cell 
swelling. However, leukotoxin does not cause release of K+, Ca2+ uptake or 
cell swelling in bovine lymphoma 3 (BL3) cells when incubated at 4 °C 
(Clinkenbeard et al., 1989a; 1989b ). After exposure of granulocytes to 
leukotoxin at 37 °C , cell damage began and, after 5 min, half of the cells, and 
after 30 min 90% of cells, may be dying. Cooling in ice water was found to 
decrease or prevent the cytotoxic effect on granulocytes (Styrt et a l, 1990 ). 
Clinkenbeard et al. (1889b) reported that cell swelling was blocked when 
bovine lymphoma cells or bovine neutrophils (Clinkenbeard et al., 1889a) 
were incubated in medium with hypertonic sucrose, but Czuprynski and Noel 
(1990) have shown that various concentrations of sucrose did not affect LktA- 
induced swelling of bovine neutrophils.
The cytotoxicity of P. haemolytica on target cells has been reported using 
several laboratory methods including electron microscopy, phagocytosis 
assays, trypan blue dye exclusion, 51Cr-release, colourimetric microtitration 
assay and luminol-dependent chemiluminescence-inhibition (LDCLI) assays. 
(Baluyut et al., 1981; Berggren et al., 1981; Shewen and Wilkie, 1982; Chang 
et al., 1985; Chang et al., 1986a; Vega et al., 1987; Craig et al., 1990). The 
LDCLI assay was reported to be more sensitive than Cr-release and trypan 
blue dye exclusion (Chang and Renshaw, 1986).
An interesting effect of active LktA on neutrophils in vitro is the 
activation, at low toxin concentrations, and suppression, at high 
concentrations, of their respiratory burst. Maheswaran et al. (1992) showed 
that P. haemolytica LktA stimulated the neutrophil respiratory burst resulting
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in the production of superoxid and H2O2. The production of free radicals was 
seen immediately after incubation with LktA from P. haemolytica A1 but, 
after 5 min, LktA suppressed this respiratory burst and caused cytolysis and 
degranulation. Czuprynski et al. (1991) reported that low concentrations of
toxin could stimulate the target cells. No such stimulation, however, was
was
found in a previous study by Czuprynski and Noel (1990), but^in a later study 
using partially purified leukotoxin. Heat-inactivated (100 °C for 30 min) LktA 
cannot stimulate the respiratory burst (Maheswaran et al., 1992). High 
concentrations of active LktA rapidly damage bovine neutrophils (Czuprynski 
and Noel, 1990).
An effect of LktA on endothelial cells has been reported (Breider et al., 
1990). Maheswaran et al. (1993) found that crude LktA preparations 
containing LPS or CPS caused some minimal injury to endothelial cells 
whereas LPS or CPS alone had no effect. A key factor in endothelial cell 
killing is involvement of neutrophils. H2O2 generated extracellularly from 
activated polymorphic cells reacts with intracellular iron to form highly 
reactive hydroxyl radicals (OH) which may cause damage and this may be a 
key factor in enthothelial cell killing. Comparing culture supemates of P. 
haemolytica A l and A l l ,  superoxide anion release from bovine neutrophils 
was greater in response to the culture supemate from an A l than from an A ll  
strain (Mdurvwa and Brunner, 1994).
LktA is thought to be an important virulence factor of P. haemolytica 
because of its action on ruminant leukocytes. Target cells are thought to 
include macrophages and blood leukocytes (granulocytes and agranulocytes). 
Granulocytes, including neutrophils, eosinophils and basophils, are formed 
from committed stem cells in the bone marrow and these granulocytes are 
actively phagocytic and contain myeloperoxidase. Neutrophils are the most 
common (>60%) of the leukocytes in the blood. It is well estabilished that
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neutrophils play an important role in host defence against many acute 
bacterial and fungal infections. The response of the neutrophils to microbial 
invasion proceeds sequentially via migration to the infected area in response 
to chemoattractants derived from both microbial and host sources.
The microbicidal process of phagocytes requires the formation and 
release of toxic agents to the phagocytic vacuole or extracellularly. The killing 
mechanism is classified as either oxygen-independent or oxygen-dependent. 
The oxygen-independent agents constitute a group of granule-associated 
proteins. The granules contain enzymes which are important for the 
destruction and digestion of microorganisms and other foreign material. The 
granules are classified into two types: primary or azurophilic and secondary or 
specific granules. The azurophilic granules contain peroxidase, 
myeloperoxidase, acid hydrolases, neutral protease, cationic antimicrobial 
protease and lysozyme. The oxygen-dependent systems include several 
reactive derivatives of oxygen. In the neutrophils, when the cell is in the 
resting phase, the consumption of oxygen is low. However, it is increased 
when the cells come into contact with activating agents which may be either 
particulate or soluble. Through the function of the hexose monophosphate 
shunt, the first carbon of glucose is oxidised to CO2 via glucose-6-phosphate. 
Nicotinamide adenine dinucleotide phosphate (NADP) serves as an electron 
acceptor. By activation of NADPH oxidase by increasing the consumption of 
oxygen, the electron transfer continues to FAD-flavoprotein which is 
associated with cytochrome b and from there to oxygen. All of these 
metabolic events are dependent on activation of NADPH oxidase system 
which has maximal activity at low pH and catalyses the reduction of O2 to 
superoxide (O2") (Badwey and Karnovsky, 1980). Subsequent reactions lead 
to the formation of hydrogen peroxide, hypochlorous acid, hydroxyl radical 
and singlet oxygen (fig. 5) (Segal and Abo, 1993). The generation of reactive
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compounds of oxygen and proteolytic enzymes from neutrophils in infected 
lungs may result in direct lung injury and contribute to the pathology 
associated with pneumonic pasteurellosis (Maheswaran e ta i ,  1992).
1.5.6 Chemiluminescence (CL)
Luminescence is the emission of light and CL is light produced by a 
chemical reaction. The reactive oxygen products generated by the phagocytes 
as described above may give rise to natural CL by reaction with cell 
constituents. This natural CL is only very slight and cannot easily be used in 
analytical systems but may be potentiated by adding compounds such as 
luminol, DNDH (7-dim ethylam ino-naphthalin-l,2-dicarbonic acid) or 
lucigenin to biological systems. Thus, CL can be used as a measure of 
phagocytic activity, and interference with phagocytic activity for example by 
leukotoxicity, and phagocytosis, can be measured as CL-inhibition. Such CL 
inhibition assays have been used as a sensitive and convenient measure of 
LktA activity on ruminant neutrophils (Chang and Renshaw, 1986).
The CL response in biological systems may be affected by the presence of 
contaminating red blood cells and by the composition of the medium such as 
phenol red and foetal calf serum (Easmon et a l ,  1980). Several factors may 
affect the colour and wavelength of the emitted light and these include the 
type of molecule being excited, the pH of the medium, the presence of metal 
ions, the type of catalyst and the amount of free energy released by the 
chemical reaction.
In addition to production of chemiluminescence by phagocytosis of 
particles such as bacteria or opsonized zymosan, the respiratory burst can also 
be produce by certain soluble stimuli such as fMetLeuPhe (fMLP)(an example 
of immature peptide chains from microorganisms) and protein kinase C 
agonists like phorbol myristate acetate (PMA) (Andrews and Babior, 1984).
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Fig. 5.
Stimulation of neutrophils and production of free radicals
The respiratory burst is initiated by binding of an opsonized particle to a 
phagocyte. This binding may initiate ingestion of the particle and activation of 
an oxidase enzyme. The NADPH oxidase is selectively activated in the wall of 
the vacuole, resulting in the production of superoxide and hydrogen peroxide 
within the vacuolar lumen.
Adapted from Rossi (1986) and Segal and Abo (1993).
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fMLP induces a two-peak CL response of human neutrophils, the first peak 
being due to on extracellular reaction and the second peak due to an 
intracellular reaction (Briheim et al., 1984). PMA, however, induces a one- 
peak CL response in normal human neutrophils.
O BJECT OF RESEARCH
Among the many virulence factors produced by P. haemolytica, 
leukotoxin (Lkt) is one which is presumed to have a central role in pneumonic 
pasteurellosis of cattle and sheep. Lkt has been reported to be specifically 
lytic for ruminant leukocytes. The main objectives of this study were to 
compare the production and activity of leukotoxin in culture supernates of 
different isolates of P. haemolytica as judged by SDS-PAGE, immunoblotting 
and CLI assay and to compare recombinant Lkt produced by E. coli, and 
native Lkt for their effect on different cell types from ruminants and non­
ruminants. Another important aspect of Lkt is its homology with other toxins 
of the RTX family. This study was also aimed at revealing the immunological 
and biochemical relatedness of Lkt to the other RTX toxins which may help in 
understanding their structure-function relationships.
2. MATERIALS AND METHODS
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2.1 BACTERIA
A description of some of the important characteristics of the P . 
haemolytica  isolates examined in this study is given in table 2. All strains 
prefixed with Ph were collected from various parts of Scotland, from 
pneumonic and healthy cattle over the period 1982-5. These were kindly 
provided by Dr. H. A. Gibbs, Veterinary Medicine, Glasgow University, except 
isolate Ph705, which was provided by Dr. W. Donachie, Moredun Research 
Institute, Edinburgh. Isolates Ph2, PhlO and P h l2  were obtained originally 
from cases of bovine pneumonic pasteurellosis and have been used for 
experimental infections in cattle to give the typical clinical picture of disease 
(Gibbs et al., 1984). Isolates Ph26, Ph30 and Ph44 were from the 
nasopharynx of clinically healthy animals from farms free from disease. Isolate 
Ph6 was isolated from a healthy animal in-contact with pneumonic cases and 
later found to be suffering from pneumonia. Isolate P h i4 originated from a 
confirmed case of bovine pasteurellosis which was slaughtered at Glasgow 
University Veterinary School. Isolates Ph2, Ph30, Ph42, Ph44 and Ph72 have 
been used for experim ental infection more recently (Davies et al., 
unpublished). Strains with 5-number designations, i.e. 10632 etc., are from the 
National Collection of Type Cultures, UK (NCTC strains) and all are ovine 
isolates. The remainder, a mixture of ovine and bovine isolates, were from the 
culture collection of Dr. W. Donachie. Many of these strains have been used 
in previous studies in our Laboratory (Ali et al., 1992; Azad et al., 1992; 
Davies et a l, 1991).
E. coli strains used in this study were obtained from the Laboratory of 
Microbiology culture collection exept D H 5aFIQ , HMS174 (genotype) and 
S Y 3 2 7 X p ir  ( g eno ty pe )  wh ich  were  ob t a in ed  f rom 
F,/?roAB+/«cIclZAM15zzf::Tn5[Kmr] cp80d/acZAM15A(/acZYA-argF)U169
Table. 2.
Characteristics of P. haemolytica isolates used in this study.
Laboratory Serotype 
designation
Species 
of origin
Previous*
designation
LPS type* 
PAGE Chemotype 
type
Isolation Disease status 
of host
Ph 2 Al Bovine S/C 82/1 1 S LRT Pneumonic
Ph6 Al Bovine S/C 84/3 - - - -
Ph 8 Al Ovine V965B 3 R Lung Pneumonic
Ph 10 Al Bovine S/B 82/1 1 S LRT Pneumonic
Ph 12 Al Bovine S/L 82/1 1 S LRT Pneumonic
Ph 14 Al Bovine H/L 82/1 1 S LRT Pneumonic
Ph 26 Al Bovine G/A 83/1 2 S NP Healthy
Ph 30 A l Bovine W/D 83/4 2 S NP Healthy
Ph 48 A l Ovine FA1 3 R Lung Pneumonic
Ph 42 A2 Bovine D/I 85/1 3 R Lung Pneumonic
Ph 44 A2 Bovine G/T85/15 5 R NP Healthy
Ph 72 A2 Ovine B664 4 R Lung Pneumonic
Ph 140 A2 Ovine T884 3 R Lung Pneumonic
Ph 142 A2 Ovine YS10 3 R Lung Pneumonic
Ph 50 A5 Ovine NCTC 10630 1 - Lung Pneumonic
Ph 52 A6 Ovine NCTC 10632 1 - Lung Pneumonic
Ph 54 A7 Ovine NCTC 10634 2 - Lung Peumonic
Ph 56 A8 Ovine NCTC 10636 3 - Lung Peumonic
Ph 58 A9 Ovine NCTC 10639 (5) - Lung Peumonic
Ph 60 A ll Ovine NCTC 10642 2 - NP -
Ph 62 A12 Ovine NCTC 10644 3 - NP -
Ph 64 A13 Ovine NCTC 11302 2 - Lung Peumonic
Ph 250 A13 Ovine - - S Lung Peumonic
Ph 66 A14 Ovine NCTC 11303 3 - Lung Peumonic
Ph 706 A16 Ovine - - - - -
Ph 68 T3 Ovine FT3 - - NP -
FT 4 T4 Ovine FT 4 - s Lung Peumonic
Ph 252 T10 Ovine FT10 - - - -
Ph 70 T15 Ovine NCTC 10641 - - - -
Ph 144 UT Bovine UT2 10 R Lung Peumonic
Ph 146 UT Bovine UT 3 1 S Lung Peumonic
Ph 152 UT Bovine UT 23 6 S Lung Peumonic
Ph 154 UT Bovine UT 27 8 R Lung Peumonic
*Data from Ali et al, (1992), All (1993).
S, smooth LPS; R, rough LPS; not known; UT, untypable; LRT lower respiratory tract 
NP, nasopharynx
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endA l recA l h sd R ll  (rK~mK+)deoR thi-\ supE44X-gyrA96 r e lA l , Gibco 
BR1, Novagen and Dr, V, Miller, University of California, LosAngeles, USA, 
respectively. Pasteurella m ultocida  NCTC 10322 and P se u d o m o n a s  
aeruginosa NCTC 6749 were from the National Collection of Type Cultures, 
UK. Staphylococcus aureus (delta toxin producer)was kindly provided by Dr.
D. Taylor Veterinary Pathology, Glasgow University, and group B 
streptococcus was kindly provided by Dr. C. G. Gemmell (Department of 
Bacteriology, Glasgow Royal Infirmary).
Stock culture of the above bacteria were stored frozen at -70 °C in BHIB 
+ 50% glycerol.
2.1.1 G row th of bacteria
The P. haemolytica were grown routinely from a glycerol stock on brain 
heart infusion agar (BHIA) (BHIA, Oxoid, Basingstoke, Hants, UK) containing 
5% defibrinated sheep blood (E & O, Limited, Scotland) and incubated 
overnight at 37 °C. For liquid culture, brain heart infusion broth (BHIB) was 
used. As part of the characterisation of the P. haemolytica isolates, their 
growth on MacConkey's agar overnight at 37 °C was examined.
2.1.2 Serotyping
To confirm the serotype of the P. haemolytica A l and A2 isolates, the 
indirect haemagglutination method of Shreeve et al. (1972) was used. Briefly, 
bovine RBCs were obtained from heparinised blood from a healthy animal. 
Ten ml of blood diluted with phosphate-buffered saline (PBS) was put on the 
top of 5 ml of Percoll (Sigma) (density 1.092) (table 3) and centrifuged at 1100 
X g for 15 min in a bench centrifuge (MSE minor) and the plasma, leukocytes 
and Percoll were removed. The RBCs were washed three times in PBS pH 
7.38 and resuspended in 10 ml of PBS and stored at 4 °C.
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lam e. j . solution
Preparation of different densities of PercolHor separation of cells
Stock Percoll:
90 ml Percoll
8.965 ml 10 x HBSS
1 ml 1M HEPES 
455 (ll 1NHC1
Density % Percoll
Volumes 
Stock Percoll
added (ml) 
RPMI
*Type of cell 
separated at 
given densiy
1.050 38.70 387 613
1.052 40.39 404 596
1.054 42.07 421 579
1.056 43.76 438 562
1.058 45.45 454 546 Monocyte
1.060 47.13 471 529
1.062 48.82 488 512
1.064 50.51 505 495
1.066 52.19 522 478 Lymphocyte
1.068 53.88 539 461
1.070 55.56 556 444
1.072 57.25 572 438
1.074 58.94 589 411
1.076 60.62 606 394
1.078 62.31 623 377 Granulocyte
1.080 64.00 640 360
1.082 65.68 657 343
1.084 67.37 674 326
1.086 69.06 691 309
1.088 70.74 707 293
1.090 72.43 724 276
1.092 74.2 742 258 Erythrocyte
*Percoll solutions of different densities were prepared, bovine blood layered on 
top and the mixture centrifuged. Seperated cells were examined for the 
presence of particular cell types.
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The antigens for coating the RBCs were prepared from P. haemolytica grown 
overnight  with shaking in BHIB at 37 °C. One ml of this culture was 
transferred to a microcentrifuge tube and heated at 56 °C for 30 min. 
TheRBCs, 8 X 108/ml final concentration, were added to each 1 ml of heated 
bacterial culture and then incubated at 37 °C in a water bath for 30 min with 
occasional gentle mixing. The suspension was centrifuged and the pellet 
washed three times in PBS and resuspended in 1 ml of PBS. Then, 25 pi of 
sensitised RBCs were mixed in round bottom microtitre plates (Sterilin) with 
25 pi of a pre-optimised dilution of type-specific antisera (kindly provided by 
Dr. W. Donachie), or foetal calf serum or PBS as controls. The plates were 
incubated for 2 h at room tem perature and after this tim e the 
haemagglutination reactions were assessed.
2.1.3 API 20 NE assays.
To identify P. haemolytica and to distinguish them from other non-enteric 
Gram-negative rods, the API 20 NE assay (API Montalieu-Vercieu, France) 
was used according to the manufacturer’s instructions. Briefly, the bacteria 
grown on BHIA overnight at 37 °C were used to prepare an inoculum by 
suspending 2-6 colonies in 2 ml of 0.85% sterile saline to a turbidity 
equivalent to 0.5 on the M cfarland's standard (API#7090) or to an 
absorbance of 0.125 at 550 nm. The microtubes comprising the conventional 
tests were carefully filled to avoid the production of air bubbles. The three 
tests tubes GLU (glucose acidification), ADH (arginine dihydrolase) and URE 
(urease) were further layered with sterile mineral oil. For the 12 assimilation 
tests, 200 pi of the bacterial suspension was inoculated into 7 ml of API 
Auxiliary Medium (which contained (g/1) ammonium sulphate, 2; agar, 1.5; 
mineral base, 82.8; amino acids, 0.25; vitamins/nutritional substances, 0.0359; 
in 0.04 M phosphate buffer pH 7.1) homogenised and the microtubes were
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filled. Test strips inoculated thus were incubated at 30 °C for 48 h. The 
assimilation tests for the given substrates were checked for opacity as an 
indicator of growth and utilisation of that substrate. The results, obtained as 
scores, were used to generate a profile to match with the Analytical Profile 
Index (API) designed for non-enterobacteriaceae.
2.2 PREPARATION OF LEUKOTOXIN
2.2.1 Native leukotoxin
All P. haemolytica strains were inoculated into 50-ml volumes of BHIB in 
conical shake flasks and incubated at 37 °C and 120 rpm. After various 
incubation periods, cultures were centrifuged at 15,000 X g for 15 min at 4 °C. 
The resulting supernates were passed through 0.45 pm membrane filters 
(Acrodisc; Gelman Sciences UK), and stored at -70 °C.
Another method used for preparation of leukotoxin was that bacteria 
were cultured in 50-ml volumes of BHIB for 4 h and then centrifuged at 7,000 
x g. The resulting cell pellets were resuspended in 100-ml volumes of RPMI 
1640 (Gibco) medium supplemented with 1% v/v foetal calf serum (Gibco) and 
incubated for 2 h at 37 °C and 120 rpm. Suspensions were then centrifuged at 
15,000 X g for 15 min at 4 °C. The supernates were passed through 0.45 pm 
membrane filters and dialysed against a large volume of distilled water for 24 h 
at 4 °C. The dialysed supernates were freeze-dried and stored at -20 °C.
P. haemolytica was also grown in Luria-Betani (LB) (see Appendix 4) 
medium in the presence of 5 pM, 10 pM, 50 pM, 100 pM, 300 pM and 500 
pM of EGTA for production of leukotoxin. The EGTA was sterilised by 
filtration (0.45 pm, Acrodisc) and added aseptically to sterile LB medium.
Growth of bacteria under different conditions of aeration was examined 
according the method of Davies et al. (1992). Briefly, for very high aeration,
M A T E R IA L S A N D  M E T H O D S 52 P A R T  2
50 ml of BHIB was contained in a 250 ml dimpled conical flask; for high 
aeration, 50 ml of BHIB was contained in a 250 ml smooth conical flask; for 
moderate aeration, 100 ml of BHIB was contained in a 250 ml smooth conical 
flask; for low aeration, 200 ml of BHIB was contained in a 250 ml smooth 
conical flask. All flask were shaken at 120 r.p.m and 37 °C. For no aeration, 
200 ml of BHIB was used in a 250 ml smooth conical flask, covered with a 
layer of liquid paraffin and incubated statically. Bacteria were also grown 
anaerobically, using an anaerobic jar in conjunction with an anaerobe gas 
generating kit (Oxoid). Each sachet contains tablets of sodium borohydride, 
tartaric acid and sodium bicarbonate. When use as directed, they will produce 
approximately 1800 ml hydrogen and 350 ml carbon dioxide.
2.2.2 Production of recom binant LktA from  E. coli
Plasmids containing the cloned lkt genes (pGW42, pGW64 and pGW78) 
were constructed and kindly provided by Dr. Gareth Westrop (Laboratory of 
Microbiology, University of Glasgow). To construct pGW42, a 3.9 kb DNA 
sequence containing the IktC and lkt A reading frames from P. haemolytica A l 
was subcloned from recombinant plasmid pLkt5 (Strathdee and Lo, 1989) into 
vector pIC20H. To construct pGW64 the complete IktA gene was subcloned 
into vector pE T lla . Plasmid pGW78 was constructed by first subcloning the 
IktC gene into vector p E T lla , to create pGW68. The region of pGW68 
containing the T7 lac promoter, the translation initiation sequence of T7 gene 
10, the IktC gene, the T7 transcriptional terminator and the lac I gene was 
then subcloned into pACYC 184 to create pGW78.
"Recombinant leukotoxin" is abbreviated "rLeukotoxin" or "rLktA". In E. 
coli strain D H 5aF'IQ  harbouring plasmid pGW42, transcription of a bi- 
cistronic mRNA encoding IktC and IktA is controlled by the lac promoter of 
the vector and is induced by IPTG.
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Different strains of E. coli (i.e. E. coli strains D H 5aFIQ  and HMS174 
containing plasmid pGW42 (encoding active rLktA) or strain SY327A, pir 
containing plasmid pGW64 (encoding IktA) and/or pGW78 (encoding IktC) 
were used to produce active rLktA.
2.2.2.1 Production of competent cells
E. coli strains (DH5aFIQ, HMS174 or SY327X pir) were grown overnight 
on 2 X YT agar (see appendix 4) plates at 37 °C to give isolated colonies. 
These were suspended in 50 ml of 2 X YT broth (see appendix 4) to give a 
starting OD650 of 0.02 in a 250 ml conical flask. The cells were grown at 37 #C 
with shaking (130 rpm) until the OD650 of the suspension reached 0.4, when 
the culture was centrifuged at 2500 X g (Sorval RC5B centrifuge) for 10 min 
at 4 °C. The cells were then resuspended in 1/10th volume of TSB (see 
appendix 4) and stored on ice for 10 min. These competent cells were stored in 
200 pi aliquots at -20 °C until required.
2.2.2.2 T ransform ation
For transformation, 2 pi of plasmid DNA (pGW42, pGW64 or pGW78) 
was added to 200 pi of thawed competent cell suspension and incubated on 
ice for 20 min and then 800 pi of TSB containing 20 mM glucose was added. 
The suspension was incubated at 37 °C for 1 h with shaking (130 rpm). 
Transformed cells (100 pi) were spread on one 2 X YT agar plate containing 
100 pg/ml ampicillin (to select bacteria containing pGW42) or 10 pg/ml 
chloramphenicol (to select bacteria containing pGW64 and/or pGW78) and 
incubated overnight at 37 °C to give isolated colonies.
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2.2.2.3 Growth of recom binant E . coli strains
An outline of the procedure for growth of E. coli and production of 
rLktA is shown in fig. 6 . The recombinant E. coli strains grown overnight on 
antibiotic plates were inoculated into 250 ml 2 X YT broth containing 100 
pg/ml ampicillin or 10 pg/ml chloramphenicol to give starting OD650 values of 
0.02-0.04. The cells were grown at 37 °C with shaking. At OD650 of 0.5, IPTG 
(Sigma) was added to the medium at a final concentration of 1 mM to induce 
expression of the recombinant proteins. The culture was incubated for a 
further 4 h at 37 °C. The cells were harvested by centrifugation at 9,000 X g 
for 10 min at 4 °C and the pellets were resuspended in 1/10 volume of ice-cold 
TEN buffer (see apendix 4), and stored at -20 °C in aliquots.
2.2.2.4 Preparation of urea extract.
Various methods were used for lysing the cells:
1. A 10 ml volume of cell pellet was thawed at 37 °C, 1 ml of lysozyme (10 
mg/ml) was added and the mixture incubated at 4 °C for 1 h. After this, 20 ml 
of TEN buffer containing 1.5% sodium deoxycholate was added and the cells 
were then centrifuged at 17,000 X g for 10 min at 4 °C. The cells were 
resuspended in 30 ml TEN buffer containing 0.5 % sodium deoxycholate to 
lyse the cells and disrupt the DNA and centrifuged as above.
2. The cell pellet was suspended in TEN buffer (see appendix 4) 
containing lysozyme (10 mg/ml) and glycerol, and kept for 1 h at 4 °C and 
then centrifuged at 17,000 X g for 10 min at 4 °C.
3. The cell pellet was suspended in Hanks Hepes (HH buffer) (see 
appendix 4) and sonicated at 4 °C and then centrifuged at 17,000 X g for 10 
min at 4 °C.
4. It was found that a combination of methods 2 and 3 gave better lysis of 
cells.
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The resulting pellet of broken cells and inclusion bodies was suspended in 
30 ml of distilled water and washed three times. The protein was extracted by 
suspending the pellet in 1 ml of TC buffer (see appendix 4) containing 8 M 
urea prior to rotation at 4 °C for 1 h. The pellet and insoluble material were 
separated by centrifugation at 15,000 X g for 20 min at 4 °C. The urea extract 
(supernate), containing the recombinant leukotoxin, and urea insoluble 
fraction were stored at -20 °C.
2.2.2.5 Dialysis
Urea was removed by dialysis of the urea extract against a large volume of 
buffer (100 mM NaCl, 10 mM Tris-HCl pH 7.5,1 mM CaCl2) or HEPES buffer 
(25 mM) for production of toxin in absence of calcium. Dialysis was done 
immediately before any toxicity assay, according to the method of Brownlie et 
al. (1988). Urea extract was placed in a dialysis membrane (size 1-8/32") and 
dialysed at 4 °C for 2 h with continuous mixing. The dialysis buffer was 
changed twice during this time. After dialysis, the samples were transferred to 
microcentrifuge tubes, and stored on ice until used.
For production of rLktA in the absence of calcium, E. coli SY327A, pir 
containing pGW42 was grown in LB medium in the presence of 100 pM  
EGTA. No calcium was added at any step in the extraction procedure.
2.3 SODIUM DODECYL SU LPHATE-POLYACRYLAM IDE GEL 
ELECTROPHORESIS (SDS-PAGE)
SDS-PAGE was according to the method of Laemmli (1970) and the 
reagents used are described in Appendix 3. The electrophoresis was 
performed in a vertical slab gel apparatus (Protean II; BioRad). Stacking gels 
contained 4% w/v acrylamide and resolving gels contained 10% w/v 
acrylamide, respectively. Samples were solubilised in equal volumes of sample 
buffer and heated in a water bath at 100 °C for 5 min. 100 pi volumes of
Fig. 6. Production of rLkt from E. coli
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solubilised culture supernate samples were loaded per well. Molecular weight 
standards (SDS-6 H, Sigma) were treated in the same way. Samples were 
electrophoresed into the stacking gel at 20 mA and then at 25 mA in the 
separating gel for 4-5 h or until the tracking dye reached the bottom of the 
gel. The gel was then stained with coomassie blue R-250 (Sigma) staining 
solution for 1 h and destained by several changes of destaining solution.
2.4 W ESTERN BLOTTING (IMMUNOBLOTTING)
After SDS-PAGE, the resolved protein bands were transferred to 
nitrocellulose membrane (Hybond-C super, Amersham) according to the 
method of Towbin et al. (1979) but with slight modification, in a Bio-Rad 
transblot cell. The transfer buffer consisted of 192 mM glycine, 25 mM Tris 
(pH 7.3) and 20% v/v methanol. Proteins were transferred at 15 volts, with 
cooling, for about 15 h, followed by 30 volts for 2 h in order to transfer the 
high molecular weight proteins. The nitrocellulose membrane was stained 
briefly (3 min) with 0.5% Ponceau S in 0.1% v/v acetic acid in distilled water, 
then destained with three changes of distilled water. The positions of 
transferred protein bands were visualised and those of the mol. wt standards 
were marked. PBS was then used for complete destaining. Non-specific 
binding sites were blocked for 1 h at room temperature with gentle shaking in 
PBS containing 0.1% Tween 20 and 5% w/v dried skimmed milk. The 
membrane was then washed twice for 5 min with fresh changes of PBS 
containing 0.1% Tween 20 at room temperature. Blots were probed with 
primary antibody diluted in PBS and incubated for 1 h at room temperature. 
After further washing as above, an appropriate HRP-conjugated secondary 
antibody diluted in PBS was added and incubation was for 1 h at room 
temperature. The nitrocellulose membrane was washed and then developed 
with a mixture of 0.03% w/v DAB (3-3 diaminobenzidine tetrahydrochloride
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dihydrate), 98 ml PBS, 2 ml of aqueous 1% w/v C0 CI2 and 100 |il of hydrogen 
peroxide. The reaction was stopped with distilled water and the membranes 
were stored in the dark.
2.5 CHEM ILUM INESCENCE (CL) ASSAY METHODS
2.5.1 Isolation of leukocytes
Heparinised blood was obtained from healthy humans, rabbits, guinea 
pigs, calves and sheep. For preparation of neutrophils, 10-ml volumes of blood 
were diluted with equal volumes of PBS and carefully layered on top of 7 ml 
of Histopaque (Sigma) 1.077 g/ml and centrifuged in polystyrene plastic 
universals at 830 g for 30 min at room temperature. The supernatant layers 
containing plasma, mononuclear cells and Histopaque were aspirated. For lysis 
of the red blood cells, the pellet was suspended in 3 volumes of ice-cold 
NH4CI medium (155 mM NH4CI, 10 mM KHCO3 and 0.1 mM EDTA). After 5-7 
min, the colour of the cell suspension changed from red to black indicating 
lysis of the erythrocytes. The suspension was then centrifuged at 400 g for 5 
min at 4 °C. The lysis procedure was repeated and the remaining cells 
centrifuged twice with PBS and finally suspended in PBS or HH (pH 7.38). 
The resulting cell suspension was >95% neutrophils. Neutrophil viability, 
determined by 0.1% trypan blue dye exclusion was >98% in all preparations 
examined.
Another method used for preparation of neutrophils, lymphocytes and 
monocytes was to use Percoll at different densities shown in table 3. The 
stock Percoll was diluted with RPMI and the density giving optimal 
separation of each cell type was determined. For example, for preparation of 
neutrophils, the diluted blood was carefully layered on the top of 7 ml of 
Percoll (Sigma) 1.092 g/ml (table 3) and centrifuged in polystyrene plastic
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universals at 830 g for 30 min at room temperature. The supernatant layers 
containing leukocytes and plasma were aspirated and carefully layered on top 
of 7 ml of Histopaque (Sigma) 1.077 g/ml and centrifuged in polystyrene 
plastic universals at 830 X g for 30 min at room temperature. The neutrophils 
were separated from mononuclear cells and washed two times with PBS and 
finally suspended in PBS or HH. The resulting cell suspension was >85% 
neutrophils. Neutrophil viability, determined by 0.1% trypan blue dye 
exclusion was >98% in all preparations examined.
A bovine leukaemia (BL3) cell line and a mouse macrophage cell line 
(J774.2) were kindly provided by Dr. G. Westrop.
2.5.2 Opsonization of zymosan
For preparation of opsonised zymosan, 100 mg of zymosan A (Sigma z- 
4250, from Saccharomyces cerevisiae) was added to 5 ml of normal bovine 
serum, 10% v/v in PBS, and this mixture was incubated at 37 °C for 30 min 
with shaking at 30 rpm. The opsonised zymosan was washed twice with ice- 
cold PBS and finally suspended in 10 ml in PBS, and stored at -20 °C in 
aliquots until used.
2.5.3 CL assay reagents and buffers
DNDH (7-dimethylamino-naphthalene-l, 2 dicarbonic acid hydrazide), 
lum inol (3-am inophthal hydrazide) (Sigm a) and lucigenin (bis-n- 
methyacridinium nitrate) (Sigma) were prepared as 10-2 M stock solutions in 
DMSO (dimethyl sulphoxide). The working dilutions (10~4 M) were prepared 
in PBS or HH. Phorbol myristate acetate (PMA) (Sigma) stock was prepared at 
2 mg/ml in DMSO and used to prepare the working solution at 10 |ig/m l in 
PBS. fMLP [formyl methionine-leucine-phenyl-alanine (Sigma)] was prepared 
as 10"5 M stock in PBS and was used as 10“7 M final concentration in the
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assay.
The usual CL assay procedure was to mix 15 |il of culture supernate 
containing leukotoxin with 785 pi of HH containing 5 X 105 neutrophils and 
100  pi of a working dilution of chemiluminogenic probe and incubated for 2 0  
min at 38 °C. Neutrophils were then stimulated with 100 pi of OZ. CL was 
measured with a Wallac luminometer connected to a IBM-PC computer with 
M ulti-use software (Bio-Orbit). The chemiluminescence emission was 
measured in millivolts (m. v) at 38 °C. Each sample was tested in duplicate and 
contained neutrophils (5 X 105), DNDH (10-5 M), OZ (0.5 mg) or PMA (lpg), 
PBS or HH( pH 7.38) and the final volume was 1 ml. The assay was performed 
in duplicate and the mean value calculated.
2.6 ANTIBODIES
2.6.1 Preparation of rabbit polyclonal antibody to rLktA
Recombinant LktA obtained from urea extracts of E. coli was resolved by 
SDS-PAGE using a 7.5% acrylamide separating gel. The gel was stained with 
coomassie blue R 250 for 5 min and then destained for 20 min. The bands at 
100-110 kDa were carefully cut out. Precautions were taken to handle the 
material carefully with gloved hands and alcohol-sterilised scalpel and forceps 
to avoid contamination. Gel bands were washed in sterile PBS, crushed, 
suspended in 2 ml sterile PBS and stored at -20 °C. One day before injection 
of protein, the sample was placed in narrow dialysis tubing and dialysed 
against large volumes of saline (mixed occasionally) for 24 h. The gel-free 
supernate was emulsified in Freund's incomplete adjuvant (Sigma) in 1:1 ratio. 
Two female New Zealand Albino rabbits were injected with 2 ml at two sites 
either subcutaneously or intramuscularly. Before injection of sample, the 
rabbits were bled for pre-immune sera. The immune sera were collected after 4
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booster injections at monthly intervals. The procedure is outlined in fig. 7.
2.6.2 Monoclonal antibodies
Mouse ascitic fluid and hybridoma culture supernate containing 
monoclonal antibody (MAb) raised against rLktA was kindly provided by Dr. 
W. Donachie, Moredun Research Institute, Edinburgh, UK.
Ascites fluid containing monoclonal antibody (9D4), (IgG2a), raised 
against B ordetella  pertussis  adenylate cyclase toxin (CyaA) was kindly 
provided by Dr. E. Hewlett, University of Virginia, USA. This MAb reacts in 
immunoblots with the 210 kDa band of CyaA as well as with the 105 kDa 
band of LktA.
Monoclonal antibodies GJMC-1 and GJMC-3 raised against the ApxAIII 
toxin of Actinobacillus pleuropneumoniae were kindly provided by Dr. J. 
Cullen, Department of Veterinary Pathology, Glasgow University. These 
monoclonal antibodies react strongly with the 120 kDa protein and also with 
the other 2 Apx toxins (ApxAI & ApxAII) to a lesser extent. They also cross- 
react with products from E. coli, A. suis, P. haemolytica, and A. equuli (J. 
Cullen, Ph. D. Thesis, University of Glasgow.
Monoclonal antibody 2-5 (IgG l) raised against AC toxin was kindly 
provided by Dr. N. Heveker, Institute of Pasteur, Paris. This MAb reacted with 
the repeat region of the AC toxin.
2.6.3 O ther antibodies
Rabbit polyclonal antibody raised against purified native AC toxin was 
kindly provided by C. Brotherston, Laboratory of Microbiology, Glasgow 
University.
Rabbit polyclonal antibodies raised against the 200 kDa band of CyaA, 
and against CyaC (21 kDa) cut out from SDS-PAGE, were kindly provided by
Fig. 7. Preparation of polyclonal antibody to rLkt
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E. K. Hormozi, Laboratory of Microbiology, Glasgow University.
Rabbit polyclonal antibodies raised against phenol-purified LPS from P. 
haemolytica strains Ph2 and Ph30 were kindly provided by Dr. R. L. Davies, 
Laboratory of Microbiology, Glasgow University.
Convalescent serum from a calf experimentally infected with P . 
haem olytica  strain Ph2 and used by Dr. Q. Ali (Ph. D. Thesis, Glasgow 
University) was also available.
2.7 HAEMOLYSIN ASSAY
Haemolytic activity of P. haemolytica leukotoxin and urea extracts of 
rLktA from E. coli was determined as follows. For preparation of RBCs, 10 ml 
of sheep blood diluted 1:1 in PBS or HH was layered on top of 5 ml Percoll 
with a density of 1.092 in a 15 ml centrifuge tube and centrifuged at 1200 X g 
for 30 min. Plasma, leukocytes and Percoll were removed and the pelleted 
RBCs were washed in PBS or HH until the supemate was clear. The RBCs 
were resuspended in HH buffer containing 1 mM CaCl2 - Serial two-fold 
dilutions of culture supernate from P. haemolytica or dialysed urea extracts 
containing rLktA of E. coli (active and inactive form of toxin) were mixed 
with equal volumes of 4 X 109 RBCs in a 96-well flat bottom microtitre plate 
and incubated overnight at 37 °C. The RBCs were mixed with BHIB or urea 
solution diluted in HH respectively as controls. After this incubation, the 
RBCs were pelleted by centrifugation at 1500 X g and the supernates 
transferred into a clean plate and the amount of released haemoglobin in the 
supernate was determined spectrophotometrically at 540 nm in an Anthos 
2001 ELISA reader. The assays were performed in duplicate and the mean 
values calculated.
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2.8 BINDING ASSAY
Purified preparations of RBCs, neutrophils, lymphocytes and monocytes 
cells, prepared as above (see sections 2.5.1 and 2.7) were resuspended in HH 
buffer containing 1 mM C aC ^. RBCs (2 X 108 in 800 p i ) ,  neutrophils, 
lymphocytes or monocytes (5 X 105) were incubated at 37 °C for 1 h in a 
microfuge tube with 200 p i  of culture supernate of P. haemolytica or with 50 
pi of dialysed urea extracts containing rLktA from E. coli. The cells were 
separated by centrifugation at 15,000 X g for 15 min to removed unbound 
toxin and the supernates were used for ELISA. The pellets were resuspended 
in 1 ml TME buffer (containing 10 mM Tris/HCl, 2 mM MgCl2, 1 mM EDTA, 
pH 7.4) and freeze-thawed twice in liquid nitrogen. The membrane pellets 
were washed three times with TME buffer and finally resuspended in 100 p i  of 
HH. The membrane proteins were separated by SDS-PAGE and then 
transferred to nitrocellulose by immunoblotting. An outline of the binding 
assay is shown in fig. 8 . The blots were probed with monoclonal antibody 
against LktA or against AC toxin (9D4), and anti-mouse HRP conjugate 
(SAPU) (Scottish Antibody production Unit, Carluke) (see section 2.4).
2.9 ELISA
The wells of flat-bottom ed, m icro titre  plates (DYNATECH 
IM M D U LO N T M , Chantilly, Virginia, USA) were coated with 350 p i  of 
monoclonal antibody raised against rLktA and diluted 1 in 100 in 0.05 M 
carbonate buffer, pH 9.6 (appendix 4). The plates were incubated at 4 °C 
overnight in a humidified box. They were washed three times by carefully 
flooding with washing buffer, containing 0.5% gelatin, 0.01% Tween 20 in 
100 ml PBS pH 7.4 and with each washing, the plates were inverted and 
dumped onto absorbent tissue to remove any remaining buffer from the wells. 
Native or rLktA was diluted in washing buffer and 300 p i  volumes added to
Fig. 8. Binding assay
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the wells. The plates were incubated for 2 h at 37 °C in a humidified box and 
then washed and dried as above. To each well, 250 pi rabbit polyclonal 
antibody raised against rLktA and diluted 1 in 3,000 in washing buffer was 
added. The plates were incubated for 4 h at 37 °C in a humidified box and 
then washed. 200 pi of a 1 in 3000 dilution of anti-rabbit IgG-HRP-enzyme 
conjugate (SAPU) in washing buffer was added to each well and the plate 
incubated overnight at 4 °C and washed as described above. The enzyme 
reaction was initiated by the addition of 200 pi of O-phenylenediamine (34 
mg/ml) and H2O2 (20 p i ) in 100 ml of citrate-phosphate buffer, pH 5.0 (freshly 
prepared, appendix 4). The plate was incubated for 30 min at room 
temperature in the dark for colour development. The reaction was stopped by 
addition to each well of 50 pi of H2SO 4 (12.5%  v/v). Absorbance was 
measured at 492 nm in an Anthos 2001 Elisa reader. An outline of the ELISA 
procedure is shown in fig. 9.
For measuring the level of polyclonal antibodies raised in rabbits against 
rLktA all procedures were the same except that instead of dilutions of rLktA, a 
standard amount of rLktA was added to each well and serial dilutions of the 
rabbit antisera were tested.
2.10 PROTEIN ESTIMATION
Protein estimation was carried out by the modified Lowry method of 
Markwell et al. (1978) using bovine serum albumin (Sigma) as a standard. The 
protein was measured at 610 nm using a spectrophotometer.
2.11 CHRISTIE ATKINS MUNCH-PETERSON (CAMP) TEST
This test detects co-haemolytic activity between B-toxin produced by 
Staphylococcus aureus and other bacteria, and has been used as in the 
differentiation of Streptococcus  species. Strains of P. haemolytica  were
Fig. 9. ELISA
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grown on BHIA containing 5% sheep blood for 18-24 h at 37 °C in air plus 10 
% CO2 . P. haemolytica isolates were streaked at right angles, and in close 
proximity to Staphylococcus aureus which produces B-toxin. A group B 
Streptococcus was used as positive control.
2.12 EFFECT OF LKT ON NEUTROPHIL CHEMOTAXIS
The micropore filter assay is a simple way of observing the reactions of 
neutrophils to chemotactic factors in vitro. It is essentially a two chamber 
apparatus in which neutrophils in the upper chamber are separated by a 5 |im 
filter from the chemotactic factor in the lower chamber.
To set up this assay, a rubber seal was first placed on top of the lower 
chamber. The chamber was then filled with 29 p.1 of chemotactic factor (OZ), 
or HH as a control, until a slight meniscus was seen. Care was taken to avoid 
trapping air bubbles. The shiny side of the filter was put on the top of the 
lower chamber and the upper chamber put in place and tightened by 6  screws. 
The apparatus was incubated for 10 min at 37 °C in 10 % CO2 . The 
neutrophils, with or without toxin, were then placed in the upper chamber and 
incubated for 45 min at 37 °C in 10 % CO2 . The chamber was then placed 
upside down and the two halves separated. The filter was removed and dried 
at room temperature. The dull side of the filter was washed in PBS and a 
rubber policeman was used to scrape off excess moisture. The filter was fixed 
in methanol for 2 min and stained with neat Leishman’s stains (BDH Ltd) for 6  
min and then with 50% Leishman's stains for 6 min. The excess stain was 
removed by washing with tap water. The filter was then mounted with DPX 
on a chemotaxis slide and the migrated cells were counted under the 
microscope with a 40 x objective. Five fields per well were counted and the 
average taken. In some experiments, the LktA preparations themselves were 
tested for their chemotactic activity by adding dilutions to the lower chamber
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in place of OZ.
2.13 EFFECT OF LKT ON LEU KOCY TE M O RPH O LO G Y  AND 
MOVEMENT
Human and bovine neutrophils were contained in a filming chamber: a 
stainless steel slide 70 x  40 X 1 mm with a 15 mm-diameter circular aperture 
and a 2 2  x  2 2  mm square glass coverslip was fixed over the aperture with 
paraffin wax. One ml of 0.5% BSA was added into the well. After 1 h, the 
solution of BSA was discarded and 200 p,l of cell suspension, 1 X 106 /ml in 
HH, was added to the well and left for 15 min at room temperature. The non­
adherent cells were removed by washing the well with HH. The adherent cells 
were treated with a 300 pi dilution of the active or inactive form of rLktA from 
E. coli or native leukotoxin from P. haemolytica . The top of the well was 
sealed with hot paraffin. The chamber was placed on the stage of an inverted 
microscope within a temperature-controlled (37 °C) box and locomotion was 
observed by means of a video camera connected to a monochrome monitor 
and also to an Archimedes A 5000 computer with a Watford video digitiser 
programmed to capture and analyse one frame every 5 seconds. The tracking 
program selected up to 80 phase bright cells. After tracking for 2 min, the 
computer displayed results which showed persistence (P), diffusion coefficient 
(D) and speed (S) of neutrophil locomotion which can be determined from the 
equation D=S2 (1+P). The speed of neutrophils was observed by displacement 
of randomly moving objects determined by the least squares approximation in 
a measured time interval and gives an apparent speed that approaches the true 
speed as the measuring interval decreases. Drift (a component of non-random 
locomotion) was calculated by determining the centre of cell density by 
carrying out a vectoral sum of the X and Y displacements of each cell centre 
to determine the average population displacement.
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2.14 ACTIVATION OF LKT IN  VITRO
The non-activated recombinant LktA (rLktA) was activated by addition 
of LktC and cytosolic activating factor (CAF), an E. coli cell extract, to LktA 
in vitro. LktA was prepared from E. coli strain SY327X pir containing plasmid 
pGW64 (encoding IktA) and the LktC was prepared from E. coli strain 
SY327X pir containing plasmid pGW78 (encoding IktC). Cytosolic activating 
factor was prepared from E. coli strain SY327A, pir at 37 °C. Cultures were 
grown with shaking, at OD 0.6, they were centrifuged at 15,000 X g for 15 
min at 4 °C and the cells were sonicated. The resulting supernate was 
separated from the pellet by centrifugation and used as CAF. For activation of 
rLktA, 50 jllI of urea extract containing rLktA was added to mixture of 50 |il of 
urea extract containing rLktC and 50 pi of CAF and incubated for 30 min at 4 
°C. The mixture was then added to bovine, human or rabbit neutrophils and 
incubated for a further 20 min at 38 °C. The cells were then tested in the CL- 
inhibition assay (section 2.5). These experiments were done in collaboration 
with E. K. Hormozi and Dr. G. Westrop
3. RESULTS
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3.1 CHARACTERISATION OF BACTERIA
The API 20 NE (see appendix 1) was used to confirm the identity of 
some of the P. haemolytica isolates which were commonly used in this study. 
All other strains used had been identified and serotyped by Ali et al. (1992); 
Azad et al. (1992); Davies et al. (1992) or D onachie (personal 
communication) and preserved as frozen stocks or freeze-dried. As appendix 
2 shows, most of the tests were negative. However, the typical positive and 
consistent reactions of P. haemolytica were found in the reduction of nitrates 
to nitrites, production of 13-galactosidase (majority of strains) and oxidase. 
Indole production was found in one P. haemolytica isolate (Ph6 ), and in P. 
multocida (both strains). Pseudomonas aeruginosa NCTC 6749 was used as 
a control organism for the API test and gave the expected biochemical 
profile. The serotypes of the strains used most frequently throughout this 
study were checked by the indirect haemagglutination method (section 
2.1.2). The above results show that the strains to be used in the present study 
were confirmed as P. haemolytica except possibly Ph6 , which was atypical in 
other characteristics but was serotype A l (Ali et al.y 1992) and possessed one 
plasmid in common with P. haemolytica (Azad et al., 1992).
3.2 PRODUCTION OF LEUKOTOXIN
3.2.1 Cultural conditions affecting production of native leukotoxin
Thirty three P. haemolytica isolates, including representatives of all 
different serotypes and untypables, were examined for Lkt production in 
culture supernates. For detection and quantitation of LktA, different methods 
were used including SDS-PAGE (7.5%, 10% and 12.5% acrylamide gels) and 
immunoblotting with monoclonal antibody, rabbit polyclonal antibody or
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bovine convalescent serum, chemiluminescence (CL) inhibition assay, ELISA 
chemotaxis and cell tracking assay.
3.2.1.1 Age of culture
The age of the culture was found to have a major influence on LktA 
yield. For example, strain Ph2 was grown in 50 ml volumes of BHIB at 37 °C 
in a 250 ml shake flask and culture supernate samples were removed after 2, 
3, 4, 5, 6 , 8 and 12 h. The immunoblot profiles of these culture supemates 
developed with a rabbit polyclonal antibody raised against recombinant 
LktA are shown in fig. 10a. The leukotoxin antigen was seen as a prominent 
band at 105 kDa. Some faint, lower mol. wt. bands were apparent in some 
samples. The time of maximum production of LktA for isolate Ph2 was around 
6 h, as judged by immunoblotting and as measured by the CL inhibition assay 
(figs. lOa-b) and toxin production with peak production of the end of log 
phase (6  h). The same result was found with two other strains (P h i2, fig. 10c; 
Phl44, fig. lOd). Thus, with these strains, there was good agreement between 
the amount of LktA antigen produced in the culture supernate and the 
amount of LktA activity detected. These results indicate that production of 
LktA by those strains in BHIB was dependent on active growth of bacteria. 
The timing of the end of log phase varied somewhat from strain to strain 
(table 4). As the culture then aged, there was a marked decline in toxin 
activity (figs 10b; 10c; lOd). Immunoblot profiles of culture supemates of Ph2, 
Ph8 , PhlO, Ph30, Ph42, Ph44 and Ph72 after growth for 24 h in BHIB show 
two or three bands which cross reacted with an anti-LktA monoclonal 
antibody, thus indicating degradation of the toxin (fig. lib ) . The immunoblot 
profiles of these culture supemates were also developed with convalescent 
serum (fig. 11a).
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Fig. 10.
Production of leukotoxin in the culture supernate.
P. haemolytica Ph2 was grown in 50 ml BHIB in 250 ml shake flask at 120
rpm at 37 °C and samples were removed at intervals. The cell-free culture
supemate/samples were resolved by SDS-PAGE in a 10% polyacrylamide gel,
immunoblotted and probed with rabbit polyclonal antibody raised against 
a
rLktA atAdilution of 1 in 2000. Arrow shows bands (105 kDa) identified as 
LktA.
a
Lane 1: culture supernate harvested at 2 h
Lane 2: culture supernate harvested at 3 h
Lane 3: culture supernate harvested at 4 h
Lane 4: culture supernate harvested at 5 h
Lane 5: culture supernate harvested at 6 h
Lane 6 : culture supernate harvested at 8 h
Lane 7 : culture supernate harvested at 12 h
b
Growth of P. haemolytica Ph2 (OD 620 nm) and toxin activity in 
culture supernate (CL-inhibition assay with bovine neutrophils).
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Fig. 10.
c
Growth of P. haemolytica P h i2 (OD 620 nm) and toxin activity in 
culture supernate (CL-inhibition assay with bovine neutrophils).
d
Growth of P. haemolytica P h i44 (OD 620 nm) and toxin activity in 
culture supernate (CL-inhibition assay with bovine neutrophils)
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Fig. 11.
Antigenic relationships between leukotoxin proteins of P. haemolytica 
isolates.
Cell-free culture supernate of P. haemolytica isolates were removed at the 
end of log phase (e.g. 6  h) (lanes 1-7) and at 24 h (lanes 8-14) and were 
resolved by SDS-PAGE (10% polyacrylamide gel) and immunoblotted and 
probed with convalescent serum raised against Ph2 at a dilution of 1 in 200
(a) or with monclonal antibody raised against of rLktA (b). Arrows show
A
bands identified as LktA.
Culture supernate was taken at the end of log phase growth of bacteria
Lane 1: Ph2
Lane 2: Ph8
Lane 3: PhlO
Lane 4: Ph30
Lane 5: Ph42
Lane 6 : Ph44
Lane 7: Ph72
Culture supernate was taken after 24 h growth of bacteria
Lane 8 : Ph2
Lane 9: Ph8
Lane 10: PhlO
Lane 11: Ph30
Lane 12: Ph42
Lane 13: Ph44
Lane 14: Ph72
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3.2.1.2 Aeration conditions
In further experiments, growth of the P. haemolytica Ph2 isolate under 
various conditions of aeration was monitored by spectrophotometry and 
LktA production and toxic activity was measured by immunoblotting and CL 
assays. Various conditions of aeration of the culture, i.e. very high aeration, 
high aeration, moderate aeration, low aeration, no aeration and anaerobic (5% 
CO2), according to Davies et al. (1992) were examined. The maximum yield 
of toxin and growth was obtained with very high aeration i.e. with 50 ml of 
culture medium contained in a 250 ml dimpled shake flask and incubated at 
120 rpm and 37 °C (fig. 12a-c). As figs 12a and 12c show, LktA production 
was dependent on growth of the bacteria. Maximum growth occurred with 
very high and high aeration (fig. 12a). Fig. 12c shows the coomassie blue 
stained gel of culture supernate samples and the band at 105 kDa (arrow 
shows band presumed to be leukotoxin). Other protein material was present 
in samples taken at 24 h. Production of LktA (fig. 12d) as judged by 
immunoblotting of the culture supernate samples with anti-LktA polyclonal 
was greatest with very high and high aeration (lane 5 and 6) and reduced 
with moderate aeration (lane 4), low aeration (lane 3) and anaerobic (5% 
CO2) (lane 2). No LktA was detected by this method when bacteria were 
grown without shaking (figs 12c and 12d lane 6 and 1, respectively). When 
LktA activity of these same samples was monitored by CL assay, similar 
results were obtained. The bacterium produced most LktA activity with very 
high and high aeration (fig. 12b).
3.2.1.3 Growth temperature
In other experiments P. haemolytica Ph2 was grown in BHIB for 5 h at 
37 °C and then for 1 h at different temperatures. Each culture was then 
centrifuged at 7,000 x g for 15 min and culture supernate resolved by 10%
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Fig. 12.
Effect of aeration conditions on growth of P. haemolytica strain Ph2 and 
leukotoxin production.
Strain Ph2 was gpwn in 50 ml of BHIB at 37 °C under various conditions i.e. 
very high aeration, high aeration, moderate aeration, low aeration, anaerobic + 
5% CO2, without shaking and the OD620 was recorded at intervals (a). The 
LktA activity of the culture supernate samples was measured by the CL 
inhibition assay. Culture supernate samples were incubated with bovine 
neutrophils for 30 min at 38 °C, then CL responses of the neutrophils were 
measured after stimulation with OZ. The data presented are the means of the 
peak CL responses during the 45 min test period after stimulation (b). Cell- 
free culture supemate/samples of each culture were removed at the end of log. 
phase (6  h) and at 24 h and were resolved by SDS-PAGE (10% 
polyacrylamide gel) and stained with coomassie blue (c), or immunoblotted 
and probed with polyclonal antibody raised against rLktA at a dilution of 1 in 
2000 (d). Arrows show bands identified as LktA.
Key to fig: 12 a 6  h growth of bacteria
1: Control (BHIB)
1: Very high aeration 2 : Control (BHIB + OZ)
2 : High aeration 3: Very high aeration
3: Moderate aeration 4: High aeration
4: Low aeration 5: Moderate aeration
5: Anaerobic + 5% CO2 6 : Low aeration
6 : Without shaking 7:
8 :
Anaerobic + 5% CO2 
Without shaking
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Keys to fig 12c and 12d
(c)
1: Mol. wt marker SDS 6 H
(d)
1: Without shaking
2 : Very high aeration 2 : Anaerobic + 5% CO2
3: High aeration 3: Low aeration
4: Moderate aeration 4: Moderate aeration
5: Low aeration 5: High aeration
6 : Anaerobic + 5% CO2 6 : Very high aeration
7: Without shaking
Lanes 8-13 in fig 12 (c) are for samples taken after 24 h growth of the bacteria
8 : Very high aeration
9: High aeration
10: Moderate aeration
11: Low aeration
12: Anaerobic + 5% CO2
13: Without shaking
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SDS-PAGE and transferred to nitrocellulose and developed with 
convalescent serum. Fig. 13 shows the production of LktA at the different 
temperatures. Lanes 1, 2, 3, 4, 5, 6 are culture supemates of Ph2 when bacteria 
were grown at 41, 37, 35, 30, 25 and 20 °C, respectively. In this immunoblot, 
convalescent serum was used to detect LktA (before the polyclonal serum 
was available) and, as shown in fig. 13, bands in addition to the 105 kDa 
LktA antigen were detected. P. haemolytica produced more toxin and grew 
optimally when grown at 37 °C (data not shown). The production of LktA 
was thus shown to be tem perature dependent and with increasing 
temperature, the production of LktA was increased. However the production 
of LktA decreased when bacteria were grown at 41 °C (fig. 13 lane 1). A faint 
band of LktA was detected when bacteria were grown at 20 °C (fig. 13 lane 
6).
3.2.1.4 Growth medium
The production of some bacterial toxins is known to be regulated by the 
composition of the growth medium.
C alcium  and  iron. To show the effect of calcium and iron on 
production and secretion of LktA, P. haemolytica Ph2 was grown in the 
presence of different concentrations of iron (FeCl3 250 .fiM, 500 pM, 1 mM, 
2  mM), 2-2'dipyridyl (50 mM, 100 mM, 200 mM), calcium (CaCh 50 mM, 100 
mM, 200 mM) and EGTA (8  mM, 16 mM, 32 mM) in BHIB. Strain Ph2 was 
grown initially in BHIB for 5 h at 37 °C. The culture was then centrifuged at 
7,000 X g for 15 min and the pellet suspended in BHIB containing either iron, 
calcium, 2-2'dipyridyl or EGTA. The bacteria were grown for a further 1 h at 
37 °C and culture supemates taken and LktA production assayed by SDS- 
PAGE and immunoblotting. The growth of bacteria over a 1 h period was
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Fig. 13.
Effect of tem perature on LktA prodction by P. haemolytica Ph2.
P. haemolytica Ph2 was grown at various temperatures in 50 ml BHIB in a 
250 ml shake flask at 120 rpm at 37 °C. The culture supernate was taken at 6 
h and resolved by SDS-PAGE and immunoblotted and developed with bovine 
convalescent serum. Arrow shows bands at 105 kDa identified as LktA.
Lane 1: growth at 41 °C
Lane 2: growth at 37 °C
Lane 3: growth at 35 °C
Lane 4: growth at 30 °C
Lane 5: growth at 25 °C
Lane 6 : growth at 20 °C
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Fig. 14.
Effect of calcium  and iron on growth of P. haemolytica stra in  Ph2 and 
production and secretion of LktA.
P. haemolytica Ph2 was grown in 50 ml BHIB in a 250 ml shake flask at 120 
rpm for 5 h at 37 °C. The culture was centrifuged at 7000 X g for 15 min and 
the pellet suspended in BHIB containing either iron, calcium, dipyridyl or 
EGTA at various concentration.Incubation was continued for a further 1 h at 
37 °C. Growth was monitored spectrophotometricaly at OD620 nm (a). Cell 
free culture supernate was taken at 6 h and resolved by SDS-PAGE and 
immunoblotted and probed with bovine convalescent serum (b). 
a
1: growth in BHIB (control)
2: growth in BHIB + 8 mM EGTA
3: growth in BHIB + 16 mM EGTA
4: growth in BHIB + 32 mM EGTA
5: growth in BHIB + 50 mM dipyridyl
6: growth in BHIB + 100 mM dipyridyl
7: growth in BHIB + 200 mM dipyridyl
8: growth in BHIB + 50 mM CaCh
9: growth in BHIB + 100 mM CaCl2
10: growth in BHIB + 200 mM CaC^
11: growth in BHIB + 250 |iM  FeCl3
12: growth in BHIB + 500 pM FeCl3
13: growth in BHIB + 1 mM FeCl3
14: growth in BHIB + 2 mM FeCl3
OD
 
620
 
nm
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b
1: Culture supemate from BHIB medium contanining 8 mM EGTA
2: Culture supemate from BHIB medium contanining 16 mM EGTA
3: Culture supemate from BHIB medium contanining 100 mM dipyridyl
4: Culture supemate from BHIB medium contanining 200 mM dipyridyl
5: Culture supemate from BHIB medium (control)
6: Culture supemate from BHIB medium contanining 100 mM CaCl2
7: Culture supemate from BHIB medium contanining 200 mM CaCl2
8 : Culture supemate from BHIB medium contanining 500 j i M  FeCl3
9: Culture supemate from BHIB medium contanining 1 mM FeCl3
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inhibited when the bacteria were grown in the presence of the highest 
concentrations of iron (2 mM) and EGTA (32 mM) (fig. 14a). Fig. 14b shows 
the production of LktA was not influenced by the presence of 1 mM iron 
(lane 9), 200 mM calcium (lane 7 ), 200 mM 2-2’dipyridyl (lane 4) and 16 mM 
EGTA (lane 2 ) i.e. concentrations which did not significantly inhibit growth 
of the organism. These results indicate that the amount of iron and calcium 
was not critical for production and secretion of LktA in BHIB, at least over a 
1 h period.
Osmolarity. Alterations in DNA supercoiling created by changes in 
osmolarity are known to effect the regulation of expression of several 
bacterial proteins (Carmona et a l ,  1993). Different concentrations of NaCl in 
BHIB were tested to determine the effect of osmolarity on LktA production. 
P. haemolytica Ph2 was grown in BHIB as above and after 5 h the bacteria 
were suspended in BHIB containing different concentrations of NaCl for 1 h. 
Fig. 15b shows an immunoblot of the resulting culture supemate and fig. 15a 
shows the growth of the bacteria in the different concentrations of NaCl. The 
bacteria produced LktA normally when grown in 0.1, 0.3 and 0.5 M NaCl 
(fig. 15b lanes 1, 2, 3). However, the bacteria did not produce detectable LktA 
in the presence of 0.8, 1 or 1.2 M NaCl (fig. 15b lanes 4, 5, 6). The highest 
concentrations (> 1.0 M) prevented growth of the organism (fig. 15a), but 
there was only slight retardation of growth of the bacteria in lower salt 
concentrations (fig. 15a) particularly at 0.8 M where little or no LktA was 
detected. In this immunoblot, convalescent serum was used to detect LktA 
and the antibody detected other products of P. haemolytica in the culture 
supemate. The arrow shows the band presumed to be leukotoxin.
Different concentrations of glucose and sucrose were also investigated. 
P. haemolytica Ph2 was grown as previously described, and after 5 h, the
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Fig. 15.
Effect of NaCl or glucose on growth of P. haemolytica Ph2 and production 
of LktA.
P. haemolytica Ph2 was grown in 50 ml volumes of BHIB for 5 h at 37 °C. 
The culture were then centrifuged at 7000 X g for 15 min and the pellet 
suspended in 50 ml volumes of BHIB containing different concentration of 
NaCl or glucose for 1 h. Growth was monitored by spectrophotometry at 
620nm (a). Cell-free culture supernates were taken and resolved by SDS- 
PAGE, immunoblotted and probed with bovine convalescent serum. Arrow 
shows the band at 105 kDa presumed to be LktA (b).
a b
1: BHIB control Lane 1: BHIB + 0.1 M NaCl
2: BHIB + 0.1 M NaCl Lane 2: BHIB + 0.3 M NaCl
3: BHIB + 0.3 M NaCl Lane 3: BHIB + 0.5 M NaCl
4: BHIB + 0.5 M NaCl Lane 4: BHIB + 0.8 M NaCl
5: BHIB + 0.8 M NaCl Lane 5: BHIB + 1 M NaCl
6: BHIB + 1 M NaCl Lane 6: BHIB + 1.2 M NaCl
7: BHIB + 1.2 M NaCl Lane 7: BHIB + 0.1 M glucose
Lane 8: BHIB + 0.3 M glucose
Lane 9: BHIB + 0.7 M glucose
Lane 10: BHIB + 1 M glucose
Lane 11: BHIB control
(a)
-o—
£c
<NsC
0.0
84 6i
Time (h)
b
MW kl)a 
205 _
1 2  3 4 5 6 7 8 9 10 11
R E SU L T S 8 6 P A R T  3
growing bacteria were resuspended in BHIB containing different 
concentrations of glucose and sucrose. After the culture supernates were 
taken and LktA production assayed by SDS-PAGE and transferred to 
nitrocellulose and developed with convalescent serum. Figs. 15b and 16 
show the production of LktA by Ph2 in BHIB containing glucose and 
sucrose. Strain Ph2 produced LktA normally when it was grown in BHIB 
containing glucose or sucrose of 0.1 M, 0.3 M, 0.7 M and 1 M. The 
production of LktA when grown in BHIB alone, is also shown. The results 
indicate that different concentration of glucose and sucrose had no effect on 
production of LktA.
pH. Production of LktA at different pH values was also examined. P. 
haemolytica Ph2 isolate was grown as above and, after 5 h the bacteria were 
resuspended in BHIB in which the pH had been changed by the addition of 
NaOH or HC1. P. haemolytica produced more toxin in alkaline (pH 8) medium 
than in acidic (pH 6) medium (fig. 16, lanes 6 and 7 respectively) but the 
amount in the former was comparable to that produced in normal BHIB (pH 
7.3).
A ntibiotics. Because of the indication that NaCl at 0.8 M was 
suppressing LktA production without affecting growth, it was decided to 
examine antibiotics which, like osmolarity, are shown to effect DNA 
supercoiling. P. haemolytica Ph 2 was grown as above and, after 5 h the 
bacteria were resuspended in BHIB in the presence of different antibiotics 
(novobiocin [25-200 jLtg/ml] and coumeromycin A1 [20-100 pg/ml]) which are 
known to affect DNA supercoiling and gene expression (Jovanovich and 
Lebowitz, 1987). The production of LktA was not altered by the presence of 
different concentrations of these antibiotics at concentration which did not
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Fig. 16.
Effect of sucrose, DBHIB and pH on production of LktA.
P. haemolytica Ph2 was grown for 5 h in BHIB and then the bacteria were 
suspended in BHIB containing different concentrations of sucrose, dialysed 
BHIB (DBHIB) or in BHIB at different pH values. Incubation was continued 
for a further 1 h and the cell free culture supemate was taken and resolved by 
SDS-PAGE and then transferred to nitrocellulose and probed with 
convalescent serum.
Lane 1: BHIB + 0.1 M sucrose
Lane 2: BHIB + 0.3 M sucrose
Lane 3: BHIB + 0.7 M sucrose
Lane 4: BHIB + 1 M sucrose
Lane 5: DBHIB
Lane 6: BHIB (pH 8)
Lane 7: BHIB (pH 6)
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Fig. 17.
The effect of serial passage of P. haemolytica on production of LktA.
P. haemolytica Ph 2 was passaged 40 times on BHIA and then was grown 
in 50 ml BHIB in a 250 ml shake flask at 120 rpm at 37 °C and samples were 
removed at intervals. The cell-free culture supernates were resolved by SDS- 
PAGE in a 10% polyacrylamide gel, immunoblotted and probed with 
convalescent serum raised against Ph2, at dilution of 1 in 200. Arrow shows 
bands identified as LktA.
Lane 1: culture supemate harvested at 6 h, after 40 subculture
Lane 2: culture supemate harvested at 6 h, after one subculture of cells
taken from a glycerol stock
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inhibit growth i.e. < 25 (Xg/ml for novobiocin and < 20 |Xg/ml for 
coumeromycin A1 (data not shown).
RPM I medium. In many previous studies on LktA, P. haemolytica was 
grown initially in BHIB, then harvested and resuspended in RPMI with 
various supplements in order to enhance toxin production (see section 1.5.5). 
In the present investigation, Ph2 was grown in BHIB for 4 h and then 
resuspended in RPMI alone or containing various concentrations of FCS (3- 
14%) or BSA (1-4 mg/ml). After further incubation for 1-2 h, samples were 
assayed for toxin production and activities. The yield of LktA was greatest in 
RPMI + FCS 7% after 2 h but this was not markedly greater than the yield 
obtained by growth in BHIB (data not shown). In view of the technical 
complexity and expense of the RPMI method, BHIB was chosen for further 
studies. In addition, the presence of serum protein in RPMI + FCS caused 
problems in interpretation of gel profiles, caused cross-reactions in 
immunoblots and also affected CL responses of some species of neutrophils, 
which did not occur with BHIB as the growth medium.
Dialysed B H IB . The production of toxin in BHIB and Dialysed BHIB 
(DBHIB) (Chang et al., 1987b) was investigated. P. haemolytica was grown 
in BHIB or DBHIB for 6 h at 37 °C. More toxin was produced in the BHIB 
than DBHIB (Fig. 16 lane 5).
3.2.1.5 The effect of serial passage of P. haemolytica on production 
of LktA.
P. haemolytica Ph2 was passaged 40 times on BHIA, a process which 
took 3 months. The production of LktA in culture supemates was measured 
by the CL-inhibition assay but there was no loss of toxicity by the passaged 
strain (data not shown). Similarly, serial passage did not affect the quantity of
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leukotoxin (LktA) protein present in these samples as judged by 
immunoblotting (fig. 17, lanes 1 and 2). These results indicate that freshly 
isolated cultures of this organism are not necessary for toxin production and 
the bacteria do not lose the ability to produce active LktA.
Thus, in comparing LktA production by different strains of P . 
haemolytica, bacteria were grown in BHIB at 37 °C, with very high aeration 
and culture supemate samples were taken at the end of log phase. The band 
at 105 kDa in the crude extract of culture supernate of BHIB and RPMI in 
SDS-PAGE or blots was identified as the 105 kDa leukotoxin protein. This 
band also reacted in blots probed with an ti-105 kDa P. haem olytica  
leukotoxin monoclonal antibody. In some samples, bands of mol. wt lower 
than 105 kDa were present indicating possible degradation of LktA.
3.2.2 Ultrafiltration
In an attempt to purify the LktA from BHIB culture supemates, different 
Amicon ultrafiltration membranes (mol. wt cut-offs 50,000, 100,000 and 
300,000) were used. Although the mol. wt of leukotoxin is 105 kDa, as 
judged by SDS-PAGE, it did not pass through an Amicon ultrafiltration 
membrane with a cut-off of 300 kDa. The LktA appears therefore to be 
combined with some other cell component or in an aggregated state. To try to 
remove the aggregation, the effect of various agents was tested (fig 18). Thus, 
LktA was treated with 2% SDS (lane 4), 2% zwittergent (lane 6), 1 mM EGTA 
(lane 8) and 8 M urea. They had no effect on the aggregation of LktA as 
judged by the failure of the treated toxin to pass through a 300,000 cut-off 
Amicon ultrafiltration membrane and when the membranes were washed with 
distilled water, the LktA was detected in the washing fluid which confirmed 
that it had not passed through the membrane (lanes 2, 3, 5, 7 and 9 of fig. 18)
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Fig. 18.
Effect of various agents on LktA aggregation.
P. haemolytica was grown for 6 h at 37 °C in BHIB. Cell-free culture 
supemate was concentrated 10-fold with an Amicon ultrafiltration membrane 
(mol wt. cut-off 300,000) at 4 °C. Various agents were tested for their effects 
on LktA aggregation. LktA was treated with 2% SDS, 2% zwittergent, or 1 
mM EGTA but none allowed the LktA to pass through the ultrafiltration 
membrane. When the LktA was concentrated with an mol. wt 300 Amicon 
ultrafiltration membrane, the membrane washed with zwittergent and distilled 
water and LktA was detected with immunoblotting. Ten j l l I  of a 10-fold 
concentration of culture supemate and washed membrane were resolved on 
10% SDS-PAGE and then transferred to nitrocellulose and probed with 
convalescent serum at a dilution of 1 in 400.
In another experiment, concentrated LktA was passed through the detoxigel. 
The culture supemate which either bound to detoxigel or passed through the 
detoxigel was resolved on 10% SDS-PAGE, immunoblotted and probed with 
convalescent serum at a dilution of 1 in 400.
Lane 1: 10-fold concentration of LktA
Lane 2: membrane washed with distilled, water
Lane 3: membrane washed with zwittergent
Lane 4: 10-fold concentration of LktA + 2% SDS
Lane 5: membrane washed with 2% zwittergent
Lane 6: 10-fold concentration of LktA + 2% zwittergent
Lane 7: membrane washed with distilled water
Lane 8: 10-fold concentration of LktA + 1 mM EGTA
Lane 9: membrane washed with distilled water
Lane 10: the culture supemate which bound to detoxigel
Lane 11: the culture supemate which passed through the detoxigel
Lane 12: the culture supemate which passed through the ultrafiltration
membrane
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Fig. 19. 
Preparation of recombinant leukotoxin (rLktA)
Active and inactive form of recombinant leukotoxin were produced by 
transfer of the IktA and IktC genes to E. coli. E . coli DH5ocF'IQ (pGW42) 
produced active rLktA of 105 kDa and an additional protein of >120 kDa 
(lane 1). E. coli HMS174 or SY327A, pir (pGW42) produced active LktA with 
a mol. wt 105 kDa (lane 2).
E. coli SY327A, pir (pGW64) produced inactive rLktA (lane 4). When plasmid 
pGW78 was transferred to E. coli strain SY327A, pir (pGW64), active rLktA 
was produced and the mol. wt of rLktA did not change (lane 3). 10 pi of urea 
extract/well was resolved on a 10% of SDS-PAGE gel, immunoblotted and 
probed with monoclonal antibody raised against rLktA. Culture supemate of 
Ph2 was used as control (lane 5).
Lane 1: P. haemolytica Ph2 culture supemate
Lane 2: E. coli strain SY327A, pir + plasmid pGW64 (inactive rLktA)
Lane 3: E. coli strain SY327^ pir + plasmids pGW64 + pGW78 (active
rLktA)
Lane 4: E. coli strain HMS174 + plasmid pGW42 (active rLktA)
Lane 5: E. coli strain DH5aFIQ + plasmid pGW42 (active rLktA)
R E SU L T S 9 2 PA R T  3
205
1 2 3 4 5
116
_  97,4
6 6
R E SU L T S 93 P A R T  3
3.2.3 Preparation of recombinant leukotoxin (rLktA)
In order to partially purify and produce large amounts of leukotoxin, the 
IktA and IktC genes were cloned into E. coli. Different strains of E. coli (i.e. 
E. coli strains DH5ocFIQ and HMS174 containing plasmid pGW42, encoding 
both IktA  and IktC  and producing active rLktA, or strain SY3272. pir 
containing plasmid pGW64 (encoding IktA) and/or pGW78 (encoding IktC) 
were used. In D H 5aFIQ , a >120 kDa protein was produced in addition to the 
105 kDa by pGW42 (fig. 19, lane 5). This higher molecular weight protein 
was recognised by a LktA specific monoclonal antibody and was most likely 
a fusion protein because D H 5aFIQ  contains an amber suppressor mutation 
that would suppress a translational stop codon between IktC and IktA. E. 
coli strains HMS174 or SY327X pir containing plasmid pGW42 (encoding 
active rLkt) produced 105 kDa protein that reacted with the monoclonal 
antibody raised against rLktA (fig. 19, lane 4). These strains had no 
suppression or mutations.
E. coli strain SY3272, pir containing plasmid pGW64 produced only 
inactive leukotoxin with the same apparent mol. wt as the active form of 
LktA (fig. 19, lane 3). When IktC  was transferred to the same E. coli 
containing the IktA gene, the mol. wt of the resulting, active rLktA did not 
change (fig. 19, lane 2). Cell-free culture supemate of P. haemolytica isolate 
Ph2 was used as a control (lane 1).
3.3 DEVELOPMENT OF THE CL ASSAY
3.3.1 Different preparations of target cells.
Bovine whole blood, isolated lymphocytes, monocytes and neutrophils 
were used to measure the normal CL response prior to setting up a CL- 
inhibition assay. No significant signal was obtained with whole-blood
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stimulated with different stimuli, presumably due to quenching of the light 
output. Small numbers of contaminating erythrocytes can cause significant 
light arrest and so steps were taken to remove erythrocytes from leukocyte 
preparations. Percoll or Histopaque at a density of 1.077 was used to separate 
the mononuclear cells from erythrocytes and neutrophils and the use of 
isotonic ammonium chloride and hypotonic shock were used for the lysis of 
the RBCs. Although each method for removing the RBCs had some effect on 
target cells, the isotonic ammonium chloride method was used routinely. The 
hypotonic shock very quickly lysed the RBCs, but it reduced the viability of 
the leukocytes.
In order to find suitable target leukocytes for LktA action and for assay 
by CL inhibition, the CL response of bovine lymphocytes, monocytes and 
neutrophils were compared. Bovine lymphocytes 100 pi (5 X 105 m l'1) were 
treated with DNDH 10'5 M and then stimulated with OZ (0.1 mg/ml). Fig. 20 
shows that purified lymphocytes did not produce a CL response when 
incubated with this stimulus. The bovine monocytes produced approx. one- 
eighth of the CL produced by bovine neutrophils. It was reported that 
human monocytes produced approx. one-third of the CL signal generated by 
neutrophils (Nelson et aL, 1976).
Two methods were used to prepare the neutrophils (see section 2.5.1). 
When these two methods, using Percoll and isotonic ammonium chloride, 
were compared, it was found that neutrophils prepared by lysis of the RBCs 
with isotonic ammonium chloride were less contaminated with mononuclear 
cells. Their responses to various stimuli (i.e. PMA OZ, latex beads, fMLP) 
were similar and leukotoxin bound to and lysed both preparations (see 
section 3.13.2).
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Fig. 20.
Measurement of the normal CL responses of lymphocytes, monocytes and 
neutrophils
Bovine lymphocytes, monocytes and neutrophils were separated from RBCs 
by Percoll density gradient centrifugation. Cells (5 X 104 ml-1) were treated 
with DNDH 10"5 M, incubated for 30 min at 38 °C and then stimulated with 
OZ(0.1 mg/ml).
1: bovine monocytes
2: bovine lymphocytes
3: bovine neutrophils
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Fig. 21.
Effect of different chemiluminogenic probes on CL response of bovine 
neutrophils
Bovine neutrophils (5 X 104 ml*1) were incubated with 10'5 M luminol, 
lucigenin or DNDH for 5 min at 38 °C. The cells were stimulated with OZ (0.1 
mg/ml). The CL response was measured at different times.
1: luminol + PM A
2: DNDH + PMA
3: DNDH + OZ
4: lucigenin + OZ
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3.3.2 Effect of different chemiluminogenic probes on CL response.
The chem ilum inescent signal is normally amplified by adding 
compounds such as luminol, DNDH or lucigenin to the assay mixture. Bovine 
neutrophils were incubated with different chemiluminogenic probes and then 
stimulated with OZ or PMA. The results in fig. 21 show that the best 
chemiluminogenic probe was DNDH, giving a far greater and more prolonged 
CL response particularly with OZ, than either the luminol or lucigenin (fig. 
21).
3.3.3 Effect of different stimuli
Different stimuli can be used to activate different signalling pathways in 
neutrophils in order to generate a CL response. The chemiluminescence 
responses of bovine neutrophils to different stimuli i.e. opsonised zymosan, 
PMA, /M LP, latex beads and zymosan were measured. Bovine neutrophils 
were mixed with DNDH at 38 °C and then stimulated with different stimuli. 
Fig. 22 shows /M LP could not stimulate CL response of bovine neutrophils 
and latex beads 108/ml (particle diameter, 1.16 p.; Sigma) were weak but PMA 
induced an obvious and rapid response. Opsonised zymosan induced a high, 
persistent response. The response of the neutrophils to zymosan was lower 
than to opsonised zymosan. Although cold OZ produced more stimulation of 
neutrophils, to prohibit the effect of temperature on the CL response, OZ at 
room temperature was found better for these experiments. Increasing the 
concentration of stimuli (i.e. OZ, PMA) per assay, caused a greater CL 
response but OZ at a concentration of 0.1 mg/ml was found to be suitable for 
subsequent work.
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Fig. 22.
Effect of different stimuli on the CL response of bovine neutrophils
Bovine neutrophils (5 X 104 ml-1) were suspended in PBS and then stimulated 
with different stimuli, PMA (1 jig/ml), fMLP (10~7 M), latex beads 108/ml, 
zymosan or OZ (100 Jig/ml) in the presence of DNDH 10 5 M.
1: opsonised zymosan
2: zymosan
3: fMLP
4: latex beads
5: PMA
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Fig. 23.
Effect of different suspending buffers
Bovine neutrophils were suspended in PBS or HH in the presence of DNDH 
10"5 for 30 min at 38 °C. The cells were stimulated with OZ (100 fig/ml).
1: PBS
2: HH
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3.3.4 Effect of different suspension buffers
The effect of different suspension buffers (PBS and Hanks Hepes (HH)) 
on the CL response of neutrophils was examined. Bovine neutrophils were 
suspended in PBS or HH with DNDH and stimulated with OZ. Fig. 23 shows 
that the neutrophil response to OZ was greater when suspended in HH. This 
high response could be due to the presence of 1 mM calcium in this buffer 
(see appendix. 4).
For assay of LktA, toxin samples and neutrophils were incubated 
together for different times before the addition of OZ. Incubation for 30 min 
was found to be most suitable to allow any toxin activity on the target cells, 
and for the system to equilibrate.
Different concentrations of urea were tested for their effect on the CL 
response of neutrophils since some toxin samples were prepared by urea 
extraction. Bovine neutrophils were incubated with different concentrations 
of urea (0.01, 0.04, 0.08, 0.1,0.4, 0 .8 ,1 ,4  and 8 M) in the presenxe of DNDH, 
then stimulated with OZ. <0.08 M urea had no affect on target cells but 
>0.08 M urea reduced the CL response and presumably it killed the cells. 
Thus, for assay of LktA urea extracts of bacteria, the concentration of urea 
was decreased by dialysis or its concentration was reduced to below 0.08 M 
by dilution (data not shown).
During initial CL experiments, it became apparent that temperature 
changes during the CL assay i.e. adding cold reagents to the cells incubated 
at 38 °C in the luminometer or transferring neutrophils suspension from room 
temperature to the luminometer at 38 °C, caused a small but detectable CL 
response. To avoid any effects of temperature changes (room and machine) 
all cell suspensions were equilibrated and kept in the machine during the 
preincubation time and addition of cold reagents was avoided.
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3.4 ASSAY O F L K T  IN C U L T U R E  SU PE R N A TE S O F 
DIFFERENT STRAINS OF P. HAEMOLYTICA
The above investigations of factors affecting LktA production by P. 
haemolytica  (seesection 3.2.1 and 3.2.2) were done with the serotype A1 
bovine isolate, Ph2. Similar results were obtained with strains Ph30, Ph42, 
FT4, Phl44, Phl46, Phl52 and Phl54, which included serotypes A l, A2, T 
and untypables. In section 3.2.1.1, it was established that LktA production 
was maximal at the end of the log phase of growth in BHIB in shaken (120 
rpm) cultures at 37 °C. A comparison of the production of LktA by other 
strains was made using the above growth conditions. Having established 
suitable conditions for generating a CL response in bovine and ovine 
neutrophils, different samples could be assayed for LktA activity in a CL 
inhibition assay. Cell-free culture supernates of P. haemolytica isolates, 
containing LktA, were incubated with bovine and ovine neutrophils for 30 
min, in the presence of DNDH, and neutrophils were stimulated by OZ. The 
activity of the toxin was measured by inhibition of the normal CL response of 
the neutrophils. The results are summarised in table 4. Culture supernate 
samples from most strains (21/33) were highly toxic >80% inhibition of the 
normal CL response of bovine and/or ovine neutrophils (table 4). Samples 
from an untypable strain, UT3, proved to be the most toxic and were the only 
samples to give 100% inhibition of CL. Three strains were moderately toxic 
(41-80% inhibition) for bovine and/or ovine neutrophils. Eight strains had 
low toxicity (<40% inhibition) for both bovine and ovine neutrophils: these 
included one serotype A l, two A2, all biotype T (P. trehalosi) and one 
untypable strain. Only one strain, Ph6, a bovine isolate of serotype A l, 
produced no detectable toxic activity. With all strains, culture supernate 
samples taken earlier or later during growth did not show any greater toxic 
activity. Results of a typical CL-inhibition assay, with samples from three
Table 4.
Summary of Lkt activity of P. haemolytica isolates and E. coli examined by CL assay
Laboratory
designation
Serotype Species 
of origin
Age of Culture
(hr
Leukotoxic activities! 
Bovine Ovine
% of 
Haemolytic 
activity
*Ph 2 Al Bovine 6.00 97 97 48
Ph 10 Al Bovine 6.00 95 96 40
Ph 8 Al Ovine 6.00 67 89 23
Ph 12 Al Bovine 8.00 85 90 31
Ph 14 Al Bovine 8.00 6 20 16
Ph 26 Al Bovine 8.00 84 90 36
Ph 30 Al Bovine 5.30 50 75 27
Ph 6 Al Bovine 6.00 0 0 2
Ph 48 Al Ovine 7.30 78 85 17
Ph 42 A2 Bovine 8.00 6 26 33
Ph 44 A2 Bovine 8.30 42 66 41
Ph 72 A2 Ovine 8.30 5 22 13
Ph 140 A2 Ovine 8.00 61 85 23
Ph 142 A2 Ovine 8.00 18 85 15
Ph 50 A5 Ovine 6.30 95 97 33
Ph 52 A6 Ovine 6.30 94 95 25
Ph 54 A l Ovine 6.30 95 95 23
Ph 56 A8 Ovine 7.00 93 94 49
Ph 58 A9 Ovine 6.30 96 97 46
Ph 60 A ll Ovine 5.00 45 60 22
Ph 62 A12 Ovine 4.30 90 92 45
Ph 64 A13 Ovine 6.30 91 94 22
Ph250 A13 Ovine 5.30 90 90 42
Ph 66 A14 Ovine 5.30 91 94 39
Ph 706 A16 Ovine 6.00 92 94 35
Ph 68 T3 Ovine 6.00 15 32 28
FT 4 T4 Ovine 4.30 36 40 11
Ph 252 FT10 Ovine 4.30 20 35 15
Ph 70 T15 Ovine 4.30 25 39 23
Ph 144 UT Bovine 3.30 75 82 21
Ph 146 UT Bovine 5.30 100 100 35
Ph 152 UT Bovine 4.30 30 39 33
Ph 154 UT Bovine 5.00 84 85 25
1. * P. haemolytica
2. P. multocida NCTC 10322 0% 0%
3. E. coli
a. rLktA inactive toxin 0% 0%
b. rLktC q% o%
c. rLktA + rLktC active toxin (the same plasmid) 100% $ 100%
d. rLktA + rLktC active toxin (different plasmids) 98% 98%
t % inhibition of CL response of neutrophils
• Time of end of exponential phase of growth 
$ At 1/5000 dilution
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Fig. 24.
Influence of P. haemolytica LktA preparations on CL response of bovine 
neutrophils
Results of a typical CL-inhibition assay, with samples from three strains of P. 
haemolytica are shown. Bovine neutrophils were incubated for 40 min at 38 
°C with late log-phase culture supernate samples from Ph2, Ph30 or Ph72. The 
cells were then stimulated with 100 jug OZ. Neutrophils in BHIB alone served 
as a control.
1: BHIB alone (no LktA sample)
2: culture supernate of Ph72
3: culture supernate of Ph30
4: culture supernate of Ph2
C L  Response (mv)
No 
inhibition 
of CL 
response
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strains of P. haemolytica, are shown in fig. 24. The culture supernate of strain 
Ph2 was highly toxic and caused almost complete inhibition of CL, that from 
strain Ph30 caused about 50% inhibition whereas that from strain Ph72 had 
little effect.
When ovine and bovine neutrophils were compared in terms of their 
sensitivity to the different toxin preparations, as shown by inhibition of the 
normal CL response (table 4) there was no significant difference (p=0.22, 
Student’s t test). Similarly, a comparison of the ovine and bovine isolates of P. 
haemolytica  showed that there was no significant difference (p=0.29) in 
their CL-inhibitory effects on neutrophils (bovine and ovine).
Culture supernate samples containing LktA showed a reduction in toxic 
activity on standing at room temperature or at 4 °C and even on prolonged 
storage. The culture supernate of P. haemolytica LktA in BHIB, BHIB + 
BSA or RPMI + FCS lost toxicity with an increase in temperature.
Cell-free culture supernate from P. haemolytica isolate Ph2 grown in 
BHIB was aliquoted and stored at different temperatures and for different 
time and then toxicity was measured by the CL-inhibition assay. After 7.5 h 
at room temperature, the sample lost more than half of its toxicity. The LktA 
even lost toxicity on prolonged storage at -70 °C (table 5) but the toxicity 
did not decrease noticeably within the first 10 days. Repeated freeze-thaw 
treatment decreased the LktA activity. The culture supernate was stored in 
microcentrifuge tubes in 1 ml volumes and kept at -70 °C, and each sample 
was frozen and thawed only once. The activity of rLktA stored in 8 M urea 
for 2 months at -20 °C was found to have decreased slightly (7%). Thus for 
comparative purposes, all preparations were tested, or frozen, immediately 
after harvest. In every assay, a culture supernate sample from strain Ph 2 was 
used as control and internal standard.
Table 5.
Effect of storage temperature on leukotoxin activity
P. haemolytica Ph2 isolate was grown in BHIB for 6 h at 37 °C. Cell -free 
culture supernate was removed, aliquoted and stored for different times and 
different temperatures and then the toxicity was measured by the CL inhibition 
assay.
Temperature Time % loss of activity
-70 °C 10 days 0
-70 °C 20 days 2
-20 °C 1 day 2
-20 °C 2 days 5
4 °C 1 day 28
4 °C 2 days 38
room temperature 1.5 h 6
room temperature 3.5 h 15
room temperature 4.5 h 32
room temperature 5.5 h 42
room temperature 7.5 h 51
-20 °C (rLkt in urea) 60 days 7
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Fig. 25.
Variation in molecular weight (mol. wt) of LktA produced by different 
strains of P. haemolytica
The cell-free culture supernate from the end of log phase of P. haemolytica 
isolates grown in BHIB were resolved by SDS-PAGE (7.5% w/v acrylamide 
separating gels) and immunoblotted, probed with monoclonal antibody raised 
against rLktA in a dilution of 1/100. Most isolates (27/33) produced LktA of 
105 kDa, as shown by the examples in lanes 1, 3, 5, 7, 9. Four strains (Ph 42, 
Ph 44, Ph54, P h i52: lanes 2, 4, 6, 8 respectively) produced LktA of 108 kDa
Lane 1: Ph2
Lane 2: Ph42
Lane 3: Phl4
Lane 4: Ph44
Lane 5: Ph48
Lane 6: Ph54
Lane 7: Phi 44
Lane 8: Phl52
Lane 9: Phi 54
RESULTS 106 FART 3
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3.5 VARIATION IN AMOUNT AND M O LECULAR W EIG H T 
(MOL. WT) OF LKT PRODUCED BY DIFFEREN T STRAINS OF P, 
H AEM O LYTICA
In addition to screening all isolates for LktA activities, their production 
of LktA protein was investigated by SDS-PAGE and immunoblotting with 
monoclonal antibody. All isolates were shown to produce leukotoxin in 
culture supernates except Ph6 (table 4). The gel and blot revealed that there 
was some variation in the mol. wt of LktA produced by different strains of P. 
haemolytica. Most isolates (27/33) produced LktA of 105 kDa, as shown by 
the examples in fig. 25 lanes 1, 3, 5, 7, 9. Four strains (Ph42, Ph44, Ph54, 
Phl52; lanes 2, 4, 6, 8 respectively) produced LktA of 108 kDa. All of the 
samples were tested for toxin activities against both bovine and ovine 
neutrophils in the CL inhibition assay as described in table 4. However, there 
was no clear relationship between the LktAs with the higher mol. wt and 
their toxic activities or the characteristics of the producing strains (table 4 
and fig. 25). Thus, Ph42 is a bovine A2 isolate from pneumonic lung and its 
culture supernate had low toxicity; Ph44 is a bovine A2 strain but from the 
nasopharynx of a healthy animal and the sample had moderate toxicity; Ph54 
is an ovine A7 isolate from a pneumonic lung and its culture supernate was 
highly toxic and a bold LktA band was evident in the blot; P h i52 is an 
untypable bovine lung isolate and had low toxicity.
Surprisingly, there was no direct relationship between the amount of 
LktA protein in the culture supernate, as judged by immunoblotting and 
leukotoxic activities. The culture supernate samples in lanes 1, 5, 6, 7 were 
highly toxic in the CL assay, that in lane 4 was moderately toxic whereas 
those in lanes 2, 3, 8 had low toxicity but appeared to contain at least as 
much LktA protein as the more toxic samples. This was confirmed by ELISA. 
For example, the sample from isolate Ph42 contained more of the 105 kDa
Table 6. Quantitation of Lkt by ELISA
Lkt preparation 
from strain:
Amount of Lkt 
antigen
(ELISA units ml‘1)
Lkt activity 
(% inhibition of CL response of 
neutrophils)
bovine ovine
Ph2 100 97 97
Ph42 150 6 26
Phl4 84 6 20
Ph48 74 78 85
Ph54 81 95 95
Phl46 <10 100 100
Ph58 200 96 97
Phl52 12 30 39
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LktA protein than strain Ph2 as determined by ELISA (150 and 100 Units of 
LktA antigen/ml, respectively) but the former had little leukotoxic activity on 
bovine and ovine neutrophils, whereas the latter was highly toxic (table 6).
3.6 ACTIVITY OF RLKT
The activity of rLktA produced from E. coli was measured by CL- 
inhibition assay. The LktA was extracted with urea from E. coli, where it was 
hyperproduced as inclusion bodies. Urea extract of rLktA was incubated 
with bovine neutrophils for 45 min and then stimulated with OZ. These urea 
extracts were typically 5,000-times more active than late log-phase culture 
supernates of P. haemolytica, e.g. strain Ph2. Active rLktA, produced by E. 
coli strains containing plasmid pGW64 + pGW78 or pGW42 alone inhibited 
the CL response of the neutrophils to OZ at a concentration of at 1 jig 
protein/ml. However, the inactive rLktA at the same protein concentration or 
higher (1-35 |ig/ml) alone stimulated a CL response when mixed with 
neutrophils i.e. before the addition of OZ. The subsequent CL response to OZ 
was not affected i.e. there was no CL inhibition. To show any effect of rLktC 
on CL response of neutrophils, the rLktC preparation from E. coli containing 
plasmid pGW78 alone was incubated with bovine neutrophils. Fig. 26 shows 
that rLktC stimulated the neutrophils at time 0 min, i.e. before addition of OZ, 
and had no effect on the subsequent CL response. In all experiments, urea at 
the same concentration as in the rLktA preparation, was used as a control. 
The production of active rLktA protein from E. coli strains HMS174 or 
SY327X pir with one plasmid containing IktA and IktC (pGW42) was greater 
than from E. coli strain SY327A, pir with 2 plasmids encoding IktA and IktC 
separately (pGW64 + pGW78) (fig. 26).
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Fig. 26.
Influence of rLktA preparations on CL response of bovine neutrophils.
Urea extracts of E. coli containing the active or inactive forms of rLktA or the 
activator protein were incubated with bovine neutrophils for 45 min at 38 °C 
in the presence of DNDH and then stimulated with OZ. Active rLktA protein 
was produced from E. coli with one plasmid expressing both the IktA and 
IktC  genes (pGW42) and from E. coli with separate plasmids encoding IktA 
and IktC  (pGW64 + pGW78). Neutrophils were incubated in presence of 
dialysed 8 M urea as a control since LktA and LktC was extracted from the 
producing cells with 8 M urea and dialysed before use. The arrow shows the 
time of addition of OZ.
1: dialysed 8 M urea
2: dialysed 8 M urea + OZ
3: 1 pg/ml of inactive rLktA (pGW42) + OZ
4: 1 pg/ml of active rLktA (pGW64 + pGW78) + OZ
5: 1 pg/ml of active rLktA (pGW42) + OZ
6: 1 pg/ml of LktC preparation (pGW78) + OZ
8001
600
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3.7 INFLUENCE OF CALCIUM ON LKT ACTIVITY
In section 3.2.1.4, it was found that growth of P. haemolytica strain Ph2 
in BHIB in presence of EGTA, in an attempt to deplete calcium ions, had no 
effect on LktA production, at sub-inhibitory concentrations of EGTA. In 
other experiments, P. haemolytica strain Ph2 was grown in BHIB and 
different concentrations of EGTA were added to culture supernates after 
harvesting, to remove any calcium present. Thi s leukotoxin preparation, 
even with EGTA up to 1 mM was still toxic for bovine neutrophils in the CL- 
inhibition assay (data not shown) and still bound to erythrocytes in the 
binding assay (see section 3.1.3.1). The role of calcium ions on the production 
and cytotoxic activity of native LktA and rLktA was also investigated by 
growing P. haemolytica and E. coli containing plasmid pGW42 in Luria- 
Bertani (LB) broth in the presence of 100 \iM  EGTA. The bacteria produced 
leukotoxin in the absence of calcium. The leukotoxin either in the culture 
supernate or in the urea extracts respectively, was sampled and incubated 
with bovine neutrophils for 30 min at 38 °C and then stimulated by OZ. No 
calcium was added at any stage. In neither case was the toxin active in the 
CL-inhibition assay and the neutrophils were not killed. However, when the 
neutrophils were incubated with either native or recombinant leukotoxin in 
the presence of 1 mM calcium, the toxin became active against bovine 
neutrophils (fig. 27).
3.8 E FFE C T  O F PR O TEA SE IN H IB ITO R S AND STO RA G E 
TEM PERATURE
LktA was shown to lose activity fairly rapidly on standing at different 
temperatures and the possibility that this was due to protease(s) in the LktA 
preparation was investigated. Thus, the stability of native and recombinant 
leukotoxin was examined in the presence of a cocktail of protease inhibitors
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Fig. 27.
Calcium and cytotoxicity of leukotoxin
Recombinant LktA was prepared from E. coli grown in Luria-Bertani (LB) 
Broth in the presence of 100 pM EGTA and dialysed urea extracts were 
incubated with bovine neutrophils for 30 min at 38 °C which were then 
stimulated by OZ. No calcium was added in any part of the procedure. The 
toxin was not active, but when 1 mM calcium was added, the toxicity was 
restored.
1: LB medium (control, without calcium)
2: rLktA without calcium
3: LB medium (control, with 1 mM calcium)
4: rLktA with 1 mM calcium
0 20 40 60 80 100 120
Time (min)
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(see section 3.13.5) and after storage at room temperature for 24 h. The 
toxicity of P. haemolytica strain Ph2 culture supernate (native leukotoxin) or 
dialysed urea extract of E. coli (rLktA) was measured by CL inhibition assay. 
The native leukotoxin or rLktA, with or without the cocktail was incubated 
with bovine neutrophils and then stimulated with OZ. Toxicity of both 
preparations decreased markedly on standing at room temperature and the 
cocktail did not preserve toxic activity of either sample.
3.9 SPECIFICITY OF THE CL ASSAY FOR LKT
The specificity of the CL assay for LktA was tested in various ways:
a) P. multocida NCTC 10322 was grown on BHIB for 6 h at 37 °C and 
the culture supernate was removed and incubated with bovine neutrophils 
for the CL-inhibition assay. This culture supernate, presumably containing 
cell products common to all Pasteurella species, had no effect on the CL 
response (table 4).
b) To exclude the possibility that the toxicity of culture supernates for 
neutrophils was due to, or affected by, any contaminating LPS, cell-free 
culture supernate from P. haemolytica isolate Ph2 or a rLktA urea extract of 
E. coli strain HMS174 containing plasmid pGW42 was boiled for 30 min and 
then incubated with bovine neutrophils for 30 min and then stimulated with 
OZ. CL inhibitory activity was destroyed (data not shown). LPS is known to 
be heat stable and would be expected to withstand this treatment.
c) P. haemolytica was grown on BHIB at 37 °C until the end of log 
phase and culture supernate was removed by centrifugation. Release of LPS 
into the growth medium was shown by resolving the cell-free culture 
supernate of different isolates of P. haemolytica by SDS-PAGE, and 
immunoblotting with either convalescent serum (fig 14b) or rabbit polyclonal 
antibody raised against purified LPS from P. haemolytica Ph2 isolate (fig.
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Fig. 28.
Production of LPS in culture supernates of P. haemolytica strains.
Different isolates of P. haemolytica were grown on BHIB until the end of log 
phase i.e. approx. for 6 h at 37 °C. Cell-free culture supernate (50 |il/well) was 
resolved on 12.5% SDS-PAGE, transferred to nitrocellulose and probed with 
rabbit polyclonal antibody raised against purified LPS of P. haemolytica Ph2 
isolate. Purified LPS of P. haemolytica Ph2 (1 jig) was used as a control.
Lane 1: LPS control
Lane 2: culture supernate of P h i0
Lane 3: culture supernate of Ph44
Lane 4: culture supernate of Ph706
Lane 5: culture supernate of Ph72
Lane 6: culture supernate of P h i2
Lane 7: culture supernate of Ph58
Lane 8: culture supernate of Ph28
Lane 9: culture supernate of Ph54
Lane 10: culture supernate of Ph30
Lane 11: culture supernate of Ph42
Lane 12: culture supernate of Ph2
Lane 13: LPS control
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Fig. 29.
Effect of purified LPS of P. haemolytica (rough and smooth) and LPS of 
E. coli (sm ooth) on bovine neutrophils.
Freeze-dried LPS was suspended in HH and bovine neutrophils were 
incubated with 400 |ig/ml LPS of P. haemolytica (rough and smooth) or LPS 
of E. coli (sm ooth) for 30 min in presence of DNDH 10’5 and then neutrophils 
were stimulated with OZ (0.1 mg/ml). Neutrophils were incubated with HH as 
a control. The arrow shows the time of addition of OZ.
1: P. haemolytica smooth LPS + OZ
2: P. haemolytica rough LPS + OZ
3: E. coli LPS + OZ
4: HH + OZ
5: HH (control)
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28). Purified LPS type 1 from Ph2 isolate (kindly provided by Dr R Davies) 
was used as a control (fig. 28 lanes 1 and 13) and high and low mol. wt bands 
were detected. Corresponding low mol. wt bands were seen in the culture 
supemate samples of most isolates. The antibody raised against LPS from Ph2 
did not cross react with LPS from some strains e.g. strain Ph30 (lane 10). A 
similar result has been reported (Ali et al., 1992; Ali, 1993). The other bands 
seen in the immunoblot are presumably due to reaction of the antiserum with 
proteins produced by the bacteria. The polyclonal antibody raised against 
purified LPS reacted with these proteins presumably because the rabbit had 
been exposed to other cross-reactive antigens before bleeding.
The effect of purified LPS of P . haemolytica (rough and smooth) and 
LPS of E. coli (smooth ) on the bovine neutrophils was investigated. Freeze 
dried, purified LPS was suspended in HH and bovine neutrophils were 
incubated with different concentrations up to 400 pg dry wt/ml for 30 min in 
presence of DNDH 10’5 M and then the neutrophils were stimulated with OZ 
(0.1 mg/ml). The bovine neutrophils were stimulated to some extent by LPS 
alone and gave a small CL response between time 0 and the addition of OZ 
(fig. 29). The stimulation by rough LPS of P. haemolytica was greater than 
by smooth LPS of P. haemolytica. The subsequent CL response to OZ of 
bovine neutrophils was only slightly reduced. E. coli LPS (smooth) used as a 
control and at 400 |ig/ml also caused slight inhibition of the subsequent CL 
response (fig. 29). Thus, any LPS present in LktA preparations, from P. 
haem olytica  or E. coli, is unlikely to be responsible for CL-inhibition 
attributed to LktA.
d) Further evidence for the specificity of the CL-inhibition assay for 
LktA was provided when urea extracts of E. coli containing rLktA were 
tested. Only rLktA produced in the presence of LktC was active on the 
bovine neutrophils (fig. 26). LktA produced in the absence of LktC was
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completely inactive, as were urea extracts containing only LktC and urea 
extracts of the E. coli without recombinant plasmids. All rLktA preparations 
were tested at the same protein concentration (1 |ig/ml) and the active and 
inactive rLktA preparations contained similar amounts of LktA antigen as 
judged by immunoblotting and ELISA.
e) The CL-inhibitory activity was shown to be inhibited by antibody 
specific for LktA. Culture supernates of P. haemolytica Ph 2 (undiluted) and 
rLktA (1 in 5,000 dilution) from E. coli were incubated for 30 min with 
polyclonal antiserum raised against purified rLktA (section 3.11) and their 
toxicity was then measured in the CL-inhibition assay. The antiserum 
completely inhibited the effect of both preparations of LktA on the 
neutrophils (fig. 30).
Detoxi-gel (endotoxin-removing gel) (Pierce, Affinity Park™, USA) was 
used in an attempt to remove the LPS from P. haemolytica  c u ltu re  
supernates. The toxicity of culture supemate was decreased, as judged by 
CL-inhibition assay, after detoxi-gel treatment. When the amount of LktA in 
the samples, before and after detoxi-gel treatment, was examined by 
immunoblotting, there was an obvious reduction in intensity of the LktA in 
the band after detoxi-gel treatment, suggesting that detoxi-gel removed LktA 
as well as LPS.
3.10 COM PARISON OF CL-INHIBITION ASSAY W ITH  OTHER 
M ETHODS OF MEASURING LKT ACTIVITY AGAINST VARIOUS 
TARGET CELLS.
In addition to the CL-inhibition assay, the effect of leukotoxin on 
different target cells was measured by other methods: Trypan blue dye 
exclusion assay, a haemolytic assay (see section 3.12), a chemotaxis assay 
(see section 3.15) and a cell tracking assay (see section 3.16). It was found
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Fig. 30.
Effect of antibody and LktA on CL response.
Culture supernates o f P. haemolytica Ph 2 (undiluted) or rLktA (1 in 5000 
dilution) from E. coli were incubated for 30 min with polyclonal antiserum 
raised against rLktA and then added to bovine neutrophils. The cells and 
mixture of toxin and antibody were incubated for 25 min at 37 °C in the 
present of DNDH. Bovine neutrophils were stimulated with OZ. Neutrophils 
incubated with leukotoxin or antibody alone as controls.
1: polyclonal antibody
2: polyclonal antibody + OZ
3: P. haemolytica Ph2 culture supemate
4: P. haemolytica Ph2 culture supemate+ polyclonal antibody
5: rLktA
6: rLktA + polyclonal antibody
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that the Trypan blue dye exclusion assay involved multiple cell counts, was 
time consuming, prone to error and appeared to be less sensitive than CL- 
inhibition assay. For these reasons it was not used for comparing LktA in 
different samples. Trypan blue exclusion was, however, used routinely for 
checking viability of leukocytes preparations before use.
3.10.1 The effect of LktA on bovine monocytes
Bovine monocytes were incubated with cell-free culture supemate of P. 
haem olytica  Ph2 isolate for 30 min in the presence of DNDH and then 
stimulated by OZ. The activity of the LktA was measured by the CL 
inhibition assay. Although the response of bovine monocytes to OZ (0.1 
mg/ml) in present of DNDH (10-5 M) was low, as fig. 20 shows, the LktA 
preparation was seen to have an effect on bovine monocytes and caused CL- 
inhibition (see also fig. 45).
3.10.2 Activity of LktA on ruminant and non-ruminant cells in CL- 
inhibition assay
To investigate the reported specificity of LktA for ruminant cells, 
different cell types from various ruminant and non-ruminant species were 
used as targets. The rum inant cells assayed were bovine and ovine 
neutrophils, which were suitable target cells as reported above and a bovine 
lymphoma cell line (BL3). These latter cells did not produce a respiratory 
burst when incubated with DNDH and stimulated with a variety of stimuli i.e. 
OZ, PMA and latex beads and, so were not used in a CL inhibition assay. 
However, rLktA killed BL3 cells as judged by Trypan blue (100% killing after 
20 min at 37 °C with a concentration of 3 |Xg protein /ml of rLktA).
The non-ruminant cells assayed were human, rabbit and guinea pig 
neutrophils, and a mouse macrophage cell line (J774.2).
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Fig. 31.
Effect of LktA on CL response of mouse macrophage cell line J774.2
Culture supernate of P. haemolytica  Ph2 was incubated with mouse 
macrophage cell line J774.2 in presence of DNDH lO 5 M for 35 min. The cells 
were stimulated with PM A (1 |ig/ml). Mouse macrophage cell line J774.2 was 
incubated with BHIB as a control. The arrow shows the time of addition of 
PMA.
1: BHIB (control)
2: BHIB + PMA
3: P. haemolytica Ph2 culture supernate + PMA
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Fig. 32.
Effect o f native LktA  and dialysis of rLktA  on inhibition of CL response 
of hum an neutrophils.
Late log phase of culture supernate of Ph2 or dialysed urea extracts of rLktA 
were incubated with human neutrophils (5 X 104) in presence of luminol ( lO 5 
M) for 40 min. The cells were stimulate with PMA (ljig/ml). Neutrophils were 
incubated with BHIB or dialysed 8 M urea as a control.
1: urea (control)
2: inactive rLktA produced by E. coli SY327X pir (pGW64) +
PMA
3: active rLktA produced by E. coli DH5aFIQ (pGW42) + PMA
4: P. haemolytica Ph2 culture supernate + PMA
5: active rLktA produced by E. coli SY327A, pir (pGW42)+ PMA
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Neither native nor recom binant LktA had any effect on the mouse 
macrophage cell line (J774.2), which gave a weak but consistent CL 
response to PMA (fig. 31). Although previous reports have suggested that 
the leukotoxin is specific for ruminant leukocytes, culture supernates from log 
phase cultures of P. haemolytica Ph2 and PhlO caused more than 50% 
inhibition of human neutrophil responses (fig. 32). Recombinant LktA from 
E. coli had different effects. In some preparation of rLktA, the E. coli strain 
used was DH5aF'IQ and in others it was SY327Xpir or HMS174. Active 
rLktA from E. coli HMS174 plasmid (pGW42) or E. coli SY327A,pir 
(pGW64 and pGW78) partially inhibited the CL response. However non­
active rLktA (produced in absence of LktC) had no inhibitory or stimulatory 
effect on human neutrophils. Surprisingly, rLktA from E. coli strain 
DH 5aFIQ , containing plasmid pGW42, did not have any effect on the human 
neutrophils. This preparation was unusual in other respects i.e. it contained a 
higher mol. wt component (see fig. 19) which indicated that it was a fusion 
protein of LktA and LktC. Although this protein was highly active against 
bovine neutrophils, it was not active against human neutrophils.
The effect of purified LPS of P. haemolytica (both R and S) and LPS of 
E. coli (S) on the human neutrophils was investigated. Human neutrophils 
were incubated with different concentrations up to 400 |ig/ml of purified LPS 
in presence of luminol and then the cells were stimulated with PMA. The 
human neutrophils were stimulated by LPS alone before the addition of PMA 
(fig. 33). The stimulation of cells by rough LPS was greater than by smooth 
LPS of P. haemolytica. The subsequent CL response to PMA of human 
neutrophils was reduced. However, with low concentration of LPS, the LPS 
had no effect on the CL response. The CL response of neutrophils to culture 
supernate and LPS before the addition of stimuli were different. The LPS
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Fig. 33.
Effect of LPS on the human neutrophils.
Freeze dried preparations of LPS were diluted in HH and human neutrophils 
were incubated with LPS 1.6 mg/ml of P. haemolytica (rough and smooth) 
and LPS of E. coli (smooth ) for 30 min in presence of luminol 10 5 M. The 
neutrophils were stimulated with PMA (1 jig/ml). Neutrophils were incubated 
with HH as a control.
1: HH (control)
2: HH + PMA
3: E. coli LPS + PMA
4: P. haemolytica smooth LPS + PMA
5: P. haemolytica rough LPS + PMA
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Fig. 34.
Effect o f native LktA on inhibition of CL response of guinea pig 
neutrophils.
Late log phase culture supernate of Ph2 was incubated with guinea pig 
neutrophils (5 X 105) in presence of DNDH (10-5) for 40 min. The cells were 
stimulated with PMA (1 jig/ml). Neutrophils were incubated with BHIB as a 
control. The arrow shows the time of addition of PMA.
1: BHIB (control)
2: BHIB + PMA
3: culture supernate of Ph2 + PMA
CL
 
R
es
po
ns
e 
(m
v)
801
60-
40-
2 0 -
0 10 20 30 40 50
Time
(m in)
R E SU L T S 125 P A R T  3
stimulated the respiratory burst of human neutrophils (fig. 33) but culture 
supernate did not (fig. 32).
The LktA preparations had no effect, either inhibition or stimulation, on 
rabbit neutrophils (table 9). When neutrophils of guinea pig were incubated 
with DNDH, the neutrophils produced two peaks, the first being bigger than 
the second. However, the LktA preparations had again no effect on guinea 
pig neutrophils (fig. 34).
P. haemolytica Ph2 culture supernate was incubated with bovine 
neutrophils at different temperatures (4 and 37 °C) for 30 min. The cytotoxin 
of culture supernate of Ph2 was active at 37 °C, but it could not lyse bovine 
neutrophils at 4 °C as judged by trypan blue dye exclusion.
3.11 TOXIN-NEUTRALISING ANTIBODIES
Neutralisation of the toxic activity of LktA for bovine neutrophils by 
different antibody preparations was investigated. The BHIB culture 
supernates (late-log phase) of different strains of P. haemolytica, or rLktA 
from E. coli were incubated for 30 min with convalescent serum obtained 
from cattle experimentally infected with P. haemolytica strain Ph2. This 
serum undiluted, completely neutralised the toxin activities, as judged by the 
CL-inhibition assay, in all strains tested.
A polyclonal antiserum raised in rabbits against the 105 kDa rLktA 
(active) purified by preparative SDS-PAGE completely abolished the CL- 
inhibitory effect of the rLktA and of the culture supernates of P: haemolytica 
A1 (Ph2 and PhlO) on bovine neutrophils. With two P. haemolytica strains, 
however, different results were obtained. This polyclonal antibody partially 
inhibited the toxicity of culture supernates of P. haemolytica NCTC 10634 
(Ph54), whereas no inhibition of the sample from P h i46 was seen. Normally, 5 
pi sample was mixed with 30 pi neat antiserum to demonstrate neutralisation,
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but with the sample from P h i46, no neutralisation occurred even with 90 |il. 
At high levels of antiserum, the CL response of bovine neutrophils to OZ was 
affected slightly. The lack of neutralisation of LktA from P hl46  by this 
antibody was paralleled by the lack of reactivity in ELISA (table 6).
Cell-free culture supernate of Ph2 was incubated with different 
monoclonal antibodies for 30 min and then incubated with bovine 
neutrophils. Monoclonal antibodies raised against rLktA, B. pertussis AC  
toxin (9D4), 2-5 (IgGl) raised against AC toxin or A. pleuroneumoniae toxin 
all had slight but different levels of neutralising activity against the toxin at 
highest doses tested (fig. 35). None of those monoclonal antibodies could 
completely neutralise the toxin.
3.12 HAEMOLYTIC ACTIVITIES OF DIFFERENT STRAINS.
At the start of this study, it was known that some RTX toxins e.g. E. 
coli haemolysin are strongly haemolytic whereas some e.g. B. pertussis AC 
toxin are weakly haemolytic. The situation with LktA was not clear and some 
reports suggested that LktA and haemolysin were separately produced by P. 
haemolytica (see section, 1.5.5). The haemolytic activity of P. haemolytica 
isolates was determined in various ways.
First, the haemolytic activity of P. haemolytica isolates was determined 
on sandwich blood agar (BHIA) containing bovine blood at a final 
concentration of 5% in the top layer. Differences in activities were seen 
between isolates, e.g. the haemolytic activity of Phl40 isolate was less than 
that of strain Ph62 (fig. 36a). Similar effects were obtained with human blood 
(fig. 36b).
The haemolytic activity of P. haemolytica on blood plates was weak 
and attempts were made to improve detection of activity. Selected strains 
were grown on BHIA plus 5%  sheep blood containing different
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Fig. 35.
Effect of different antibodies on native LktA and rLktA.
N eutralisation o f leukotoxin was measured by incubation of bovine 
convalescent serum (dilution 1 in 50), rabbit polyclonal anti-LktA (1 in 30), or 
monoclonal antibodies to various RTX toxins (1 in 20) with P. haemolytica 
Ph2 culture supernate or active rLktA for 30 min at room temperature. The 
mixtures of antibody and toxin were then incubated with bovine neutrophils 
for 20 min before the neutrophils were stimulated with OZ. Column 1 shows 
the control CL response of neutrophils to OZ in the absence of LktA.
1: antibody (control, no LktA)
2: convalescent serum + LktA
3: polyclonal antibody + LktA
4: monoclonal antibody raised against rLktA + LktA
5: monoclonal antibody raised against B. pertussis AC toxin (9D4)+
LktA
6: monoclonal antibody 2-5 (IgGl) raised against AC toxin + LktA
7: monoclonal antibody raised against A. pleuroneumoniae toxin + LktA
Different antibodies
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Fig. 36.
Haemolytic activity of P. haemolytica for bovine and hum an blood.
The haem olytic activity of P. haemolytica  isolates was determined on 
sandwich blood agar containing bovine (a) or human blood (b). Different 
strains of P. haemolytica  were growm on BHIA containing 5%  of either 
sheep or human blood overnight at 37 °C.
P. haemolytica  strains
A: Ph62
B: UT2
C: P hi 40
D: FT4
E: Ph64
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Fig. 37.
Haemolytic activity of P. haemolytica on BHIA.
The haemolytic activity of P. haemolytica Ph2 was determined on BHIA plus 
5% sheep blood in the presence 20 mM CaCl2- Plates were incubated for 
overnight at 37 °C.
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concentrations of calcium (CaCb) (1 mM, 5 mM, 10 mM, 20 mM, 50 mM) or 
iron (FeCIs) (50 |iM, 100 \iM , 200 |iM, 300 pM) in attempts to increase the 
haemolytic activity on plates. The best condition for showing haemolysis was 
with 20 mM calcium chloride (fig. 37). Adding iron had little effect, 
presumably since BHIA is an iron-rich medium.
Even under the optimal conditions, the haemolytic activity was still low 
and not suitable for a close comparison of different strains. For this reason a 
microplate haemolysin assay was developed. The haemolytic activity of 
different cell-free culture supernates or rLktA was determined in a microplate 
assay with ovine erythrocytes. Ovine RBCs were incubated with serial 
dilutions of culture supernates from different isolates of P. haemolytica or 
dilutions of rLktA overnight at 37 °C. Sterile BHIB and P. multocida culture 
supernate or diluted urea were used as negative controls and saponin 0.1% 
was used as a positive control. The percentage of released haemoglobin was 
measured by ELISA reader at 540 nm. Although P. haemolytica generally 
has low haemolytic activity as seen on blood agar plates, culture supernates 
of different strains had different activities in the microplate assay (table 4). 
The highest activity was found with strain NCTC 10636 (Ph56) whereas 
strain FT4 had low activity. Only Ph6 had no haemolytic activity. However, 
in no case was the % haemolytic activity greater than 50%.
The haemolytic activity of culture supernate of P. haemolytica or rLktA 
was abolished by heating (100 °C for 30 min).
The haemolytic activity of LktA was temperature dependent, in that 
toxin did not produce lysis after overnight incubation at 4 °C. However, the 
toxin was shown to be bound to the cells at 4 °C (fig. 38). A comparison of 
haemolytic activity and cell binding of various LktA samples is given in the 
next section.
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Fig. 38.
Binding of native and recombinant LktA to ovine RBCs.
The ovine RBCs were incubated with culture supernate of P. haemolytica 
Ph2 or rLktA from E. coli D H SaFIQ  (pGW42). The RBCs were then lysed 
and membrane proteins were separated by SDS-PAGE then immunoblotted 
after transfer to nitrocellulose. Rabbit polyclonal antibody raised against 
rLktA was used to detect binding. Culture supernate (lane A4) or rLktA (lane 
IB) were used as positive controls and RBCs alone (lanes A5 and B2) were 
used as negative controls.
A native LktA
Lane 1: culture supernate of Ph2 with 1 mM CaCh + ovine RBCs for 1 h
at 37 °C
Lane 2: culture supernate of Ph2 with 1 mM CaCh+ ovine RBCs for 1 h
at 4 °C
Lane 3: culture supernate of Ph2 with 1 mM EGTA + ovine RBCs for 1
h at 37 °C.
Lane 4: culture supernate of Ph2 (no RBCs, control)
Lane 5: ovine RBCs alone (no LktA, control)
B rLktA
Lane 1: active rLktA alone (control)
Lane 2: ovine RBCs alone (control)
Lane 3: active rLktA bound to ovine RBCs
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3.13 BINDING OF LKT TO TARGET CELLS.
3.13.1 Binding of native and rLktA to ovine RBCs
In preliminary studies, sheep RBCs were incubated with native 
leukotoxin, from P. haemolytica strain Ph2, as well as with active rLktA from 
E. coli strain D H 5aFIQ  containing pGW42 in order to determine ability of 
the toxins to bind to target cell membranes. Binding studies were done at 37 
°C for 1 h in the presence of 1 mM calcium. The RBCs were incubated with 
BHIB or urea as controls. The RBCs were then lysed and membrane proteins 
were immunoblotted after transfer to nitrocellulose. Rabbit polyclonal 
antibody raised against rLktA was used to detect membrane-bound toxin. 
Fig. 38 shows the native LktA from P. haemolytica Ph2 (lane A l) and rLktA 
(lane B3) from E. coli was bound to the RBCs after 1 h at 37 °C. Native LktA 
was also shown to bind at 4 °C (lane A2) and in the presence of 1 M EGTA 
(lane A3) at 37 °C.
3.13.2 Binding of rLktA to various ruminant cells
Bovine neutrophils or mononuclear cells which had been separated 
from red blood cells were incubated with active and inactive rLktA at 
different temperatures (4 or 37 °C) for 1 h. The toxin band was detected by 
transferring the membrane proteins to nitrocellulose and probing with 
monoclonal antibody raised against rLktA. Fig. 39 shows the active (lane 2) 
and inactive (lane 3) rLktA bound to bovine RBCs at 37 °C and at 4 °C (lane 
4, inactive; lane 5, active) and RBCs alone were used as control (lane 1). The 
inactive and active rLktA was also incubated with mononuclear cells for 1 h 
at 37 °C and 4 °C and again both forms were shown to bind (e.g. lanes 7 and 
8, results for 37 °C). Similarly the rLktA (inactive lane 10) bound to bovine 
neutrophils at 37 °C and active was bound at 4 °C (lane 12) as well as 37 °C. 
In the leukocyte membranes preparation, the anti-rLktA reacted with a
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Fig. 39.
Binding of rLktA to ruminant cells.
Bovine neutrophils or mononuclear cells which had been separated from red 
blood cells were incubated with active and inactive rLktA from E. coli 
SY327A, pir (pGW42) at different temperatures (4 or 37 °C) for 1 h. The toxin 
band was detected by transferring the membrane proteins to nitrocellulose 
and probed with monoclonal antibody raised against rLktA.
Lane 1: bovine RBCs (control)
Lane 2: bovine RBCs + active rLktA at 37 °C
Lane 3: bovine RBCs + inactive rLktA at 37 °C
Lane 4: bovine RBCs + inactive rLktA at 4 °C
Lane 5: bovine RBCs + active rLktA at 4 °C
Lane 6: bovine mononuclear cells (control)
Lane 7: bovine mononuclear cells + inactive rLktA at 37 °C
Lane 8: bovine mononuclear cells + active rLktA at 37 °C
Lane 9: bovine neutrophils (control)
Lane 10: bovine neutrophils + inactive rLktA at 37 °C
Lane 11: bovine neutrophils + active LktA at 37 °C
Lane 12: bovine neutrophils + active rLktA at 4 °C
Lane 13: active rLktA (control)
Lane 14: inactive rLktA (control)
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number of bands of <105 kDa indicating that LktA bound by leukocytes was 
degraded, presumably due to leukocyte proteases. The active rLktA (lane 13) 
and inactive rLktA (lane 14) were used as controls.
Although some of the native LktAs have low haemolytic or leukotoxin 
activities, they still bound to the target cells (data not shown). In addition, the 
inactive form of rLktA was bound to RBCs (fig 39, lane 3), but it had no 
detectable haemolytic activity. This result indicates that modification of LktA 
by LktC was important for lysis of RBCs but not for binding to RBCs.
3.13.3 Binding of LktA to human cells
To investigate the effect of LktA on non-ruminant cells, human 
leukocytes were separated from erythrocytes and then incubated with LktA. 
The activity of LktA on non-ruminant leukocytes was also measured by the 
CL inhibition assay (section, 3.10.2). Fig 40 shows faint bands indicating that 
both the active (lane 13) and inactive (lane 14) forms of rLktA were bound to 
some extent by human RBCs. The rLktA (active and inactive) was also 
bound to some extent by human mononuclear cells (lane 10 and 11, 
respectively) as well as to human neutrophils (lane 7 and 8). After incubation 
of human neutrophils with rLktA for 1 h , the neutrophils were separated and 
supernate was used for evaluation of unbound toxin by resolving the 
supernate by 10 % SDS-PAGE and then transferred to nitrocellulose and 
probed by monoclonal antibody raised against rLktA. Unbound protein of 
active (lane 5) and inactive (lane 6) form of rLktA were found. The same 
results were found with rabbit blood cells (data not shown).
3.13.4 Binding kinetics assessed by ELISA of unbound LktA
Bovine RBCs were incubated with native or rLktA toxin at different 
temperatures. The mixture was then centrifuged for 15 min at 15,000 X g and
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Fig. 40.
Binding of LktA  to hum an cells.
Human neutrophils, mononuclear cells or red blood cells were incubated with 
active or inactive rLktA at 37 °C for 1 h. The toxin band was detected by 
transferring the membrane proteins to nitrocellulose and probed with 
monoclonal antibody raised against rLktA. The RBCs, mononuclear cells, 
neutrophils, native LktA, active rLktA and inactive rLktA were used as 
controls.
Lane 1: active rLktA (from E. coli SY327X pir (pGW42)(control)
Lane 2: native LktA from Ph2 culture supernate (control)
Lane 3: inactive rLktA from E. coli SY327A, pir (pGW64)(control)
Lane 4: rLktC from E. coli SY327A, pir (pGW78)(control)
Lane 5: supernate of active rLktA + neutrophils
Lane 6: supernate of inactive rLktA + neutrophils
Lane 7: active rLktA + neutrophils
Lane 8: inactive rLktA + neutrophils
Lane 9: neutrophils (control)
Lane 10: active rLktA + mononuclear cells
Lane 11: inactive LktA + mononuclear cells
Lane 12: mononuclear cells (control)
Lane 13: active rLktA + RBCs
Lane 14: inactive rLktA + RBCs
Lane 15: RBCs (control)
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the supernate was used for evaluation of unbound toxin by ELISA. A 
reduced level of toxin remaining in the supernate showed that the toxin was 
bound to RBCs at 4 °C as well as at 37 °C and when the two different 
temperatures were compared, more toxin was bound to the RBCs at 37 °C 
than at 4 °C (fig. 41).
The results with bovine mononuclear cells in the binding assay are 
shown in fig. 42. The mononuclear cells were incubated with rLktA for 3, 5, 
10 and 60 min at 4 °C or at 37 °C and then unbound toxin was measured by 
ELISA. More toxin was bound at 37 °C for 3 min than at 4 °C for 1 h (fig. 
42).
With bovine neutrophils, similar results were obtained. As fig. 43 shows, 
the binding of rLktA at 37 °C was quicker than at 4 °C.
These ELISA results supported the findings of the previous 
investigation where binding was assessed by immunoblotting.
3.13.5 Binding assays in presence of protease inhibitors
In binding assays with some target cell types e.g. neutrophils, the bound
kDa
toxin appeared to be degraded even at 4 °C i.e. only low mol. wt (<105)
A
bands were seen by immunoblotting of membrane fractions with antibodies 
specific for LktA (figs. 39 and 41). Thus, protease inhibitors were investigated 
in an attempt to improve the resolution of the assay. The stability of urea 
extract of rLktA in HH and native LktA in BHIB was examined in the 
presence and absence of a cocktail comp-rising: serine and thiol protease 
inhibitor, leupeptin; a serine protease inhibitor, PMSF; an acidic protease 
inhibitor, pepstatin; and a metalloprotease inhibitor, EDTA (Boehringer- 
Mannheim, Biochemical Information Leaflet, May 1987). The cocktail was 
added to bovine and human neutrophils and incubated for 30 min at room 
temperature before adding the LktA preparation. The mixture were then
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Fig. 41.
Measurement by ELISA of unbound LktA in binding assays with bovine 
RBCs.
The amount of unbound toxin was evaluated by ELISA. The RBCs were 
incubated with the active form of rLktA from E. coli SY327A, pir (pGW42) for 
3, 5 and 10 min at room temperature or 3 and 5 min at 4 °C. The mixture was 
centifiiged for 15 min at 15,000 X g and supernate was used for evaluation of 
unbound toxin by ELISA.
1: control rLktA (no RBCs).
2: rLktA after incubation with RBCs for 3 min at 37 °C.
3: rLktA after incubation with RBCs for 5 min at 37 °C.
4: rLktA after incubation with RBCs for 10 min at 37 °C.
5: control rLktA (no RBCs).
6: rLktA after incubation with RBCs for 3 min at 4 °C.
7: rLktA after incubation with RBCs for 5 min at 4 °C.
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Fig. 42.
M easurem ent by ELISA of unbound LktA in binding assays with bovine 
m ononuclear cells.
The unbound rLktA was measured by ELISA. The mononuclear cells were 
incubated with active rLktA from E. coli SY327A, pir (pGW42) at 3, 5, 10 and 
60 min at 4 °C or at 37 °C and the supernate was separated as described in 
fig. 41 and used for evaluation of unbound toxin.
1: control rLktA (without mononuclear cells).
2: rLktA after incubation with mononuclear cells for 3 min at 4 °C.
3: rLktA after incubation with mononuclear cells for 5 min at 4 °C.
4: rLktA after incubation with mononuclear cells for 10 min at 4 °C.
5: rLktA after incubation with mononuclear cells for 60 min at 4 °C.
6 : control rLktA (without mononuclear cells)
7: rLktA after incubation with mononuclear cells for 3 min at 37 °C.
8 : rLktA after incubation with mononuclear cells for 5 min at 37 °C.
9: rLktA after incubation with mononuclear cells for 10 min at 37 °C
10: rLktA after incubation with mononuclear cells for 60 min at 37 °C
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Fig. 43.
Measurement by ELISA of unbound LktA in binding assays with bovine 
neutrophils.
The unbound rLktA with bovine neutrophils in binding assay also was 
measured by ELISA. The neutrophils were incubated with rLktA for 3, 5 and 
10 min at 4 °C or at 37 °C and then supernate was separated and used for 
ELISA. The binding of rLktA at 37 °C was quicker than at 4 °C.
1: control rLktA (no neutrophils).
2: rLktA was incubated with neutrophils for 3 min at 37 °C.
3: rLktA was incubated with neutrophils for 5 min at 37 °C.
4: rLktA was incubated with neutrophils for 10 min at 37 °C.
5: control rLktA (no neutrophils).
6 : rLktA was incubated with neutrophils for 3 min at 4 °C.
7: rLktA was incubated with neutrophils for 5 min at 4 °C.
8 : rLktA was incubated with neutrophils for 10 min at 4 °C.
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incubated at 37 °C for 1 h. The cells were then lysed, washed and the 
membrane proteins were resolved by SDS-PAGE and immunoblotted after 
transfer to nitrocellulose. Polyclonal antibody raised against rLktA was used 
to detect bound toxin. The cocktail of protease inhibitors did not appear to 
inhibit the toxin degradation.
3.14 CAMP test
The haemolytic activity of some RTX toxins has been reported to be 
enhanced in the presence of Staphylococcus aureus p-toxin (Jansen et al.y 
1995). In this investigation, the haemolytic and non-haemolytic strains of P. 
haemolytica were compared in the CAMP test.
All strains of P. haemolytica used in this study were grown on BHIA 
containing 5% sheep blood for 24-48 h at 37 °C in air plus 10 % CO2 and 
tested against a p-toxin-producing Staphylococcus aureus . A group B 
Streptococcus was used as positive control (fig. 44).
Analysis of all P. haemolytica serotype reference strains revealed that 
all serotypes produce a co-haemolytic CAMP effect although with unequal 
intensity. Fig. 44 shows the results with 7 strains of P. haemolytica (5 
biotype A, 1 biotype T, 1 untypable strain) and 1 strain of Streptococcus 
tested against Staphylococcus aureus. The biggest co-haemolytic zone was 
found with strain UT3 (untypable, No. 6 ). No obvious differences were found 
between the two biotypes or the various serotypes. Only one strain of A1 
(Ph6 ) did not produce a co-haemolytic CAMP effect (No. 7).
3.15 Measurement of chemotaxis
The micropore filter assay is a simple way of observing the reactions of 
neutrophils to chemotactic factors in vitro. It is essentially a two chamber
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Fig. 44.
T he synergistic haem olytic effect of P. haemolytica and Staphylococcus 
aureus (CAM P test)
Five strains of P. haemolytica were grown on BHIA containing 5% sheep 
blood for 24 h at 37 °C in air plus 10 % CO2 and tested for haemolysis against 
a P-toxin-producing Staphylococcus aureus. A group B Streptococcus was 
used as CAMP positive control. Analysis of all P. haemolytica serotype 
reference strains revealed that all serotypes (except Ph6 ) produce a co- 
haemolytic CAMP effect, although with unequal intensity.
1: Staphylococcus aureus.
2: group B Streptococcus
3: P. haemolytica Ph2
4: P. haemolytica Ph42
5: P. haemolytica Ph58
6 : P. haemolytica UT3
7: P. haemolytica Ph6
8 : P. haemolytica Ph70
9: P. haemolytica Ph60
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apparatus in which neutrophils are placed in the upper chamber and 
separated by a 5 pm filter from the chemotactic factor in the lower chamber. 
In order to investigate the effect of LktA on the chemotactic response of 
neutrophils two assays were set up: the neutrophils, with or without toxin, 
were placed in the upper chamber and OZ as the chemotactic factor was 
placed in the lower chamber or neutrophils alone were placed in the upper 
chamber and different concentrations of LktA or purified LPS were placed in 
the lower chamber to see if either had any chemotactic activity. The chamber 
was then incubated for 45 min at 37 °C in 10 % CO2 and the filter was then 
fixed and stained. The migrated cells on the underside of the filter were 
counted. As table 7 shows, culture supernate, rLktA (active and non-activate) 
and purified LPS had chemotactic activity to different extents. The highest 
chemotactic activity was found with culture supernate of Ph2. There was no 
significant difference in chemotactic activity between active or non-activated 
rLktA. LPS of 40 |ig/ml had chemotactic activity although this activity was 
abolished with high concentrations of LPS (4 mg/ml) (table 7).
3.16 EFFECT OF LKT ON LEUKOCYTE MORPHOLOGY AND 
MOVEMENT
3.16.1 Effect of LktA on bovine leukocytes
The above CL-inhibition assays showed that leukotoxin binds to and 
affects the respiratory burst of both ruminant and human neutrophils. The 
effect of LktA on leukocyte morphology and movement was investigated in 
a cell tracking assay. Purified leukocytes (containing 85% neutrophils and 
15% monocytes and lymphocytes) were placed in a filming chamber along
i
with different concentrations of active or inactive rLktA and native 
leukotoxin. None of the LktA preparations had any significant effect on
Table 7.
Chemotactic response of bovine neutrophils to different preparations of 
LktA
Chemotactic response of bovine neutrophils to different preparation of LktA 
from culture supemates of P. haemolytica (29 pi), rLktA from E. coli (29 p i of 
1 in 5000 diluti-on) and LPS (40 pg/ml).
Chemotactic response of bovine neutrophils 
(Average number of migrated cells per field)*
Negative control 19.5
positive control (OZ) 89
Ph2 202.4
Ph26 82.6
Ph42 50.6
Ph48 32.5
Ph54 37
Ph58 2 0 2
Ph60 51.6
Ph250 56
LPS (40 pg/ml) 105
Active rLktA 2 0 0
non-active rLktA 180
*mean of three separate experiments
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movement of the bovine neutrophils. The effect of LktA on bovine 
neutrophil morphology is shown in fig. 45a, b, c, d and e. Fig. 45b shows the 
target cells mixed with active rLktA for 10 sec at 37 °C, before any effect was 
noticed. After 2 min the toxin had caused cell swelling and some of cells were 
lysed (fig. 45c). After 5 min, more than 50% of the cells were lysed (fig. 45d). 
All the cells were killed by active rLktA in less than 15 min by the process of 
cell swelling and lysis (fig. 45e). However during this time inactive rLktA at 
the same protein concentration had no effect on bovine leukocytes (fig. 45a) 
and these were identical to untreated controls. Native LktA had a similar 
effect to that of active rLktA (not shown). The rLktA also killed monocytes 
and neutrophils but it had no effect on lymphocytes as these are the only 
cells surviving after 15 min (fig. 45e).
3.16.2 Effect of LktA on human leukocytes
Human leukocytes were separated as above and then treated with 
active or inactive rLktA. The leukotoxin did not kill the cells. However, the 
toxin caused the migration of these cells (fig. 46). The speed of the 
neutrophils was observed by displacement of randomly moving objects 
determined by the least squares approximation in a measured time interval 
which gives an apparent speed that approaches the true speed as the 
measuring interval decreases. It was reported that the use of 5 second time 
intervals gave considerably higher cell speeds than did a 10  second intervals 
(Chettibi et al., 1994). With active rLktA, the human neutrophils appeared to 
move with high speed, and with persistence and a high diffusion coefficient. 
This contrasted with non-active rLktA where speed was 1/2 that with the 
active toxin and there was no persistence or diffusion coefficient. This 
indicates that with active toxin, cells appear to move in the same direction for 
sometime before changing direction. This may be due to a lack of adhesion to
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Fig. 45.
Effect of LktA on bovine leukocyte morphology and movement.
To show the effect o f LktA on bovine leukocytes, the leukocytes were 
separated from RBCs with Percoll and most of monocytes and lymphocytes 
were removed with Histopaque. The purity of neutrophils was 85 % and most 
o f the remaining cells were lymphocytes. The cells were treated with 1 pg/ml 
final concentration of active rLktA from E. coli SY327A, pir (pGW42) or the 
inactive form of rLktA from E. coli SY327A, pir (pGW64) in a filming chamber 
at 37 °C.
a: neutrophils incubated with inactive rLktA after 20 min
b: neutrophils incubated with active rLktA after 10 sec
c: neutrophils incubated with active rLktA after 2 min
d: neutrophils incubated with active rLktA after 5 min
e: neutrophils incubated with active rLktA after 15 min
RESULTS 145 P ARI  3
RESULTS
c
146 PART 3
I
R E SU L T S 147 PART 3
R E SU L T S 148 P A R T  3
the substrate (albumin-coated) with active rLktA. With non-active rLktA, 
cells are moving and adhering and therefore were not able to displace from 
their original position (table 8).
3.17 LKT ACTIVATION IN VITRO
The inactive toxin was activated in vitro by addition of LktC and 
cytosolic activating factor (CAF), an E. coli cell extract. LktA was prepared 
from E. coli strain SY327X pir containing pGW64 (encoding IktA) and LktC 
was prepared from E. coli strain SY327A, pir containing pGW78 (encoding 
IktC). Activated LktA killed the bovine neutrophils and inhibited the CL 
response but did not kill the rabbit neutrophils. The LktC and CAF or LktA 
were used as controls and had no effect on CL inhibition assay (table 4). 
Recombinant LktC alone did not activate rLktA, but in the presence of CAF, 
the inactive rLktA was activated (table 9).
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Fig. 46.
Effect of LktA on human leukocyte morphology and movement
Human leukocytes were separated as in fig. 45 and then treated with 300 |il 
(5 |ig /m l) active or inactive rLktA. The migration o f cells and the speed of 
neutrophils was observed by displacement o f randomly m oving objects 
determined by the least squares approximation in a measured time interval. 
This gives an apparent speed that approaches the true speed as the measuring 
interval decreases. Drift (a component o f non-random locom otion) was 
calculated by determining the centre of cell density by carrying out a vectoral 
sum o f the X and Y displacements o f each cell centre to determine the 
average population displacement. Plots shown the mean accumulated  
displacem ent o f  neutrophils in response to active and inactive rLktA. 
Uncorrected data (•), drift-corrected data (□). Straight lines drawn thought the 
linear part o f the drift-corrected curved for active rLktA-treated cells and drift- 
corrected curve for inactive rLktA-treated cells gave persistence values o f 
38.51 seconds and -48 seconds, respectively.
1: 300 jil o f active form of LktA
2: 300 pi o f inactive form of rLktA
1100SGC.
r 2 5 ^ / n i n .
180sec ,
D i f f ,  c o e f t  0.128jjw2/ s e c . . D i s t a n c e  6 . 3 8 jjm Sneed ? . 6pn / fdn
P e r s i s t e n c e  3 8 . 5 1 s e c ,  D r i f t  0 . 98i/« at  - 9 6 °  C e l l s  58-32
flrea 29 .5yf l2- 2 9 . 5 y f i 2 
Frames 38*5sec .
j
25|jn/rt in.
c d 5
280sec .
Diff, coeft 0 . 0 1 2 y n 2/ s e c ,  Distance 1 .47yf l  Speed 4.6jjfl^tun
Persistence - 4 8 . 0 0 s e c .  Drift 8 . 9 9 y n  at  - I 1 9 ° C e I i s  42-16
Brea 2 4 , 4 y n 2-17 .9j jn2 
Franes 4 2* 5sec .
Table. 8.
The diffusion coefficient, persistence and speed of locomotion of human 
neutrophils treated with active and inactive rLkt.
Human neutrophils were treated with 300 p i (5 Jig/ml) of active and inactive 
rLkt.
treatment diffusion coefficient persistence speed
(pm2/s) (s) (pm/min)
active rLkt 0.128 38.51 7.6
inactive rLkt 0 .0 1 2 -48.00 4.6
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Table 9. 
Activation in vitro
T he inactive toxin was activated by addition of LktC and CAF to LktA in 
vitro. LktA was prepared by growing the E. coli strain SY327A, pir containing 
plasmid pGW64 (encoding IktA) and the LktC was prepared by growing the 
E. coli strain SY327X pir containing plasmid pGW78 (encoding IktC). For 
activation of inactive toxin, 50 pi of inactive form of rLktA was added to 
mixture of 50 pi of LktC and 50 pi of CAF and incubated for 30 min at 4 °C. 
The mixture was then added to bovine, human and rabbit neutrophils and 
incubated for further 20 min at 38 °C. The cells were stimulated with OZ. The 
activity of LktA was measured by CL inhibition assay. Activated LktA killed 
the bovine neutrophils and inhibited CL but did not kill the human or 
rabbit neutrophils. The LktC and CAF or LktA were used as controls and had 
no effect on the CL inhibition assay.
Table 9.
Chemiluminescence assay of in vitro-activated recombinant leukotoxin and 
comparison with in vivo-activated toxin.
Activation reaction % Inhibition of CL response
Bovine neutrophils
1: rLktA+rLktC+CAF 78
2: rLktA+rLktC+Hepes 0
3: rLktA+Hepes 0
4: LktC+Hepes 0
5: CAF+Hepes 0
6: Active rLkt(m vivo, control) 100
7: Native Lkt (undiluted, control) 95
Rabbit neutrophils
1: rLktA+rLktC+CAF 25
2: rLktA+rLktC+Hepes 0
3: rLktA+Hepes 0
4: LktC+Hepes 0
5: CAF+Hepes 0
6: Active rLkt(m vivo, control) 0
7: Native Lkt (undiluted, control) 0
Human neutrophils*
1: rLktA+rLktC+CAF 100
2: rLktA+rLktC+Hepes 0
3: rLktA+Hepes 0
4: LktC+Hepes 0
5: CAF+Hepes 0
6: Active rLkt (in vivo, control) 50
7: Native Lkt (undiluted, control) 45
*Samples 1-5 were tested at a dilution of 1 in 200 whereas all other samples 
were tested at 1 in 1000.
4. DISCUSSION
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4.1 PASTEURELLA HAEM OLYTICA  ISOLATES
In the present study, representatives of all 16 recognised serotypes and 4 
bovine untypable strains were obtained from both pneumonic and healthy 
cattle, with the aim of detecting differences and similarities which could prove 
useful in characterisation of LktA and its role in disease. The initial part of the 
present study confirmed previous findings that all strains were correctly 
identified as P. haemolytica (Ali et al., 1992; Azad et al., 1992; Davies et al., 
1992). For some strains the serotypes were also confirmed by the indirect 
haemagglutination test.
Many commercial media, such as API 20 NE, are available for 
identification of E nterobacteriaceae  and are suitable for preliminary 
identification of P. haemolytica , but for confirmation of this bacterium 
additional tests are necessary. Production of haemolysis on blood agar and 
growth on MacConkey’s medium differentiated P. haemolytica from other 
pasteurellae and most related organisms. Actinobacillus species however, are 
haemolytic and grow on MacConkey’s medium but also produce urease. 
Indole production was found in the P. multocida  strain but not in P. 
haemolytica isolates (except Ph6 ). In identification of P. haemolytica by the 
API 20 NE system, most of the tests were negative. However, typical positive 
and consistent reactions of P. haemolytica were found in the reduction of 
nitrates to nitrites, production of B-galactosidase (majority of strains) and 
oxidase. The above results showed that the strains to be used in the present 
study were confirmed as P. haemolytica, except possibly Ph6 , which was 
atypical in other characteristics but was serotype A l (Ali et al., 1992) and 
possessed one plasmid in common with other P. haemolytica isolates (Azad et 
al., 1992).
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4.2  PR O D U C T IO N  O F N A T IV E  AND R E C O M B IN A N T  
LEUKOTOXIN (rLktA)
4.2.1 C ultural conditions affecting production of native leukotoxin
Thirty three P. haemolytica isolates, including different serotypes (1-16) 
and four untypables, were examined for LktA production in culture 
supemates. The production of LktA was optimised by growing the bacteria 
for different times in different media and under different condition of aeration, 
temperature, iron and pH.
Growth media. The production of some bacterial toxins is known to be 
regulated by the composition of the growth medium and in previous studies P. 
haemolytica has been grown in many different media to produce LktA: brain- 
heart infusion broth (BHIB) (Strathdee and Lo, 1989), dialysed BHIB 
(DBHIB) (Chang et al., 1987b); RPMI alone (Kaehler et al., 1980); RPMI 
containing 0.05, 0.1 and 0.5% bovine serum albumin (Confer and Durham, 
1992); RPMI containing 2.5% fetal calf serum (FCS), RPMI containing 700 
pg/m l FeSC>4, RPMI containing FCS and FeSC>4 (Gatewood et al., 1994); 
growth of the bacteria in BHIB for 4.5 h and then in RPMI 1640 containing 
7% FCS ( Shewen and Wilkie, 1982). The growth curves of bacteria in RPMI 
alone and with different concentrations of BSA were similar, but maximum 
LktA activity was found when bacteria were grown in RPMI containing 0.5% 
BSA (Confer and Durham, 1992). In different media, such as BHIB, RPMI, 
RPMI + FCA and RPMI + FCS + FeS0 4 , LktA activity was greatest in RPMI 
containing FCS and final optical density of the culture in this medium was 
greater than in the other media (Gatewood et al., 1994).
In the present study comparing BHIB and DBHIB, more toxin was 
produced in BHIB. Bacterial growth curves in the various media were similar. 
However, LktA activity in culture supernates varied between the various
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media tested. The yield of LktA was greatest after growth in RPMI + FCS 7% 
for 2  h, but this was not markedly greater than the yield obtained by growth 
in BHIB. In view of the technical complexity and expense of the RPMI 
method, BHIB was chosen for further studies. In addition, the presence of 
serum protein in RPMI + FCS caused problems in interpretation of gel profiles, 
caused cross-reactions in immunoblots and also affected CL responses of 
some species of neutrophils, which did not occur with BHIB as the growth 
medium.
4.2.1.1 Age of culture
The age of the culture was found to have a major influence on LktA 
yield from different strains. For example, the time of maximum production of 
LktA by isolate Ph2 was 6  h whereas for isolate Ph72 it was 8 h, although this 
represented the end of log phase in both cases. Thus, the amount of LktA 
activity in these culture supemate samples closely paralleled bacterial growth. 
There was good agreement between the amount of LktA antigen produced in 
the culture supemate as judged by SDS-PAGE and immunoblotting and the 
amount of LktA activity detected by the CL inhibition assay. These results 
indicate that production of LktA in BHIB was dependent on active growth of 
bacteria. As the culture aged, there was a marked decline in toxin activity and 
this might have been due to degradation of the toxin. The same result was 
reported by Baluyut et a l  (1981). In another report, the optimum time for 
maximal toxin production for one isolate of P. haemolytica A l was found to 
be in the logarithmic phase of bacterial growth, whereas culture supemates 
from stationary phase contained a minimal amount of active LktA (Chang et 
a l ., 1986b). Strathdee and Lo (1989) also reported that secretion of 
leukotoxin started in early log phase and continued throughout log phase and 
in stationary phase, secretion of toxin began to decrease (Strathdee and Lo,
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1989).
Bacterial genes respond to a number of environmental changes such as 
temperature shock, osmotic shock and anaerobiosis. Environmental stress 
induces changes in DNA supercoiling and thus provides a global 
communication network, coordinating the cell’s responses to different 
stresses. When cells are shifted from one condition to another such as 
changing from aerobic to anaerobic growth, the rate of synthesis of many 
proteins is altered. Osmolarity is involved in expression of the staphylococcal 
enterotoxin type C gene (Regassa and Betley, 1993) but not type A. In E. 
co li , low osmolarity caused a considerable enhancement of haemolysin 
production (Carmona et a l, 1993). In this study, the ability of P. haemolytica 
to response metabolically to changes in aeration, temperature, osmolarity and 
pH was tested.
4.2.1.2 Aeration conditions
Growth of the P. haemolytica Ph2 isolate under various conditions of 
aeration was monitored by spectrophotometry and LktA production and toxic 
activity was measured by immunoblotting and CL inhibition assays. The 
maximum yield of toxin and maximal growth was obtained with high and very 
high aeration. When LktA activity of these same samples was monitored by 
CL assay, similar results were obtained. The bacterium produced most LktA 
activity with very high and high aeration. There are no previous reports on 
the effect of aeration on toxin production from P. haemolytica , although 
Davies et al. (1992) showed differences in OMP and LPS profiles of P. 
haemolytica strains under the same conditions.
4.2.1.3 Temperature
The production of LktA at different temperatures was examined. P.
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haemolytica produced more toxin and grew optimally when grown at 37°C. 
At 41 °C production of LktA decreased and no LktA was detected at 20°C. In 
previous work, Strathdee and Lo (1989) used im m unoblotting with 
monoclonal antibody to show that secretion of LktA by a P. haemolytica A l 
strain was not different at 37 and 40 °C, but it was slightly decreased at 35 °C 
and not detected at 30 °C. These slightly different results could be due to 
strain differences or to the sensivity of the detection system used.
4.2.1.4 Stability of LktA
Temperature also has a profound effect on LktA activity. The toxicity of 
LktA was destroyed by boiling for 30 min or autoclaving for 15 min. The same 
result was reported by Sutherland and Redmond (1986). These workers also 
showed that heating the LktA at 60 °C for 30 min did not affect its 
cytotoxicity. In the present work, however, the toxicity in culture supemate 
samples decreased even at -70 °C after 20 days, and they lost more than half 
of their activity at room temperature for 7.5 h. These different results might be 
due to the use of a less sensitive method for measuring LktA activity by 
Sutherland and Redmond (1986). The results reported agree with a previous 
report by Chang et al. (1986b) who showed that the toxicity of LktA 
decreased by approximately 10-20% per hour at 37 °C and with prolonged 
incubation at 22 °C for 2 days and at 4 °C for 5 days, the activity of LktA was 
completely destroyed.
Iron. P. haemolytica requires iron for growth and production of LktA. 
According to Gentry et al. (1986) production of LktA required a higher 
concentration of iron than is needed for growth of P. haemolytica . It was 
shown that secretion of LktA in the presence of 50 jiM EDDA in BHIB was 
reduced whereas secretion of LktA was not affected at 25 (iM EDDA 
(Strathdee and Lo, 1989; Gentry et al., 1986)
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To show the effect of iron on production and secretion of LktA, P. 
haemolytica  Ph2 was grown in the presence of different concentrations of 
iron and 2-2'dipyridyl in BHIB. The production of LktA was not influenced 
by addition of either 1 mM iron or 200 mM 2,2'-dipyridyl to BHIB. Neither 
significantly affected growth of the organism nor the production of LktA. 
These results indicate that the amount of iron in BHIB was sufficient for 
growth of bacteria and production and secretion of LktA. This difference in 
results from those of Gentry et al. (1986) and Strathdee and Lo (1989) might 
be due to using different media or a different iron chelator or perhaps 2 - 
2'dipyridyl could not remove all the iron from BHIB. However, there was a 
significant alteration in the expression of three iron-regulated proteins when 
P. haem olytica  was grown in BHIB with 2,2’-dipyridyl at the same 
concentration (Davies et a l., 1992).
Osmolarity . Different concentrations of NaCl in BHIB were tested to 
determine the effect of osmolarity on growth and LktA production. P. 
haem olytica  produced LktA normally when grown in 0.1, 0.3 and 0.5 M 
NaCl. However, the bacteria did not produce LktA in the presence of 0.8, 1 or
1.2 M and the highest concentrations (>1.0 M) prevented growth of the 
organism. However, there was only slight retardation of growth of the bacteria 
in lower salt concentrations. There are no previous reports of effect of high 
salt on LktA production but such conditions have been reported to reduce 
HlyA production in E. coli (Carmona et al., 1993).
Different concentrations of glucose and sucrose were also investigated. 
Strain Ph2 produced similar amounts of LktA when it was grown in BHIB 
with different concentration of the sugars (0-1 M).
pH . Production of LktA at different pH values in BHIB was examined. P. 
haemolytica produced more toxin in alkaline (pH=8 ) medium than in acidic 
(pH=6 ) medium but the amount in the former was comparable to that
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produced in normal BHIB (pH 7.3). This result confirms previous results that 
secretion of LktA was reduced at low pH (<7) (Strathdee and Lo, 1989).
Antibiotics. In-vivo, the DNA of all prokaryotes is reported to be in the 
supercoiled state. The degree of supercoiling may have an effect on 
expression of certain genes and is maintained by a balance of the actions of 
DNA gyrase and DNA topoisomerase I. Supercoiling may be affected by 
environmental conditions and these in turn can thus alter gene expression 
(Dorman and Ni Bhriain, 1993). DNA gyrase is an essential enzyme in E. coli 
and is inhibited by antibiotics coumermycin A l and novobiocin. T o  
investigate any effect of these antibiotics on LktA production, P. haemolytica 
Ph2 was grown in BHIB in the presence of novobiocin and coumeromycin 
A l. The production of LktA was not altered by the presence of different 
concentration of these antibiotics at concentration which did not inhibit 
growth (<25 pg/ml for novobiocin and <20 Jig/ml for coumeromycin A l).
4.2.1.5 The effect of serial passage of P. haemolytica on production of 
LktA .
In the present study it was found that some strains of P. haemolytica 
produced only low amounts of active toxin in culture supemates. To show 
w hether toxin production or toxic activity decreased after repeated 
subculture of P. haemolytica, strains Ph2 and PhlO were passaged 40 times 
on BHIA, a process which took 3 months. Serial passage did not affect the 
LktA activity and quantity of LktA protein present in culture supernates of 
the organism during and after passage, as judged by the CL-inhibition assay 
and immunoblotting, respectively. These results indicate that P. haemolytica 
does not lose its ability to produce active LktA on subculture and freshly- 
isolated cultures of this organism are not necessary for assessing toxin 
production. Similar results have been reported by Gentry et al. (1987).
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A ggregation of LktA . In an attempt to purify the LktA from BHIB 
culture supernates, different Amicon ultrafiltration membranes were used. 
Although the mol. wt of leukotoxin is 105 kDa, as judged by SDS-PAGE, it 
did not pass through an Amicon ultrafiltration membrane with a cut-off of 300 
kDa. A similar result was reported by (Baluyut et al., 1981). The mol. wt of 
LktA was reported to be around 1,000,000 as judged by gel filtration 
chromatography with Sephacryl S400HR and when 3 mM guanidine was 
added, the apparent mol. wt of toxin decreased to 800 kDa (Clinkenbeard and 
Clinkenbeard, 1993). The LktA appears therefore to be combined with some 
other cell component or in an aggregated state. To try to reverse the 
aggregation, the effect of various agents were tested. Thus, LktA was treated 
with 2% SDS (to prevent hydrophobic interactions), 2% zwittergent 
(zwitterionic detergent), EGTA (1 mM to remove calcium) and 8 M urea 
(known to prohibit aggregation of B. pertussis CyaA and other RTX toxins). 
They had no effect on the aggregation of LktA as judged by the failure of the 
treated toxin to pass through a 300 kDa cut-off Amicon ultrafiltration 
membrane.
4.2.2 Production of recom binant LktA (rLktA) from  E. coli
4.2.2.1 Preparation  of urea extracts
To produce large amounts of leukotoxin, the lkt A  and IktC genes were 
transferred to E. coli. These two genes are responsible for production of 
active toxin and two other genes (IktB and IktD) are necessary for secretion of 
leukotoxin. In absence of IktC , bacteria produce a non-activated form of 
LktA. In the absence of B  and D  gene products, LktA accumulates inside the 
cells as inclusion bodies. In this study, IktA alone or with IktC, was transferred 
to different E. coli strains to produce rLktA. Various methods were used for 
lysing the cells to extract the rLktA from within. Method 1, involving sodium
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deoxycholate, was inconvenient because of the viscosity of this compound. 
Method 3, involving sonication, is suitable for small volumes of samples. A 
combination of method 2, involving lysozyme and glycerol, and method 3 
gave the best lysis of cells to allow recovery of toxin which was relatively 
uncontaminated with other cell products.
Monoclonal antibody was used for detection of rLktA and the mol. wt of 
both active or non-activated (rLktA) was 105 kDa as judged by 
immunoblotting. E. coli strains HMS174 or SY327X pir containing plasmid 
pGW42 (encoding active rLktA) produced protein of 105 kDa that reacted 
with the monoclonal antibody. However, with E. coli DH5aFIQ, a protein 
>120 kDa was produced in addition to the 105 kDa protein. Both forms were 
recognised by an LktA-specific monoclonal antibody. The higher molecular 
weight species is most likely to be a fusion protein of LktA (105 kDa) and 
LktC (19.8 kDa). Translation of IktC is terminated by a UAG (amber) stop 
codon. Suppression of UAG would produce a protein in which LktC is linked 
to LktA by a 6  amino acid sequence translated from the inter-cistronic region.
4.3 DEVELOPM ENT OF THE CL ASSAY
For evaluation of the effect of LktA on leukocytes, the CL inhibition 
assay was used. This assay has been reported to be 100 and 2000 times more 
sensitive than the Cr-release assay and the trypan blue dye exclusion (TBDE) 
assay, respectively (Chang and Renshaw, 1986). The CL assay is a measure of 
functional activation of phagocytic cells which can be inhibited by killing the 
cells. To confirm killing of leukocytes or to determine other functional 
changes induced by LktA, additional assays such as TBDE, cell tracking and 
chemotaxis assays were used in this study.
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4.3.1 Different preparations of target cells
Preliminary work was aimed at finding suitable preparations of target 
cells for LktA activity, for assay by CL-inhibition. The most important 
consideration for each technique was the purity and viability of the resulting 
cell preparation. Bovine whole blood, isolated lymphocytes, monocytes and 
neutrophils were used to measure the normal CL response. Small numbers of 
contaminating erythrocytes in the neutrophil preparation can cause significant 
light arrest and it is recommended that erythrocytes should be removed as far 
as possible (Easmon et al., 1980). Hypotonic lysis and isotonic ammonium 
chloride are often used for the lysis of the RBCs.
The hypotonic lysis method gave rise to several problems. It produced 
neutrophil suspensions with low viability and purity because of the difficulty 
in restoring isotonic conditions sufficiently quickly. A method which was 
more suitable for preparation of neutrophils for CL assay used Histopaque and 
subsequently ice-cold NH4CI medium. This resulted in a preparation 
containing >95% neutrophils and with >98% viability. However, neutrophils 
prepared in this way do not respond to interleukin 8 (IL-8 ) and are not 
suitable for cell tracking assays (S. Chettibi, personal communication). This 
may be due to the movement of NH4 across the plasma membrane. However, 
extracellular NH4CI has no effect on generation of superoxide and the CL 
response (Activation of NADPH oxidase p i30).
For cell tracking assays another method was used involving Percoll and 
Histopaque. The resulting cell suspensions contained >85% neutrophils with 
>98% viability. The problem with this method, in addition to the lower purity 
o f neutrophils, was contamination with RBCs which might effect the CL 
response. Another method, adding 5% w/v dextran to a final concentration of 
0.5% to whole human blood, was suitable for processing large volumes of 
blood but the neutrophils were contaminated with RBCs and this method was
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not suitable for bovine blood.
Neutrophils prepared with NH4CI gave a good CL response to 
appropriate stimuli. Purified bovine lymphocytes however, did not produce a 
CL response when incubated with any stimulus. This result agrees with that of 
Nelson et al. (1976) with human lymphocytes. However, since LktA was 
shown to bind to lymphocytes and these may therefore interfere with the CLI 
assay, it was thought necessary to remove them from neutrophil preparations. 
Bovine monocytes produced approximately l / 8 th of the CL response 
produced by the same number of bovine neutrophils when used as target 
cells. Nelson et al. (1976) had shown previously that human monocytes 
produced approx. one-third of the CL response produced by human 
neutrophils.
4.3.2 Factors affecting the CL assay
4.3.2.1 Chemiluminescence
Several factors may affect the CL response of neutrophils, including the 
presence of RBCs, phenol red and fetal calf serum (Easmon et al., 1980). The 
temperature also has an affect on CL response and at 20 0 C the peak of CL is 
less than at 37 °C. Human serum albumin (HSA) at concentrations between 
0.01 and 1% totally inhibited the CL response (Brihein et al., 1984). In the 
present study, these factors were avoided in the CL assay.
4.3.2.2 Effect of different chemiluminogenic probes on CL response.
The chemiluminescent signal is normally amplified by adding compounds 
such as luminol, DNDH or lucigenin to the assay mixture. Luminol (5-amino-2, 
3-dihydro-l, 4-phthalazinedione) is a synthetic compound which emits light 
when oxidized by either peroxides or oxygen radicals. It interacts with the 
oxidizing species to produce larger, more measurable amounts of light at a
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peak wavelength of approximately 425 nm (LKB Application note 100). 
Lucigenin is sometimes used as an alternative to luminol but needs the 
presence of divalent cations to function. Lucigenin has been used in the study 
o f a number of cell types including neutrophils, alveolar macrophage and 
Acanthamoeba castellanii (Dahlgren et al., 1985; Ward et al., 1990; Davies et 
a l 1991a). The results of Edwards (1987) showed that luminol-dependent 
chemiluminescence is dependent on oxidase activity as well as degranulation 
(myeloperoxidase activity) whereas lucigenin monitors oxidase activity 
independently of the extent of degranulation. DNDH is apparently more 
sensitive than luminol in enhancing the production of light during neutrophil 
responses.
In the present work, lucigenin and luminol were compared. The peak CL 
response with lucigenin was much less than with luminol. This could have 
been due to impermeability of neutrophils to lucigenin as it is a larger molecule 
(510 daltons) than luminol (177 daltons) and only measures extracellular 
events (Dahlgren et a l, 1985).
4.3.2.3 Effect of different stimuli
The chemiluminescence response of bovine neutrophils to different 
stimuli i.e. opsonised zymosan, PMA, fMLP, latex beads, and zymosan was 
measured. Different stimuli act on different cell surface receptors and via 
different signalling pathways. fMLP could not stimulate CL responses in 
bovine neutrophils. The lack of response of bovine and ovine neutrophils to 
fMLP has been reported previously and may be due to the absence of specific 
receptors on ruminant neutrophils (Carroll et al., 1982). Brihein et a l  (1984) 
showed that when human neutrophils were exposed to fMLP, the cell 
produced two peaks of CL, the first peak within 2 min and the second peak 
10 min after addition of stimulus. These 2 peaks were increased by increasing
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the luminol concentration. With addition of HSA, the first peak was reduced, 
but there was no effect on the second peak which indicates that the first peak 
is a result of an extracellular reaction whereas the second peak is a result of 
intracellular reaction. Human neutrophils were used as target cells for LktA in 
the present work but the response to fMLP was rapid and the first peak was 
sometimes missed. It was more convenient to use PMA as a stimulus with 
these cells as it gave only one, large peak.
The response of bovine neutrophils to latex beads was weak and PMA 
induced a transient and rapid response. Opsonised zymosan, however, 
induced a slow but high and persistent response. In the presence of calcium 
the response was faster and greater and so 1 mM calcium was added routinely 
to the CL assay. Non-opsonized zymosan stimulated a CL response in bovine 
neutrophils but it was lower than the response to opsonized zymosan. The 
temperature of the stimulus was found to have an effect on CL responses. 
Addition of ice-cold buffer or a change in temperature of the neutrophil 
suspension alone could stimulate a CL response and so such changes were 
avoided. Addition of OZ warmed to room temperature was found to be 
suitable for these experiments. Increasing the concentration of stimulus (i.e.. 
OZ, PMA) produced a greater CL response. In individual assays, different 
neutrophil preparations gave different levels of response and so the stimulus 
concentration was adjusted when necessary to give a reasonable peak 
response.
Using DNDH as chemilumiipgenic probe, OZ as stimulus and 1 mM 
calcium was found to be the best conditions in order for bovine and ovine 
neutrophils to give a CL response.
4.4 CL-INHIBITION ASSAY
The animal source of neutrophils e.g. ovine or bovine and day-to-day
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handling variables contributed to variations in susceptibility of neutrophils to 
the effect of LktA in each experiment. A similar functional variability of 
neutrophils from different cows has been reported (Maheswaran et al., 1993). 
However, the relationship between neutrophils and crude leukotoxin 
concentration was similar for each experiment and culture supemate of Ph2 
was used as internal control.
4.4.1 Assay of LktA in P. haemolytica isolates
The present study was designed to investigate whether different strains 
of P. haemolytica, used previously in our laboratory and which showed 
variation in LPS and OMP profiles (Ali et al., 1992; Ali, 1993), produced 
different amounts of LktA activity.
Loss of LktA activity in the ageing cultures was accompanied by the 
appearance of immunoreactive material of lower mol. wt than the usual 105 
kDa form, as reported by Chang et al. (1987b). Samples taken at the end of 
log phase, which always contained the greater amount of LktA activity, also 
lost activity on standing and on prolonged storage. For these reasons, it was 
important to standardise the time of harvest of culture supemates and to assay 
toxin activity promptly.
Of the 33 strains tested, most (24) were highly or moderately toxic. All 4 
of the biotype T (P. trehalosi) strains had low toxicity, as did one serotype 
A l, two A2 and one untypable strain. Strains representative of serotypes 1-12 
of P. haemolytica  have been shown previously to produce leukotoxin 
activity although some were reported to have only low toxicity (Shewen and
Wilkie, 1983; Chang et al., 1987a; Gentry et al., 1988; Gerbig et al., 1992).
CL
Some untypable strains did not appear to produce LktA but these h ^  been 
isolated from chickens rather than ruminants (Chang et a l,  1987a) and so their 
identity may be in doubt. The low toxicity of a T3 strain has been reported
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previously (Winfield and Lo, 1991). In the present panel of strains, 9 A l and 5 
A2 strains were tested and both of these serotypes contained high, moderate 
and low toxin producers. This inter-strain variation within the serotype 
groupings parallels the variation in outer-m em brane protein  and 
lipopolysaccharide profiles in a similar panel of P. haemolytica strains (Ali et 
al., 1992; Ali, 1993; McCluskey et al., 1994). Only one strain, Ph6 , produced 
no detectable toxic activity. This strain is serotype A l from a pneumonic calf 
but is atypical in other respects such as its biochemical, outer-membrane 
protein and lipopolysaccharide profiles (Ali, 1993) and plasmid profile (Azad 
et al., 1992).
A surprising finding in the present study was that there was no clear 
relationship between the amount of LktA protein in the culture supernate, as 
judged by immunoblotting and ELISA, and leukotoxic activity in the CL 
inhibition assay. For example, the culture supemates from strains P h i4 and 42 
contained the 105 kDa LktA protein in amounts comparable to that from 
strain Ph2 but had little leukotoxic activity. Such differences in toxicity of the 
LktA preparations could be due to intrinsic differences in the LktA proteins 
produced by the different strains or due to strain differences in other 
Pasteurella products such as the LktC activator protein or LPS. It has been 
suggested that LPS may have a role in the haemolytic activity of E. coli 
haemolysin (Welch, 1994) and mutations in LPS biosynthesis have been 
shown to be responsible for reduction in haemolysin activity (Stanley et al., 
1993). There is inter-strain variation in the LPS profiles of our P. haemolytica 
isolates (Ali et al., 1992) but there was no obvious correlation between LktA 
activity and LPS type. In addition, neither smooth nor rough LPS from P. 
haemolytica  alone caused any significant inhibition of the CL response of 
bovine neutrophils but a synergistic effect with LktA cannot be excluded.
The results of Breider et al (1990) showed that P. haemolytica produces
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a soluble factor, presumed to be lipopolysaccharide, that was directly toxic to 
bovine pulmonary endothelial cells in-vivo. These workers prevented 
enthothelial cell damage by removal of LPS from culture supernates with 
polymyxin B. However, in contrast, Maheswaran et al. (1993) with the same 
technique, reported that LktA, not LPS, was responsible for killing the 
endothelial cells and in the presence of neutrophils killing was increased.
High concentrations of LktA rapidly abolished CL responses and killed 
the bovine and ovine neutrophils. The same result has been reported by other 
researchers (Chang and Renshaw, 1986; Czuprynski and Noel, 1990). 
Czuprynski et al. (1991b) reported that a low concentration of LktA 
stimulated bovine neutrophils. This result, however, contrasted with their 
previous work that reported low concentrations of LktA did not have any 
direct activity on CL response (Czuprynski and Noel, 1990). The reason for 
this different result has not been found (C. Czuprynski, personal 
communication). In the present study, repeated attempts were made with 
different concentrations of LktA including recombinant LktA, but no 
stimulation of CL was obtained in any assay. Perhaps these discrepancies 
might be due to different preparations of LktA being used or to different 
degrees of purification of LktA, or an effect of other P. haem olytica  
components.
4.4.2 Recombinant LktA (rLktA)
The leukotoxin activity of non-active and active forms of rLktA was 
evaluated by CL inhibition assay. Recombinant LktA was produced in E. coli 
in large amounts as inclusion bodies and was then extracted with urea. The 
active form of rLktA prepared in this way was considerably more toxic in the 
CL assay than the native LktA from culture supernates in BHIB. A 1 in 5000 
dilution of the active rLktA had approximately the same CL-inhibition activity
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as the native LktA from strain Ph2.
Active rLktA inhibited the CL response of the bovine or ovine 
neutrophils to OZ at a concentration of 1 |ig protein/ml. However, the non­
activated form of rLktA (rLktA) or a preparation of rLktC used as controls, at 
the same protein concentration or higher (1-35 pg/ml), stimulated a CL 
response when mixed with neutrophils at time 0 i.e. before the addition of OZ. 
The subsequent CL responses to OZ were not affected by either inactive 
rLktA or rLktC and there was no CL inhibition. The reason for stimulation of 
bovine neutrophils by inactive rLktA was not due to leukotoxin because the 
same result was found with rLktC which did not contain any LktA. This 
stimulation must be due to some other component of E. coli but it was not due 
to urea present in urea extract. Although high concentrations of active rLktA 
inhibited the CL response, they also prohibited the effect of other components 
of E. coli from stimulating bovine neutrophils. Serial dilution of active rLktA 
did not cause any stimulation of the response of bovine neutrophils, 
presumably due to the dilution of these components. This supports the idea 
that the reported stimulation of neutrophils by LktA may have been due to 
another component in the preparation.
Active rLktA protein was obtained from E. coli containing either the 
IktA and IktC genes on one plasmid and under control of the same promoter or 
on 2 separate plasmids. The activity of rLktA produced by E. coli containing 
one plasmid was greater than that from E. coli containing two plasmids. The 
lower activity of the latter was possibly due to a gene dosage effect because 
of the need to maintain two separate plasmids instead of one in the cell.
4.4.3 Effect of LktA on different target cell types
Because of the inconvenience of requiring freshly-drawn ruminant blood 
for preparing neutrophils for CL assay, an attempt was made to find a more
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convenient target cell. Although LktA killed the bovine lymphoma cell line 
(BL3), as judged by trypan blue dye exclusion or release of lactate 
dehydrogenase as reported previously (Clinkenbeard et al., 1989a), these cells 
did not produce a respiratory burst in response to any stimulus tested and 
with various chemiluminogenic probes.
The effects of native and rLktA were investigated with non-ruminant 
cells, including human, rabbit and guinea pig neutrophils, and a mouse 
macrophage cell line (J774.2) in CL-inhibition assay. None of the LktA 
preparations had any effect, either inhibitory or stimulatory, on J774.2 cells, on 
rabbit or guinea pig neutrophils, even at 10 -fold high concentration than 
those used with bovine neutrophils. A similar lack of effect of LktA has been 
reported on leukocytes from pigs, horses (O’Brien and Duffus, 1987) and man 
(K aehler et al., 1980). Although previous reports have suggested that the 
leukotoxin is specific for ruminant leukocytes, in the present study native and 
rLktA caused an inhibition of human neutrophil CL responses. The effect on 
human and bovine neutrophils, however, was different in that complete CL- 
inhibition was not obtained, even at highest doses tested, and the human 
neutrophils were not killed, as judged by trypan blue dye exclusion and as 
seen in the cell tracking assay. An unexplained finding was that rLktA from E. 
coli strain D H 5aFIQ  did not have any effect on human neutrophils, even 
though it was highly active on bovine neutrophils. This may have been 
related to the fact that a fusion protein of LktC and LktA was produced by 
this strains in addition to normal LktA. Non-activated rLktA had no inhibitory 
or stimulatory effect on human neutrophils. Apart from the finding with rLktA 
produced by E. coli strain D H 5aFIQ , these results indicate that LktA, not 
other components of E. coli or P. haemolytica, has some effect on human 
neutrophils. This will be discussed further in the section of leukocyte 
morphology and movement.
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4.5 ANTI-LKT ANTIBODIES
A number of different antibodies were used in this study to characterize 
the LktA in terms of its mol. wt, amount and activity. These antibodies 
included bovine convalescent, rabbit polyclonal antisera raised in the present 
study, and monoclonals against various RTX toxins.
Previous work had shown that serum from adult cattle and serum from 
calves immunized with log-phase culture supernates of P. haemolytica  
completely neutralized LktA activity (Baluyut et al., 1981), whereas FCS and 
neonatal calf serum (before immunization) did not. Similar results had been 
found with convalescent serum after experimental challenge (Ali, 1993) or 
from healthy cattle vaccinated with P. haemolytica whole cells (Gentry et al., 
1988). These results were confirmed by the present investigation in which 
bovine convalescent serum neutralized the activity of LktA of all P. 
haem olytica  culture supernates tested. In addition, the rLktA and culture 
supernates of P. haemolytica A 1 (Ph2 and PhlO) had no effect on bovine 
neutrophils in the presence of a polyclonal antiserum raised against the 105 
kDa rLktA (active) purified by preparative SDS-PAGE. However, this 
antibody only partially inhibited the toxicity of culture supernates of other 
strains such as P. haemolytica NCTC 10634, and the culture supernate of 
Phl46  was not inhibited even with increased amounts of antibody. In the 
latter case, however, the CL response of bovine neutrophils to OZ was 
affected slightly by antiserum alone. The lack of neutralisation of LktA from 
P h i46 by this polyclonal antibody was paralleled by its lack of reactivity in 
ELISA. It has been reported that rabbit sera produced against formalin-killed 
whole P. haemolytica from serotypes 1-12 were capable of neutralizing the 
homologous toxins (Shewen and Wilkie, 1983). The reason for incomplete 
neutralization in some cases may have been due to the method of preparation 
of antisera because whole bacteria contain little toxin. However, they showed
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complete neutralization of homologous toxin with rabbit antisera raised 
against lyophilized toxin. In this case, all sera, except that against one strain, 
also neutralized heterologous toxin but less effectively than homologous 
toxin. Gentry et al. (1988) found that there was no cross-neutralization of 
LktA between their different strains of P. haemolytica. These results indicate 
that there are differences in structure in LktA proteins produced by different 
P. haemolytica isolates This is also supported by Burows et al. (1993) who 
describe seven LktA variants on the basis of southern blot analysis of 
chromosomal DNA restriction enzyme digests. Another possibility for failure in 
cross-neutralization in the present work is that the polyclonal sera were raised 
against denatured recombinant protein which would be structurally different 
from the native proteins.
Although RTX toxins share some regions of homology, there are some 
differences. RTX toxins possess a series of glycine-rich amino acid repeats 
within the toxin structure and it has been reported that the repeat region is 
necessary for haemolytic activity of HlyA (Ludwig et al., 1988; Boehm et al., 
1990b). The number of glycine-rich repeat units varies in different RTX toxins 
e.g. CyaA has 41 glycine-rich repeats, P. haemolytica LktA has 6  repeat units 
and HlyA has 11 repeat units. There is no information about the glycine-rich 
repeats in other isolates and whether this domain is the same in all 16 P. 
haemolytica serotypes and untypable strains
Although LktA was detected in im m unoblotting by polyclonal 
antibodies raised against the other RTX toxins such as CyaA, these 
polyclonals did not prohibit the effect of LktA on target cells. Different 
monoclonal antibodies, to Lkt, CyaA and Apx toxins, were used to detect 
native and rLktA and all cross-reacted with Lkt. However, none of them could 
completely neutralize the effect of LktA on target cells as judged by CL assay. 
Gerbig et al. (1992) reported that of six hybridoma monoclonal antibodies
D IS C U S S IO N 1 7 2 P A R T  4
raised against LktA from serotype A l, only one of them could neutralize 
leukotoxin produced by serotypes A l, A5, A6 , A7, A9 and A12 but this 
antibody did not neutralize LktA from A2 and the T biotype. The epitope 
recognized by this monoclonal antibody was localized between amino acids 
768-939. The same result was reported by Gentry and Srikumaran (1991) in 
that of five monoclonal antibodies raised against LktA from serotype A l, only 
two of them could neutralize the leukotoxin of P. haemolytica A l. In the 
present study the T biotype had low toxic activity but this was not 
neutralized by the monoclonal antibodies, possibly due to different domains 
being responsible for leukotoxin activity.
From 12 monoclonal antibodies produced against HlyA, only five of them 
neutralized haemolytic activity of HlyA to varying degrees. The epitopes for 
these neutralizing antibodies were found to reside within the following HlyA 
regions: two monoclonal antibodies recognized amino acids 2-160; one, amino 
acids 161-194; one, amino acids 518-598; one, amino acids 626-726 (Pellett et 
a l ., 1990). These results imply that a number of different domains are 
responsible for HlyA activity and, because of the functional similarity between 
the RTX toxins, this would be expected to occur in Lkt.
4.6 V A R IA TIO N  IN  AM OUN T AND M O L. W T O F L K T  
PRODUCED BY DIFFERENT STRAINS OF P. HAEMOLYTICA
Differences in mol. wt and toxicity of the leukotoxin from different 
serotypes have been reported previously, although in most studies only a 
single strain of each serotype was examined (Shewen and Wilkie, 1983; Lo, 
1988; Gerbig et al., 1992; Burrows et al., 1993). LktA produced by a serotype 
T3 strain was significantly less toxic for bovine leukocytes than LktA from 
serotype A l and had a slightly higher mol. wt (Winfield and Lo, 1991). 
Recently, Burrows et al. (1993) showed by SDS-PAGE and immunoblotting
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that reference strains of all 16 serotypes produced LktA proteins that were 
antigenically related and had similar, but not identical, mol. wt values. Other 
workers have demonstrated some antigenic differences in the LktA proteins 
from certain serotypes by antibody neutralisation tests (Shewen and Wilkie, 
1983; Gerbig et al., 1992) and genetic differences in the LktA determinants 
were revealed by Southern blotting with the serotype 1 determinant as a 
probe (Burrows et al., 1993). In this study, antigenic differences in the 
leukotoxin proteins could account for the apparent discrepancies between the 
amounts of some of the LktA antigens detected by immunoblotting and by 
ELISA. With preparations from strains P h i46 and P h i52, for example, bands 
were clearly visible in the immunoblots and yet little antigen was detected by 
ELISA. This may relate to the fact that the ELISA system used here depended 
on the interaction of two antibodies with the toxin, neither of which were 
homologous, although both antibodies gave similar results in immunoblotting.
In the present study, most strains produced LktA of 105 kDa but four 
strains, (Ph42, Ph44, 10634 and Phl52) produced a higher mol. wt(108 kDa) 
form. However, there was no obvious relationship between the LktAs with 
the higher mol. w tand their toxic activities or the characteristics of the 
producing strain (table 1). Thus, Ph42 is a bovine A2 isolate from pneumonic 
lung and its culture supemate had low toxicity; Ph44 is a bovine A2 strain but 
from the nasopharynx of a healthy animal and the sample had moderate 
toxicity; Ph54 is an ovine A7 isolate from a pneumonic lung and its culture 
supernate was highly toxic and a bold LktA band was evident in the 
immunoblot; P h i52 is an untypable bovine lung isolate and had low toxicity.
Although the mol. wt of P. haemolytica LktA is 105 kDa in SDS-PAGE 
and immunoblotting, additional fainter bands at approximately 95 and 97 kDa 
were sometimes seen in different preparations of LktA from different isolates. 
Similar results have been reported by other researchers (Chang et al., 1987b;
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Gentry and Srikumaran, 1991) and the bands are presumed to be breakdown 
products of the 105 kDa LktA.
4.7 SPECIFICITY OF THE CL ASSAY FOR LKT
In present study the specificity of the CL assay for LktA was shown in 
various ways:
a) culture supemate of P. multocida NCTC 10322, which presumably 
contained cell products common to all Pasteurella species, had no effect on 
the CL response.
b) In order to determine whether the toxicity of culture supemates of P. 
haemolytica  for target cells was due to, or affected by, any contaminating 
LPS, additional studies were done: P. haemolytica culture supemate or rLktA 
boiled for 30 min had no effect on the normal CL response. LPS is known to 
be heat-stable and would be expected to withstand this treatment.
c) In present study it was shown that P. haemolytica released LPS into 
the culture supemate. To investigate whether the LPS was responsible for CL 
inhibition in bovine neutrophils, the effect of purified LPS of P. haemolytica 
(rough and smooth) and LPS of E. coli (smooth) on bovine neutrophils was 
investigated . The result of this study found no evidence for linking the 
purified LPS from P. haem olytica  or E. coli with effects on bovine 
neutrophils. In other experiments, culture supemate of P. haemolytica were 
treated with polymyxin B to neutralize the activity of LPS. This failed to 
prevent killing of bovine neutrophils by LktA.
d) Detoxi-gel was also used to remove the LPS from P. haemolytica 
culture supemates. However, the toxicity of culture supemate was decreased, 
as judged by CL-inhibition assay, after detoxi-gel treatment. Further 
investigation showed that detoxi-gel removed LktA as well as LPS, as judged 
by immunoblotting.
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e) Further conclusive evidence for the specificity of the CL-inhibition 
assay for LktA was provided when urea extracts of E. coli containing rLktA 
were tested. Active recombinant toxin killed the bovine neutrophils. However, 
non-activated rLktA was completely inactive, as were urea extracts 
containing only LktC and urea extracts of the E. coli without recombinant 
plasmids.
f) The toxicity of culture supemates of P. haemolytica Ph2 and from E. 
coli were measured after incubation for 30 min with polyclonal antiserum 
raised against purified rLktA as judged by the CL-inhibition assay. The 
antiserum completely inhibited the effect of both preparations of LktA on the 
neutrophils.
4.8 HAEMOLYTIC ACTIVITIES OF DIFFERENT STRAINS
In the present work, culture supemates and rLktA had low haemolytic 
activity for bovine and ovine erythrocytes and different strains of P . 
haemolytica had different haemolytic activities. Low haemolytic activity of 
native and rLktA has been reported previously (Forestier and Welch, 1990; 
Burrows et al., 1993). However, some workers reported that leukotoxin was 
not haemolytic for bovine or ovine erythrocytes (Berggren et a l, 1981). Thus, 
the possibilities existed that leukotoxin activity and haemolytic activity of P. 
haemolytica  or rLktA may be different. Certainly, the cytocidal activity of 
LktA is greater and haemolytic activity is weak. The P. haemolytica isolate 
Ph6  which did not produce toxin in culture supemate was non-haemolytic, 
and the non-activated form of rLktA had neither haemolytic nor leukotoxic 
activity. The results of this study indicated therefore that LktA has leukotoxic 
activity as well as haemolytic activity, but different domains of LktA may be 
responsible for the two activities. These results support the previous 
suggestion of Forestier and Welch (1990) that haemolytic activity of culture
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supemate of P. haemolytica is due to LktA. A similar situation occurs with A. 
p leu ro n eu m o n ia e  toxins in that Apxl is both strongly cytotoxic and 
haemolytic whereas ApxIII is cytotoxic but not haemolytic. However, ApxII is 
a good cytotoxin but weakly haemolytic (Frey et al., 1993; Tu et al., 1994). 
Rogel et al. (1991) showed that the toxic and haemolytic functions of CyaA 
were separable and probably mediated by different domains on the molecule.
4.9 CALCIUM AND ACTIVITY OF LKT
Calcium has been shown to have an important role in the activity of RTX 
toxins but some conflicting results have been reported and there is little 
information on the role of calcium in LktA activity and cell binding. The 
calcium can bind to the HlyA and the binding site is the glycine-rich units 
(residues 739-849) (Boehm et al., 1990a). The conformation of CyaA is 
changed in the presence of calcium and this change is necessary for its 
insertion into the target cell membrane and for maximal intoxication of target 
cells, However, haemolytic activity of CyaA has been shown in the absence of 
Ca2+ and the presence of EGTA (Hewlett et al., 1991). The role of calcium for 
binding of HlyA to cell membranes was investigated. Ludwig et al. (1988) 
suggested that calcium was necessary for binding of HlyA to natural 
membranes. Rowe et al. (1994) reported that HlyA could bind to BL3 cells 
under calcium-deficient conditions that would not allow cytolysis and they 
suggested that calcium may not be necessary for HlyA to initiate an 
association with leukocyte membranes (Rowe et al., 1994). However, it was 
previously shown that haemolytic activity of HlyA produced by E. coli 
grown in the absence of calcium was calcium-dependent whereas that 
produced by E. coli grown in the presence of calcium was ca lc iu m - 
independent (Boehm et a l, 1990a). The same result was reported by van 
Leengoed and D ickerson (1992) in that toxin produced by A .
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pleuropneum oniae  in the absence of calcium required calcium both for 
binding to RBCs and haemolytic activity.
Calcium also binds to LktA and is required for leukotoxin activity at low 
concentrations of the toxin (Chang et a l ,  1987b). Cruz et a l  (1 9 9 0 ) 
suggested that lysis of neutrophils was dependent upon the presence of 
calcium whereas Clinkenbeard et a l  (1989a) found that LktA could bind to 
BL-3 cells in the presence of EGTA. Platelet lysis by P. haemolytica  A l  
culture supemate was found to be Ca2+ dependent and that adding increasing 
amounts of calcium to calcium-free medium increased the toxin activity 
whereas addition of EGTA to the m edia decreased toxin activity 
(Clinkenbeard and Upton, 1991). The release of LDH by LktA from BL3 was 
blocked in the presence of EGTA but it had no effect on K+ release or cell 
swelling (Clinkenbeard et a l, 1989a). rLktA had lytic activity for BL3 in the 
presence of 1 mM calcium, and was inhibited by preincubation with 5 mM 
EDTA (Cruz et a l, 1990).
In present study both P. haemolytica and E. coli, containing plasmid 
pGW42, produced LktA as judged by immunoblotting when they were grown 
in BHIB or 2YT in the presence of EGTA. These organisms also produced 
LktA when grown in LB medium containing EGTA and no added calcium. 
The LktA was active when bacteria were grown in BHIB or 2YT but no LktA 
activity was detected in LB medium. A similar result was reported by van 
Leengoed and Dickerson (1992) in that secretion of A. pleuropneumoniae 
toxin was independent of calcium but cytolytic activity and binding of this 
protein to RBCs and neutrophils was dependent on calcium being present 
either in the growth medium or the assay buffer. These results contrast with 
finding of Frey and Nicolet (1989) that secretion of 105 kDa haemolysin of A. 
pleuropneumoniae serotype 1 was calcium-dependent.
When the native or recombinant toxin, prepared in the absence of
D IS C U S S IO N 1 7 8 P A R T  4
calcium, was incubated with the bovine or ovine neutrophils in the presence 
of 1 mM calcium, the toxin became active. This different result with different 
media was presumably due to the availability of calcium in BHIB even when 
the EGTA was added. The sub-inhibitory concentration of EGTA, apparently 
did not remove all of the calcium.
4.10 BINDING OF NATIVE AND RECOMBINANT LKT TO 
TARGET CELLS.
In this study it was found that the active and non-activated form of 
rLktA were bound by ruminant cells, including RBCs, mononuclear cells and 
neutrophils. The same result was found with the non-ruminant cells, human 
and rabbit blood cells. With the leukocyte membrane preparations, a number 
of lower mol. wt bands were detected by the anti-rLktA antibody, indicating 
that LktA was degraded by leukocytes, presumably due to leukocyte 
pro teases. More degradation was found when LktA was incubated with 
human leukocytes than with bovine presumably because the latter are rapidly 
killed whereas the former are not killed and in fact are stimulated. In an 
attempt to inhibit the degradation of LktA by leukocytes, the toxin was 
incubated in the presence of a cocktail of protease inhibitors. The cocktail did 
not appear to inhibit toxin degradation.
Active extracellular and intracellular HlyA was reported to bind to RBCs 
(Oropeza-Wekerle et al., 1989) whereas the non-activated form of HlyA or 
HlyA in which amino acids 673-726 were deleted, did not bind, suggesting 
that in the absence of HlyC modification, HlyA does not bind to RBC (Rowe 
et al., 1994). In contrast, however, it was reported that non-activated CyaA 
could bind to Jurkat cells as effectively as the active form (Hewlett et al., 
1993). In this present study, the same result was found with LktA in that non- 
activated rLktA bound to erythrocytes as well as to leukocytes, as judged by
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immunoblotting.
Although some of the native LktAs have low haemolytic or leukotoxic 
activities (e.g. these from Ph72, Ph42), they still bound to the target cells (data 
not shown). In addition, the non-activated form of rLktA bound to RBCs, but 
it had no detectable haemolytic activity. These results indicate that 
modification of LktA by LktC was important in lysis of target cells but not for 
binding to target cells. Another possibility is that the binding domain is 
different from the domain for lysis of target cells.
The native LktA from P. haemolytica Ph2, and rLktA from E. coli when 
grown in BHIB or 2YT media, respectively, was examined for binding to the 
RBCs at different times and temperatures as well as in the presence of 1 M 
EGTA. When different temperatures were compared, more toxin was bound to 
the RBCs at 37 °C and haemolysis occurred. At 4 °C, however, binding but 
no haemolysis was obtained. A similar result was obtained with mononuclear 
cells as well as neutrophils. E. coli haemolysin can bind to erythrocytes both 
at 0 and 37 °C (Eberspacher et a l, 1989). Similar results have been reported 
with CyaA in that insertion of toxin into the cell membrane occurred over a 
wide temperature range (4 °-36 °C) but haemolysis did not occur at the lower 
temperature (Rogel and Hanski, 1992). These results indicated that the toxin 
first binds rapidly to the cell surface, with membrane insertion and pore 
formation following as a second slower step. Thus, the process of binding and 
pore formation by RTX toxins are two distinct processes that may be 
temporally-dissociated from each other.
In present study it was found that the LktA prepared in the absence of 
calcium in LB medium plus EGTA, did not bind to any target cells. Similar 
results were reported with A. pleuropneumoniae toxin by van Leengoed and 
Dickerson (1992). Thus the work reported here indicated that activation of 
LktA was not important for cell binding, but that association of Ca2+ with the
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toxin was necessary. The binding of Ca2+ presumably stabilises a domain in 
the toxin necessary for binding. Recently, Baumann et al. (1993) reported the 
3-dim ensional structure of another protein, alkaline protease from 
Pseudomonase aeruginosa, that contains glycine-rich repeat units. The region 
forms a P-barrel structure where successive P-tums are stabilised in a spiral 
by Ca2+ ions which bind to the glycine rich repeat units in adjacent stands. A 
structure such as this is presumably necessary for LktA interaction with target 
cell membranes.
4.11 EFFECT OF LKT ON LEUKOCYTE MORPHOLOGY AND 
MOVEMENT
The binding assays showed that leukotoxin binds to various target cells 
but different effects were found in the CLI assay with ruminant and non­
ruminant neutrophils. To confirm the results of CLI assay and binding, the 
effects of LktA on leukocyte morphology and movement were investigated in 
a cell tracking assay.
4.11.1 Effect of LktA on bovine leukocytes
None of the LktA preparations ( native and rLktA) had any significant 
effect on the movement of bovine neutrophils. The effect of toxin on bovine 
neutrophils was seen as cell swelling followed by lysis. In less than 15 min, 
most the cells were killed by active rLktA. However, during this time, non- 
activated rLktA, at the same protein concentration, had no effect on bovine 
leukocytes. Clinkenbeard et al. (1989b) had shown previously that native 
LktA killed BL3 cells by swelling and lysis as shown by measuring the release 
of LDH. In the present work, the rLktA also killed monocytes and neutrophils 
but it had no effect on lymphocytes and these were the only cells surviving 
after 15 min. This result indicates that only lymphocytes are resistant to killing
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by LktA. No such effect has been reported previously although LktA is 
known to prevent lymphocyte proliferation (Majury and Shewen, 1991).
4.11.2 Effect of LktA on human leukocytes
Human leukocytes were treated with active or non-activated rLktA. The 
surprising finding of the present work was that, although leukotoxin bound to 
human neutrophils, it did not kill the cells. In fact, the toxin stimulated the 
migration of these cells. A similar stimulation of movement of neutrophils has 
been found with fMLP (S. Chettibi, personal communication). With active 
rLktA, neutrophils appear to move with high speed, and with persistence and 
a high diffusion coefficient. However, in contrast, with non-activated rLktA, 
the speed was half that seen with the active form and there was no persistence 
or diffusion coefficient. This indicates that with active toxin, the cells appear 
to move in the same direction for sometime before changing direction. This 
migration could be due to both decreased adhesion to the substrate (an 
albumin-coated covering) and to increased motility. With non-activated 
rLktA, the cells were adhering and therefore were not able to displace from 
the original position.
Inflammatory reactions can be suppressed by glucocorticoids by 
inhibiting neutrophils accumulation at sites of inflammation (Chettibi et al.,
1993). The effect of LktA on migration of human neutrophils might be worth 
further investigation, as a potential way of intervening in the inflammatory 
response, because it might induce non-specific movement of neutrophils 
w ithin the host and prevent the accumulation solely at the site of 
inflammation. These results with cell movement, where active LktA stimulated 
movement but did not kill the cells, contrasted with the apparent ability of the 
toxin to partially inhibit the CL response in human neutrophils. This 
observation requires more investigation because it suggests that the various
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effect of LktA can be dissociated.
4.12 CHEMOTAXIS
In the present study, the chemotactic responses of bovine neutrophils 
were evaluated by incubation with culture supemates of different isolates of 
P. haemolytica, purified LPS and active and non-activated rLktA. Bovine 
neutrophils responded chemotactically to all P. haem olytica  culture 
supemates but to different extent. There was no direct relationship between 
CLI activities of culture supemates and chemotactic activity i.e. Ph54 was 
very toxic but had low chemotactic activity. Similar responses were found to 
purified LPS of P. haemolytica Ph2 as well as active and non-activated rLktA. 
Others have reported that bovine neutrophils respond chemotactically to 
culture supemates of P. haemolytica A l and A l l  (Mdurvwa and Brunner,
1994). These results indicate that the chemotactic response of bovine 
neutrophils might be due not only to LktA but also to other components of 
the bacteria such as LPS.
4.13 IN-VITRO ACTIVATION OF RLKT
The first activation in-vitro of an RTX toxin was reported for E. coli 
HlyA (Issartel et al., 1991). The process involves fatty acylation and the fatty 
acid was found to be amide-linked (Stanley et al., 1994). The acylation site on 
HlyA has been shown to lie between the pore-forming domain and the 
calcium-binding RTX motif.
In the present studies in-vitro, non-activated rLktA from a urea extract of 
E. coli containing plasmid pGW64 was activated by mixing with an LktC 
preparation from E. coli and a cytosolic activating factor (CAF), also an E. 
coli cell extract. The activity of LktC was absolutely required for LktA 
activation but its exact function is unknown.
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LktA activated in this way killed bovine neutrophils and inhibited the
someCL response but it had effect on rabbit neutrophils. The LktC and CAF or 
non-activated LktA were used as controls and did not have any effect on the 
CL inhibition assay. Recombinant LktC alone cannot activate rLktA, but in 
the presence of CAF, the non-activated rLktA became active. In the present 
work the problem with in-vitro activation was the quick loss of activity of the 
activated toxin which after 1 h at 4 °C had lost half of its activity. This might 
have been due to aggregation of the toxin but further investigation is 
necessary.
Various acyl groups can activate prohaemolysin but there is no 
information about which fatty acids are better able to activate LktA. It has 
been reported that myristoylation succeeded in better activation of CyaA than 
palmitoylation when proCyaA was activated chemically in vitro (Heveker et 
a l,  1994). It was shown that undirected transfer of fatty acid to the CyaA 
protoxin was able to confer both haemolytic and toxic activities to CyaA. As 
in the wild-type toxin, calcium was required for activity of the chemically- 
modified (Heveker et a l, 1994).
In this present study, lower LktA activity was found with in-vitro- 
activated toxin than with m-v/vo-activated rLktA. Similar result have been 
reported with CyaA modified in-vitro and in-vivo (Heveker et al., 1994). This 
suggests that in-vitro  fatty acylation of the protoxin may involve random 
modification of residues present in the toxin in contrast to the in -v ivo  
modification of specific sites. However, in vitro activation deserves further 
study because it will enable the protoxin to be activated with specific fatty 
acyl groups. The effect that specific acylation has an biological activity of the 
toxin can then be tested.
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Appendix 1.
API 20 NE tests, substrates and reactions.
Test Test code Test substrate Reactions involved
1 N 03 potassium nitrate reduction of nitrates to nitrites
2 TRP tryptophan indole production
3 GLU glucose acidification
4 ADH arginine arginine dihydrolase
5 URE urea urease
6 ESC aesculin hyrolysis (p-glucosidase)
7 GEL gelatin hydrolysis (protease)
8 PNPG p-nitrophenyl-p-D P-glactosidase
-glactopyranoside
9 GLU glucose assimilation
10 ARA arabinose assimilation
11 MNE mannose assimilation
12 MAN mannitol assimilation
13 NAG N-acety 1-glucosamine assimilation
14 MAL maltose assimilation
15 GNT gluconate assimilation
16 CAP caprate assimilation
17 ADI adipate assimilation
18 MLT malate assimilation
19 CTT citrate assimilation
20 PAC pheny 1-acetate assimilation
21 OXI tetramethyl-p- cytochrome oxidase
phenylene diamine
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Appendix 3.
SODIUM  DOOECYL SULPH ATE-PO LYACRYLAM IDE GEL 
ELECTROPHORESIS (SDS-PAGE).
(A) Chemical and reagents.
a. Acrylamide/bisacrylamide
Aciylamide 29.2 g
N,N-methylene bis acrylamide 0.8 g
Dist water 100 ml
b. Lower gel buffer (1.5 M Tris-HCl pH 8.8)
Tris 18.1 g
SDS 0.4 g
Dist. water 100 ml
The pH was adjusted to 8.8 with 1 N HC1 and the final volume made up to 
100 ml with dist. water and the buffer passed through Whatman No.l 
and stored at 4 °C.
c. Upper gel buffer (0.5 M Tris-HCl pH 6.8)
Tris 6.0 g
The pH was adjusted to 6.8 with 1 N HC1 and the final volume made up to 
100 ml with dist. water and the buffer passed through Whatman N o.l 
and stored at 4 °C.
SDS
Dist. water
0.4 g 
100 ml
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d. TEMED
e. Ammonium persulphate solution (APS)
A 10% solution (100 mg/1 ml dist. water) was made up fresh befor use.
f. Solubilising buffer 
Glycerol
2-mercaptoethanol 
SDS
Bromophenol blue 
Upper buffer (pH 6.8) (c)
g. Running buffer (8.3)
Tris 3.03 g
Glycine 14.4 g
SDS 1.0 g
Dist. water 1000 ml
h. Staining solution
Coomassie Blue R 250 1.525 g
50% (v/v) methanol 454 ml
Glacial acetic acid 46 ml
i. Destaining Solution
Methanol 50 ml
Glacial acetic acid 75 ml
Dist. water 875 ml
10 ml 
5 ml 
4 g
0.01 g
as 1 in 4 dilution to 100 ml
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(B) Slab gel preparations
a. Lower (separating) gel
Percent acrvlamide
7.5% 10% 12%
Acrylamide/Bis (30%) 5 10 15 ml
Lower gel buffer (pH 8.8) 10 10 10 ml
Dis. water 25 20 15 ml
APS (10%) 200 200 200 Pi
TEMED 20 20 20 Pi
b. U pper (stacking) gel
4% acrvlam ide
Acrylamide/Bis (30%) 
Upper gel buffer (pH 6.8) 
Dis. water 
APS (10%)
TEMED
2.6 ml 
5 ml 
9 ml 
30 |il 
20 |il
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Appendix 4. Buffers and reagents
A. Phosphate-buffered saline (PBS pH 7.38)
0.2 M KH 2PO4 (Solution A)
KH2PO4 (2.7 g) was dissolved in 100 ml of deionised water
0 .2  M Na2H P 0 4 (Solution B)
Na2HPC>4 (2.8  g) was dissolved in 100 ml of deionised water
NaCl 7.99 g
KC1 0.199 g
NaCl (7.99 g) and KC1 (0.199 g) were dissolved 930 ml deionised water 
(Solution C)
38 ml of solution B was added to solution C and pH was adjusted with 
solution A
B. Hanks Hepes
g/l__________ final concentration
Sodium cloride 8 140 mM
Potasium chloride 0.4 5 mM
Calcium chloride (6H20) 0.19 1 mM
Magnesium chloride (6H20) 0.2 1 mM
D-Glucose 1 5 mM
Hepes 2.3 10 mM
Adjust to pH 7.38 with 5 M NaOH.
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C. TEN buffer
Tris-HCl pH 8.0 50 mM
NaCl 150 mM
EDTA 100 mM
D. TC buffer
Tris-HCl pH 8.0 50 mM
CaC12 0.2 mM
E. TSB (Transform ation and storage buffer)
TSB is 2 x YT containing;
PEG 10%
DMSO 5%
MgCl2 10 mM
MgSC>4 10 mM
F. W estern blotting/Immunoblotting 
a. E lectroblotting buffer
Tris 3.03 g
Glycine 14.4 g
Methanol 20% (v/v) in dist. water 1000 ml
Blot developing substrate solution
3,3f-diaminobenzidine (DAB)* 0.05 g
Cobalt chloride 1% (w/v) in dist. water 2.00 ml
PBS pH 3.38 98.0 ml
Hydrogen peroxide 30% 0.10 ml
*DAB is a carcinogen, so handle with care.
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c. Ponceau-S solution
0.5 g
1.0 ml 
100 ml
G. ELISA BUFFERS AND SOLUTIONS
Ponceau-S 
Glacial acetic acid 
Dist. water
a. Coating buffer (0.05 M carbonate buffr pH 9.6)
Sodium carbonate 1.59 g
Sodium bicarbonate 2.93 g
Dist. water 1.00 1
b. Washing buffer
PBS 1.00 1
Tween-20 0.05 ml
c. Blocking buffer
PBS 100 ml
Tween-20 0.05 ml
Gelatine 0.50 g
d. Citrate-phosphate buffer
Solution A: 0.1 M citric acid 21.01 g
Solution B: 2 M Na2H P 04 28.31 g
To prepare a 0.15 M solution o f citrate-phosphate pH 5.0, 49 ml o f solution  
A  and 51 ml of solution B were added to gether just before use.
e. Substrate solution
OPD (O-phenylenediamine, Sigma)
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f. Developing solution
Citrate phosphate buffer (pH 5) 50 ml
OPD 17 mg
Hydrogen peroxide 10 pi
g. Reaction stopping solution
12.5% v/v sulphuric acid in dist. water
H. MEDIA
a. 2 x YT
Tryptone 16 g
Yeast extract 10 g
NaCl 5 g
Dist. water 1 1
Dissolved and autoclaved at 15 lb psi for 15 min.
b. 2 x YT agar
Tryptone 16 g
Yeast extract 10 g
NaCl 5 g
Agar technical 12 g
Dist. water 1 1
Dissolved and autoclaved at 15 lb psi for 15 min.
LB media
Tryptone (Oxoid) 10 g
Yeast extract 5 g
NaCl 10 g
h 2o 1 1
Dissolved and autoclaved at 15 lb psi for 15 min.
